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THE PREPARATION AND IMMUNOLOGICAL PROPERTIES OF 
DETOXIFIED BACTERIAL ENDOTOXINS 
INTRODUCTION 
The toxicity of available vaccines against Salmonella typhosa and 
other enterobacteriaceal infections is a problem, particularly under 
military conditions where the loss in personnel time due to immunization 
reactions may be significant. Attempts to provide protection against 
Salmonellae and Salmonella-like enteric diseases with polyvalent vaccines 
must also take into account the additive nature of the toxicities of the 
component organisms. Since the antigenic potential of a bacterial vaccine 
is influenced by its concentration of bacteria, a procedure that would 
minimize side reactions would be to reduce the amount of each component 
until the toxicity of the individual components was within tolerable limits. 
However, this procedure might result in using less than immunogenic 
concentrations of'vaccine. In recent years, the attempt to chemically 
detoxify these bacterial components (endotoxin) without destruction of 
antigenicity has been under investigation (See Part V, Literature Review). 
This thesis describes work carried out employing chemical detoxification 
procedures which appear promising. However, instead of applying these 
detoxification procedures to a Boivin or other purer form of'endotoxin, 
a Roschka-Edwards~crude endotoxin preparation (ethanol-acetone washed 
cells) of a mouse virulent strain of Salmonella typhimurium was employed 
as the starting material. Once these preparations were made, they were 
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first tested for capacity to induce fever and lethality in rabbits and 
mice, respectively. In addition, studies concerning the immunogenic 
potency of these preparations by the active mouse protection test were 
also determined by comparing these results with the parent Roschka-
Edwards preparation. The hypothesis proposed was that a nonpyrogenic, 
nontoxic product may still retain its immunogenicity, i.e., act as an 
"endotoxoid". The ultimate practical purpose of such work is to use 
this product as a less toxic enteric fever vaccine. 
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REVIEW OF LITERATURE 
I. A HISTORICAL REVIEW OF IMMUNIZATION AGAINST TYPHOID FEVER 
I!! THE ARMED FORCES 
It has been well recognized that the typhoid bacillus is one of the 
greatest potential enemies to the soldier in the field. During the 
nineteenth and twentieth centuries, nearly all the armies of the 
civilized world have been devastated by infection with typhoid feve~ but 
the dangers of specific epidemiC communication were not realized until 
after the discovery of the organism by Eberth in 1880. In spite of the 
great losses of troops in the field, most nations were hesitant to adopt 
methods of immunization control for their armed forces. However, to 
control typhoid in its military forces during the Russo-Japanese war, 
the Japanese Army is credited with the first attempt by employing specifi-
cally designed sanitary procedures (Jennings and Mathieson, 1940). It 
is of interest that some success was probably obtained by these procedures 
as the incidence of typhoid fever in the Japanese Army was one-fourth 
of that reported by the Russian Army. It should be noted, however,' 
that in sptteof the strict sanitary disciplines whioh were followed in 
most armies, typhoid fever still prevailed at an excessive rate until 
active immunization became widely praoticed. 
Although it is claimed by some that Pfeiffer and Kolle, who in 
1896 reported on experimental vaccination with killed typhoid bacilli 
in 13 individuals, were the first investigators to attempt vaocination 
4 
of man, the first significant attempt is usually credited to Wright 
(Wilson and Miles, 1964). In 1896, Wright (1896) mentioned, apparently 
as a mere incident concerning research on another project, the inoculation 
of two Indian Medical Service Officers with a killed broth culture of 
typhoid bacilli. Since subsequent challenge with living typhoid organisms 
into one of the volunteers did not produce infection, this author believed 
he had produced effective immunization against typhoid. The following 
year this same author (Wright, 1897) further reported on the blood 
changes in 17 individuals following typhoid vaccination with bacterial 
cultures by employing methods used successfully in the immunization 
against cholera. As a result of these data, this investigator apparently 
became convinced that the prevention of typhoid fever by vaccination was 
a definite possibility and suggested its use primarily in armies as well 
as in hospital personnel. 
During the Boer war the British Army was the first to practice 
active immunization on a large scale. The case mortality rate was reduced 
by approximately one-half while the incidence of typhoid fever among the 
immunized troops was decreased by a similar amount as compared to the 
case reports involving non-immunized troops (Jennings and Mathieson, 1940). 
Immunization against typhoid fever was also practiced in India 
on a large scale. Leishman (1910), in a summary covering the period 
1904-1909, reported a typhoid incidence of 5.39 per 1,000 in 10,378 
immunized individuals, whereas the typhoid incidence in 8,936 nonimmunized 
personnel was 30.4 per 1,000. In addition the mortality rates were 
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3.9 and 16.9%, respectively. In this same report Leishman described in 
detail the effects of vaccination with dead typhoid organism.s on a 
battalion of British soldiers. In this experiment four groups of 
approximately six men each were immunized. Each group was immunized by 
a different dosage schedule prior to their departure for India in 1904. 
In one of the earliest carefully controlled studies of immunization 
against typhoid fever, Leishman took blood specimens from each man for 
a period of four weeks. Sera were pooled within each group and tested 
for the presence of antibodies. He noted that the titers of antibody 
response were approximately proportional to the amount of vaccine injected. 
It was noted that the degree of reaction, though to a lesser extent, 
was also proportional to the amount of vaccination. On the basis of 
this study, it was found that 500 million and 1,000 million dead organisms 
for the first and second injections respectively was established as a 
compromise between the degree of reaction obtained and the amount of 
protection established. Following these first experiments, no cases 
of typhoid fever resulted even though the battalion was stationed for one 
year in India. Further studies on the antibody levels of these men were 
made. Within six months, it wa,s found that the antibody titers of 
these men had dropped to approximately normal levels. It is of interest 
to note that this immunized battalion was moved to an area of great 
exposure during its second and third years in India resulting in the 
same incidence of typhoid fever as was shown in the nonimmunized men. 
In spite of this early promise in the prevention of typhoid feve~ 
6 
the British authorities were reluctant to adopt the procedure of vaccination 
as mandatory for military personnel (Batson, 1949) However, an anti-
typhoid committee evaluating the evidence favoring immunization against 
tJ~hoid fever, reported in 1913 that of a total of 328 cases of typhoid 
which were observed in 19,314 troops, 272 cases in 8,936 nonimmunized 
troops while only 56 caSE~S were noted in 10,378 immunized individuals. 
Greenwood and Yule (1915) analyzed these data and found that the odds 
against this difference in the number attacked were greater than 10,000 
to 1 by chance distribution. 
Typhoid vaccination was initiated in the United states Army in 
1908 by Major F. F. Russell largely as a result of the experience the 
British were having in immunizing their troops in India and South Africa 
(Russell, 1913). The typhoid bacilli employed for the production of 
this vaccine was the Rawlings strain. This strain was originally isolated 
by the British from a fatal case of ty·phoid in 1900. Leishman (1910) 
selected this strain on the basis of criteria which included low toxicity 
for guinea pigs, active stimulation of agglutinins in rabbits, mildness 
of reactions elicited in man, and the ease of emulsification from solid 
media. This Rawlings strain was used for the production of the vaccine 
by the United States Army from 1908 to 1936 (Siler !1 al., 1941). 
Typhoid fever vaccination was first adopted on a voluntary basis 
in the United States Army in March, 1909. During this year, under the 
direction of Col. F. F. Russell, less than 1,000 individuals were 
immunized. By 1910, approximately 15% of the Army had been vaccinated 
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(Siler et al., 1941). In 1911, the first instance of compulsory 
vaccination in the United States Army was in a division (approximately 
20,000 men) of troops mobilized in Texas and elsewhere along the southern 
border (Russell, 1913). Compulsory immunization of the entire command, 
with the exception of a few individuals over 45 years of age, was actually 
accomplished after the troops arrived at their destination. These 
troops remained in the field for over 4 months, during which time only 
2 cases of typhoid fever were recorded with neither terminating in death. 
By September 30, 1911, immunization against typhoid fever was made 
compulsory for all army recruits excluding all army personnel over 45 
years of age. By the end of that year approximately 85% of all army 
personnel had been immuni.zed (Siler et al., 1941). It is interesting 
to note that Russell (1913) reported that in 1910 there were 198 cases 
of typhoid in all army personnel, whereas in 1911 there were 68 cases, 
and in 1912 there were only 27 cases out of 88,478 personnel with 19 
of these latter cases being nonimmunized individuals. Russell further 
noted that these figures were of greater significance than those 
reported by the British Army where vaccination was continued on a 
volunteer basis. He considered it logical to assume that volunteers 
are predominently of a hi.gher order of intelligence and, thus, more 
capable of practicing individual hygiene. 
The strength and composition of the typhoid fever vaccine used 
in the United States Army has been changed on several occasions (Siler 
et al., 1941). During the years between 1909 and 1916 only a monovalent 
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typhoid vaccine was employed, whereas in 1917, following an outbreak 
of paratyphoid fever in troops stationed along the Mexican border, 
the paratyphoid fractions were added. This triple vaccine, later termed 
TAB, was used by the Uo So Army continuously from 1917 through 1927. 
In 1928, the paratyphoid B fraction was eliminated while in 1934 inclu-
sion of the paratyphoid A fraction was discontinued. However, in 
September, 1940, both paratyphoid fractions were readded to the vaccine 
in view of the anticipatE~d increase of troops in the field plus an 
increased likelihood of exposure of these troops to enteric organisms 
(Long, 1955). This vaccine contained 1, 000 million typhoid bacilli 
and 250 million each of the paratyphoid A and B strains in each cubic 
centimeter. As stated earlier in this section, use of the classic 
Rawlings strain adopted by the United States Army for vaccine production 
in 1908 was terminated in 1936. At that time, investigations made by 
the Army Medical School (Siler et al., 1941; Longfellow and LUippold, 
1943) had shown that the immunogenic strains of the typhoid bacillus 
were highly virulent and it was concluded that these strains should be 
employed for vaccine production. As assayed by mouse protection tests, 
the Rawlings strain was found to be inferior, and substituted in its 
place was the highly virulent Panama carrier strain 58. The para A 
strain employed was Salmonella paratyphi but this was replaced in 1942 
by the English strain HA-6. The para B organism employed was 
Salmonella schottmuellerl (Long, 1955). 
The criteria for the selection of these strains, their characteristics, 
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and the history of the vaccine will be discussed at length in another 
sectlon. However, it is notable that these strains represented the 
most immunogenic strains obtainable and were selected on the basis of 
their virulence, their biochemical properties and productivity of 
agglutinins and protective substances, and their production of cross-
immunity against other strains of homologous species. Throughout 
World War II these strains were employed in the manufacture of the TAB 
vaccine and are presently used today. Long (1955) reported that the 
effectiveness of this triple vaccine during World War II was indicated 
by the fact that the combined average annual rates for typhoid and 
paratyphoid fevers was approximately 0.05 per thousand, whereas the 
annual rates for the combined diseases during World War I was 0.42 
per thousand. Commenting on these results, this author stated: 
tiThe occurrence of typhoid and paratyphoid fevers does not bring forth 
evidence against the efficacy of vaccination for the prevention of these 
diseases nor does it gainsay the probability of a considerably improved 
typhoid vaccine. These observations do, however, emphasize again that 
the incidence of typhoid fever and the paratyphoid fever, as well as 
of the other enteric infections, tends to be in proportion to the 
opportunities for infection existing in the environment and that specific 
protection through vaccination does not eliminate the necessity for 
proper application of sanitary measures for the control of these 
infections." 
The active immunization against typhoid fever was made compulsory 
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for all personnel in the United States Navy in December, 1911 (Siler 
et al o , 1941)0 Results were shown to be essentially similar to those 
observed in the United States Army with admission rates per 1,000 as 
follows: 1911, 3.62; 1912, 0.92; and 1913, 0.35. Rates continued low 
in the Navy and in 1925 decreased to 0.03 per 1,000. In 1924, the Navy 
adopted the use of the monovalent (Rawlings strain) typhoid vaccine. 
However, the triple vaccine remained in use for the immunization of 
personnel stationed in either the Caribbean or Central American areas 
(Siler et al., 1941). 
Based on the assumption that they increased the toxicity of the 
vaccine, the paratyphoid A and B strains were omitted from the vaccine 
during the years 1911-1939 (Siler et al., 1941). In addition, para-
typhoid fever infections reported in all military personnel during this 
time were both mild and rare. To support these assumptions, there 
were 382 cases of paratyphoid fever in the Army: 257 due to para A, 
100 due to para B, and 25 unclassified. There were eleven deaths: 
6 associated with paratyphoid A and 5 with paratyphoid B. With one 
exception, all of these deaths occurred in France during World War I. 
Within the United States, 84% of the paratyphoid infections from 
1915 to 1939 were caused by paratyphoid A. 
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II. THE EFFECTIVENESS OF ACTIVE TYPHOID IMMUNIZATION 
OF MILITARY AND NON-MILITARY PERSONNEL 
A significant evaluation of the effectiveness of immunization 
against typhoid fever is obtained by studying the reported results of 
such trials in military personnel. One of the earliest reports on the 
results of typhoid fever vaccination in American troops was given by 
Russell (1910). This author stated that from the introduction of 
vaccination in 1909 until March, 1910, there were 135 cases of typhoid 
among approximately 75,000 men. Russell further reported that one of 
these cases developed typhoid immediately following administration of 
the second dose of vaccine. However, since a total of approximately 
1,400 men had been vaccinated during this time, it appeared reasonable 
to conclude that vaccination had provided real protection. In another 
report, Russell (1912) stated that there was a total of only 6 cases of 
typhoid among immunized military personnel in 1910 and 12 cases out of 
80,000 individuals which had been vaccinated in 1911. This investigator 
suggested that if the prevailing incidence of typhoid in the nonvaccinated 
military personnel had occurred, about 250 cases would have been expected 
in this group. 
Although the most extensive early trials of active immunization of 
military personnel were conducted in the British and American Armed 
Forces, military leaders in other countries followed these trials with 
interest and made some attempt to introduce the practice in their troops. 
However, in many instances, there is evidence that sufficient attention 
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was not given to the administrative phases of their vaccination procedures. 
Jude (1934) reported that prior to World War I the average morbidity 
of typhoid fever in the French Army was approximately 12 per 1,000 
mean strength. However, after the result of some bitter experiences 
in the early stages of World War I, stricter attention was paid to 
vaccination and the morbidity rate declined sharply, reaching 0.22 per 
1,000 by 1929. Similar results in the German Armed Forces were given by 
Thone (1938) who reported that the incidence of typhoid per 1,000 
dropped from 9.3 in 1915 to 1.4 in 1917. This author indicated that 
this reduction was due to a rigid program of prophylactic inoculation 
against typhoid. 
As a result of the high morbidity of typhoid encountered in the 
Italian Army during World War I, Castellani (1937) reported on the 
extra precautions taken to protect the troops prior to the Italian-
Ethiopian War. During the 6 month period of the war, there were about 
500,000 Italian troops committed in this campaign with a total of 458 
cases of typhoid and paratyphoid and 161 deaths. These troops had 
received "tetra vaccine" containing typhoid, paratyphoid A and B, and 
cholera organisms o Castellani concluded from these results that the 
precautions taken showed a definite improvement over the previous 
experience of the Italian Army during World War I. 
Malbin (1940) reported a water-borne epidemic of typhoid in a 
military hospital in Spain during the Spanish Civil War. In this hospital 
ninety JEr cmt of the 1,700 patients and 200 staff members had been 
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vaccinated within the preoeding 3 to 12 months. A total of 147 cases 
of typhoid fever were studied with the incidence among the nonimmunized 
being approximately 25% as compared with only 6~ in the immunized. The 
case fatality rates for the two groups were 10.~ and 4%, respectively. 
Further evidence of the efficacy of .typhoid vaccination can be 
obtained from a study of the occurrence of the disease among the Civilian 
Conservation Corpso Lull (1934) stated that out of an approximate 
450,000 men in the various camps during 1933 there were reported 54 
cases of typhoid, 11 cases of paratyphoid B, and 2 cases of paratyphoid 
Ao The incidence of typhoid was 0.32 per 1,000 per year, whereas, 
during the same period, the incidence in the regular Army was 0.04 per 
1,000. 
It is of interest that not all reports of the results of vaccination 
of military personnel against typhoid fever appear in favor of the practice. 
Nichols (1916) reported on 32 cases of typhoid in immunized military 
personnel during the period 1911-1915. Although this author did not state 
the total number exposed to comparable risk nor how many doses of vaccine 
were given to those who developed the infection, he did indicate that no 
toxic effect could be demonstrated in rabbits with vaccines over 8 months 
old. He concluded that vaccines over 1 month old were nearly inert 
and were responsible for the failure to protect against typhoid. 
An outbreak of typhoid in vaccinated personnel at an American 
rest camp in England during July, 1918, was reported by Hawn et al. (1919). 
These authors noted that the original infections probably occurred when 
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members of the group went swimming in a lake at Meridian, Tennessee 
prior to being transported to England. During the outbreak, 248 men 
were exposed with 98 developing typhoid either as a result of the 
original exposure or from prior contact with cases. All of these 98 
men had been immunized against typhoid fever. The number of doses 
each had received, with one exception, varied from 3 to 12. According 
to these authors, the resultant case fatality rate was high, (13.15~) 
and possibly may be explained by the lateness of admission to the hospital. 
Although United States Army personnel in World War I were well 
vaccinated against typhoid, Burrage (1932) reported that 1,065 cases of 
this enteric infection occurred Q He suggested that these cases were in 
individuals refractory to immunization or in those exposed to over-
whelming doses of the infectious agente Of the 76 vaccinated men observed 
by this author, 73 were in individuals who had their full course of 3 
inoculations, most of them within 1 year of their injection. This series 
also included 9 fatal cases e Burrage did point out, however, that there 
was only one case in every 3,756 men in World War I as compared with 1 
case in every 7 men during the Spanish-American Ware 
One of the most thoroughly investigated failures of vaccine to 
protect against typhoid was reported by Boyd (1943). This failure 
occurred among Axis prisoners of war captured by the British in Africa. 
Although the total number of prisoners observed was not given, this 
author noted that from January, 1941 through February, 1943, there 
were 305 cases of typhoid, 202 cases of paratyphoid A, and 65 cases 
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of paratyphoid B in these prisonerso These Axis troops supposedly had 
been immunized previously and during the first few days of their intern-
ment were re-immunized with a captured Italian four component vaccine. 
Despite this treatment a typhoid epidemic occurred among these prisoners. 
Subsequently, all prisoners were re-vaccinated with a British typhoid 
vaccine and no further epidemics occurred. Minimal laboratory tests 
comparing the protective potency of the British vaccine with that of 
the captured Italian vaccine indicated to this author that the British 
vaccine product was superior. It is interesting to note that Boyd 
contrasted the above experience with that observed among British prisoners 
of the Axis forces. Approximately 24,000 British troops had been captured 
and kept in Axis concentration camps where sanitary conditions were 
stated to have been deplorable o Enteric infections were common among 
the Axis personnel and, as evidence of the unsanitary conditions and 
undoubted exposure to infection, this author reported that approximately 
11~000 to 12,000 cases of dysentery occurred among the British prisoners. 
In spite of these conditions, however, there were essentially no cases 
of typhoid or paratyphoid o Boyd concluded that the difference in the 
occurrence of enteric infections in the two groups of prisoners was 
due to differing degrees of immunity resulting from use of a more potent 
vaccine preparation by the British. He emphasized that the strains of 
organisms used in the preparation of the British vaccine were rich in 
Vi antigeno 
Studies of enteric infections occurring among vaccinated American 
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military personnel stationed in Okinawa during World War II were reported 
by Syverton and his associates (1946). The outbreak occurred on Okinawa 
but was first noted among evacuated personnel on Guam. Infection probably 
resulted from eating raw vegetables including sugar cane which had been 
cut and allowed to lie on the ground fertilized with human excrement and, 
thus y heavily contaminated with enteric organisms. These authors noted 
that on Okinawa in the late spring and early summer of 1945 there were 
many cases of undiagnosed fever of unknown origin. Of the 24 cases of 
enteric fever reported, however, 21 were due to paratyphoid A and 3 
were due to typhoid. Complete data relative to vaccination were available 
on 20 of the patients with nineteen of these having received the full 
standard course of injections, and 15 having received one or more booster 
injections. The interval between the last injection of vaccine and the 
onset of infection ranged from 5 to 15 months. No deaths were reported 
in these patients, but complications developed in 5 cases. 
An additional account of instances of failure of vaccination to 
protect against enteric infections was reported by Jordan and Jones 
(1945)0 They reported that 44 cases of typhoid fever, part of an 
epidemic of 80 cases, were treated in a military hospital which resulted 
in 2 deaths o Despite the fact that all 44 of these patients had been 
up to date with their yearly "TAB" inoculations, all had at least 3 
and the majority had 4 or 5 prior inoculations, the course of the disease 
was severe and unmodified. From this epidemic, these authors concluded 
that when artifioially induced immunity to typhoid is overwhelmed, 
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protected men can suffer from the disease in the same way and quite as 
severely as though they had never been immunized e On the other hand, 
it was pointed out, inoculation may prevent the majority of those 
exposed to infection from contracting the diseas90 
Tribby et al u (1948) reported results gathered by the Second 
Medical Laboratory in French Morocco and Italy in which 19 men of the 
349th Infantry regiment were hospitalized with typhoid fever within 
2 to 14 months of their last dose of typhoid vaccine. These authors 
suggested that these soldiers were subjected to an overwhelming challenging 
dose of typhoid bacillio Also, they questioned the degree of protection 
afforded by the various typhoid vaccines, and whether or not they have 
as high a protective capacity as has been claimed on the basis of 
statistical evidence. 
Although it is generally believed that an attack of typhoid fever 
confers a considerable degree of immunity, recurrences occasionally take 
place 0 The second attaok rate has been reported to range from 1 to 4%, 
but second attack rates as high as 15% are on record (Gay, 1918). 
Recently, Marmion !i al o (1953) published an account of a second attack 
of typhoid fever in a British Royal Air Force unit in the Suez Canal 
Zone in 19500 Two large outbreaks, occurring in the same community 
within 5 months, produoed 11 examples of seoond attacks. The first 
outbreak was caused by phage~type J bacilli and the second by phage-
type E organisms, indicating that the second infections were new attacks 
of the disease rather than relapses of the original infection. Though 
18 
inconclusive, the evidence of these facts and figures suggested to these 
workers that an attack of typhoid fever does not confer more than a moderate 
degree of specific immunityc The possible relationship of hypo-gamma-
globulinemia under these circumstances remains to be evaluated. 
Understandably it is usually more difficult to evaluate the efficacy 
of active immunization in a civilian rather than in a military group. On 
the other hand, some well-controlled studies have been conducted with 
civilians concerning the effectiveness of immunization against typhoid. 
In addition, there have been occasions where recently discharged military 
personnel have been exposed with civilians to a common risk of infection. 
In these latter instances reliable estimates of the effectiveness of 
immunization are obtainable more readily from military personnel who 
usually are vaccinated under close supervision. However, evidence of 
protection against typhoid can be obtained from changes within the civilian 
population following an immunization program. 
The value of immunization against typhoid was demonstrated by 
studies conducted by the New York City Department of'Hea1th (1916). The 
typhoid death rate per 1,000 decreased from 0.12 in 1910 to 0.04 in 1916. 
Much of this decrease coincided with an active program of vaccination 
where individual records revealed that, of 3,023 immunized persons 
directly exposed to typhoid, only 4 cases occurred. However, of 4,420 
non-immunized individuals, who likewise were directly exposed to typhoid, 
108 subsequently contracted the disease. In each case there was an 
indication that exposure to infection antedated vaccination. 
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Halliday and Beck (1928) reported on the protection offered by 
vaccination from observations made during a prolonged epidemic of typhoid 
in Santa Ana, California in 1924. An epidemic of gastrointestinal disorders 
occurred following a period of heavy rainfall during the last 2 weeks 
in December, 192). It was estimated that 10,000 persons out of a 
population of 27,000 were attacked. During the period January to April, 
1924, there were 620 cases of typhoid with the following breakdown: 226 
occurred following pollution of the water supply in December, 14) followed 
a subsequent pollution in February, 200 cases resulted from contaminated 
Iulk, and 51 cases apparently resulted from contacts with other cases. 
Forty-eight of the cases terminated fatally. It is interesting to note 
that 9 cases occurred in persons who had had typhoid several years previously, 
and that only 5 cases occurred among the approximate 1,000 ex-servicemen 
in the city who had been vaccinated against typhoid in 1918. It appeared 
to these workers that vaccination had afforded a high degree of protection 
which was still effective after a period of 5 to 6 years. 
Further evidence that individuals previously immunized during 
military service have retained their resistance to infection for a long 
period of time is evident from the report of an outbreak of typhoid at 
Salem, Ohio in 1920 (Pryor, 1928). In this epidemic, 882 cases of typhoid 
occurred in a population of 10,)05. This author reported that in the age 
group of 20 to )0 years there were 210 ex-servicemen (World War I veterans) 
all of whom had received vaccination against typhoid approximately) 
years previously. The attack rate for these ex-servicemen was 1 in 70, 
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whereas in women of the same age group the attack rate was 1 in every 8. 
A limitation in evaluating the effectiveness of immunization in 
civilian populations is the difficulty of determining if the immunized 
and non-immunized groups have been equally exposed to comparable risks 
of infectiono By restricting observations to secondary typhoid cases 
in household contacts, Stebbins and Reed (1937) reported from a study 
conducted in New York State, 1930-1934, that the attack rate among the 
nonvaccinated to be approximately five times that of the vaccinated contacts. 
The effects of sanitation and group immunization on the incidence 
of typhoid was obtained by Williams and Bishop (1936) during an intensive 
typhoid control program conducted in Williamson County, Tennessee 
(population 22,84;). This program covered 13 years, ending in 193;, 
during which time a total of 21,1;7 persons received at least one full 
series of inoculations. As a result, these workers reported that there 
was a decrease in cases from an annual average of 62 for the period of 
1916-1921 to only 3 for the period of 1931-193;. In addition, the typhoid 
rates decreased significantly in specific areas only after a major portion 
of the population in that area had been immunized. In other words, while 
typhoid practically disappeared in an area in which 87% of the population 
was vaccinated, there was little decrease in another area in which only 
41% had been vaccinated until a specific program of sanitation was accom-
plished. 
The efficacy of immunization in an acute water-borne outbreak of 
typhoid in a consolidated school in Dade County, Georgia was reported 
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by Bowdoin and Petrie (1940)0 From direct sewage pollution, twenty-
seven cases of typhoid developed among a total of 323 pupils. Within 
the preceding 2 years, 151 of the pupils had been vaccinated and only 
4 of these contacted the disease. Thus, the attack rate, according 
to these authors, was five times greater in the non-immunized group 
than in the immunized group. 
Another comparison of the resistance to typhoid of immunized and 
non-immunized individuals was afforded in an aoubreak investigated by 
Duncan et alo (1946). These workers noted that infection resulted from 
drinking contaminated orange juice in a Cleveland residence hotel for 
women. Approximately 360 young women including 150 female military 
personnel resided in the hotel, among whom seventeen of the civilians, 
including one who had been vaccinated, contracted typhoid. However, as 
a result of immunization against typhoid, none of the female military 
personnel developed the disease. 
The suooess of vaccination against typhoid in other countries has 
been essentially comparable to that experienced in the United States. 
Hogg and Latham (1926) reported the incidence of enteric fever among 
inmates and staff members of mental hospitals in New South Wales, Australia, 
during the period 1900-19240 During this time, the number of individuals 
upon whom the report was based increased from 4,350 to approximately 
8,700 of which from 1900-1914, 241 cases of typhoid were recorded. 
However, vaccination was adopted in 1914 and during the period 1915-1924 
there occurred a total of 12 cases, 2 of which were in vaccinated 
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individuals. These authors stated that their feelings were mixed in 
having to record in 1914-1915 that the mentally disturbed of New South 
Wales were better protected against typhoid than were many of the 
Commonwealth's soldiers in Egypt and on the Peninsula. 
The failure of immunization to protect non-military groups is more 
difficult to evaluate than in military groups; that is, it is difficult 
or impossible to obtain accurate records of immunization in civilian 
personnel as well as to evaluate the typhoid vaccine or vaccines employed 
under these conditions. However, the literature does record a few isolated 
cases of failure to protect in typhoid vaccination of the civilian 
population. Seckinger (1933) reported that of 216 cases of typhoid in 
Georgia in 1931-1932, 21 (9.7%) of these cases were in persons immunized 
2 weeks to 12 months prior to the onset of symptoms. The mortality rate 
in these individuals was 23.8%. The percentage of the exposed population 
who had been vaccinated was not known, but it appeared, according to 
this author, that vaccination was markedly ineffective. It is interesting 
to note that the Rawlings strain of organisms was used for preparation 
of the vaccine which apparently failed to protect. Following this 
investigation a study of vaccine production methods was conducted by 
the State Health Department and, as a result, a new strain of organisms 
was substituted (Mitchell strain). 
Hodgson (1945), in a study of 84 cases of typhoid and paratyphoid 
in the British-American Hospital, Lima, Peru, reported that 71 of the 
cases were typhoid and that 12 of these were known to have been vaccinated 
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within the preceding 3 years. On the average the severity of the disease 
was less than in the non-vaccinated group; that is, the duration of the 
fever averaged only 6 days less. In addition, one of these patients 
died 0 The author concluded from this study that vaccination against 
typhoid fever offers some protection but it does ~ give absolute 
protectiono 
Allan (1943) observed 27 cases of typhoid among 114 individuals 
in the Devon Mental Hospital, England, in which 14 of the cases were in 
previously vaccinated individuals while 13 were in non-vaccinated persons. 
Of these 27 cases, 7 of the 17 seriously ill patients had been previously 
vaccinated, whereas 7 of the 10 mild cases observed had been protected. 
This author indicated that while inoculation did not appear to give much 
protection against an attack of typhoid, those who were immunized had a 
better chance of a mild attacko In addition, the disease in the more 
serious cases did not seem to be influenced by vaccination and relapses 
were common to both typeso 
III. AN EVALUATION OF ~ LABORATORY ANQ FIELD £AIA 
CONCERNING ACTIVE IMMUNIZATION AGAINST TYPHOID FEVER. 
Although much of the information concerning active immunization 
to typhoid fever has been obtained by laboratory experimentation, the 
experimental conditions and the methods employed in different investi-
gations have become so extensive that interpretation and comparative 
evaluation of the reported findings are exceedingly difficult. Making 
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allowances for differences in methodology by various investigators, the 
following is primarily a resume rather than a critical evaluation of 
the laboratory findings pertaining to active immunization against typhoid 
fever. 
Although the use of bacterial suspensions grown on solid media 
was introduced early, the first vaccines employed by Wright were essentially 
broth cultures of typhoid organisms killed by heating and preserved with 
lysol (Leishman, 1910). Heating has been the most commonly used procedure 
for killing the organisms and there is little doubt that in some instances 
the heating has been excessive and has resulted in lessened immunogenic 
potency of the typhoid vaccine (Batson, 1949). The heat-killed, tricresol 
or phenol-preserved vaccines are the most commonly available commercial 
vaccines today. Slightly different temperatures are employed by different 
manufacturers for killing the organisms, but 560 C for 1 hour apparently 
does not significantly lower the antigenicity. The ability of the 
various typhoid vaccines to stimulate antibody production, whether 
measured by mouse-protection tests or by serological means, will be 
considered later in the text. 
Following an extensive preliminary study (Felix, Rainsford and 
Stokes, 1941), the British Army, in 1944, discarded the heat-killed, 
phenol-preserved vaccine for a vaccine, whioh has since been abandoned 
as a result of field trials in Yugoslavia, in which the organisms were 
killed with 75% alcohol and preserved with 22.5% alcohol as recommended 
by Felix (1941). The criteria for this production method was the observation 
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by Felix and Pitt (1936) that alcohol did not destroy the 0 antigen, 
which Felix considered essential for good protection against typhoid 
fever, and that this concentration of alcohol was an effective preserva-
tive (Felix, 1941; Cruickshank ~ !l., 1942), whereas both heat and 
phenol reportedly destroy the a antigen (Felix and Pitt, 1934; Felix and 
Bhatnagar, 1935). While the superior immunogenicity of the alcohol-
type vaccine has been confirmed by others (Climie, 1942), Drysdale (1947) 
on the other hand, found no difference in the mouse-protective potency 
of the alcohol-type vaccine and the heat-killed, phenol-preserved vaccine. 
Other killing and preserving agents that have been investigated 
in relation to typhoid vaccine production include formalin, acetone, 
chloroform, ether, and merthiolate (Rainsford, 1939; Rainsford, 1942; 
Sen, 1947). Although each of these agents may possess certain theoretical 
advantages, conclusive evidence from field trials ~hich would provide 
justification for changing from the use of the present vaccine product 
has not as yet been presented. However, evidence may eventually be 
forthcoming to equal or lower the morbidity rates sufficiently from 
those observed during World War II by employing newer and more potent 
vaccines as compared to the heat-killed, phenol-preserved vaccine used 
at the present time against typhoid fever. 
The results obtained by Grasset and his co-workers (Grasset, 1939; 
Grasset and Lewin, 1936) and by others (Miller, Van Blommestein and 
'Williams, 1936; Goldsmith, Miller and Buchanan, 1938 ) with "endotoxoids" 
have been of particular interest not only because the results apparently 
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were highly satisfactory but also because of the immunizing product 
employed. This Itendotoxoidn was prepared by alternately freezing 
and thawing fully virulent typhoid organisms followed by detoxification 
of the contents of the disrupted organisms with formalin at 370 C for 
long periods of time. The resultant product proved on extensive 
laboratory tests and in experimental trials in humans to be relatively 
nontoxic yet apparently fully immunogenic. This "endotoxoid" was 
subjected to an extensive study (Grasset, Lewin and Van Der Merwe, 
1937) in 1936 and 1937 involving laborers in one of the gold mines in 
South Africa. Prior to 1936, the annual incidence of typhoid in this 
mine had ranged from 16 to 101 cases. Between September, 1936 and 
July, 1937, 5,445 of the 6,652 laborers in the mines were inoculated 
with a single injection of the "endotoxoid". During the following 
10 months there were only 9 cases of typhoid and 8 of these were in 
non-immunized workers while the other case was in an individual who had 
been immunized only 4 days previously. 
A later report (Grasset, 1939) reviewed the results of preventive 
immunization of native laborers of the Rand gold mines of South Africa 
and the statistics covered the period 1934-1936. Out of a total of 
810,475 persons at risk during the above period, 152,390 laborers 
were immunized with the "endotoxoid" vaccine. Among. these immunized 
workers, there were 174 cases and 35 deaths or an incidence of 1.14 per 
1,000. In addition, a second group of 77,971 laborers were given oral 
vaccination. In this group there were 638 cases and l36 deaths, an 
27 
incidence of 8.24 per 1,000. On the other hand, in the control group 
of 580,514 non-immunized workers, there were 2,231 cases and 477 deaths 
or an incidence of 3.84 per 1,000. Since the incidence of typhoid fever 
in this latter non-immunized group was less than one-half that in the 
orally immunized group, it appears to cast some doubt on the accuracy 
of these results reported by this investigator. However, it is 
reasonable to conclude that the "endotoxoid" vaccine was apparently 
protective under the conditions specified since accurate statistics 
on the incidence of typhoid in a test population such as the native 
workers in these gold mines are difficult to obtain. 
Rauss (1942) reported a study of the effectiveness of an immunizing 
agent somewhat similar to that employed by Grasset. Apparently, the 
main difference between the two vaccines employed by Rauss and by 
Grasset is that the former vaccine was an alum-precipitated detoxified 
extract. The field trial was conducted in 23 parishes in a district 
of upper Hungary where the mortality rate had been 36.5 per 10,000 
population. The study was carefully controlled and no persons under 2 
or over 60 years of age were included. In June 1937, 12,813 individuals 
were given 1 injection of the alum-precipitated vaccine; 10,962 were 
given 3 injections of a type unspecified vaccine; and 10,059 non-
immunized persons served as a control group. This control group included 
several individuals who previously had received 1 or 2, but not the full 
3 doses of vaccine. All persons known to have had typhoid fever within 
10 years of the study were excluded. The mortality rates per 10,000 
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within 3 years of vaccination for the alum-precipitated immunized, 
vaccine immunized, and non-immunized groups were approximately 8, 7, 
and 23 respectively. Although there was some variation within age 
groups, there was no apparent difference in the protection afforded 
by the alum-precipitated vaccine and the conventional vaccine. 
However, the reduction in incidence of typhoid in the immunized as 
compared with the controls was highly Significant. 
As stated previously (See Part I, Literature Review), the strain 
of ~. typhosa first used by the British for the production of typhoid 
vaccine was the Rawlings strain isolated in 1900. The basis upon which 
this selection was made was primarily good agglutinin production in 
rabbits, low toxicity for man, and ease of emulsification and suspension 
of the bacterial growth from solid media. 
The Rawlings strain was adopted by Russell (1913) for production 
of typhoid vaccine for the U. S. Army by the Army Medical School in 1908 
and was used until 1936. Since that time, strain 58, or Panama Carrier 
strain, has been employed continuously (Siler et !l., 1941). However, 
it was not until the late twenties that the protective efficacy of 
the Rawlings strain was questioned seriously, although many investigators 
had noted its ability to dissociate (S~R) readily. For example, 
Grinnell (1930) noted that the bactericidal power of blood of persons 
immunized with a vaccine prepared from a smooth strain was increased 
markedly while that of individuals immunized with vaccine prepared from 
rough organisms was not. This author (1932) later compared the virulence 
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of 12 Rawlings substrains G He found that the rough strains were less 
virulent than were the smooth strains and that virulence and smoothness 
were correlated with the mouse-protective potency of vaccines made from 
such strains. 
Other workers reported findings in general agreement with Grinnell. 
Perry, Findlay and Bensted (1933, 1934) observed that the original 
Rawlings strain and another strain given multiple passages through mice 
were more virulent and produced vaccines of somewhat greater protective 
potency. However, these authors did observe that the vaccine produced 
from a rough variant still was highly protective. Brown (1936) reported 
similar observations regarding the correlation between mouse virulence 
of cultures and mouse-protective potency of vaccines made from such 
cultures. Moreover, he concluded that variations in virulence and 
mouse-protective potency were dependent upon the presence or absence 
of the a antigen. 
An extensive study of the relationship of mouse-virulence 
and cultural smoothness to immunogenic potency was made by Siler and 
his co-workers (1936, 1941). Their studies noted a definite relation-
ship between those qualities, virulent strains being more highly 
immunogenic when measured either directly by active-immunity protection 
test in mice or indirectly by measuring the protective potency of the 
blood serum of humans immunized with vaccines prepared from virulent 
and avirulent strains. These workers felt that the mouse-protective 
potency of the serum of vaccinated humans was a better measure of their 
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immunity than was the agglutination titer. In addition, they found 
no consistent relationship between the agglutination and mouse-protective 
titers. Similar findings were reported by Grinnell (1931) who suggested 
further that smooth strains might possess a carbohydrate antigenic 
component associated with virulence and immunogenicity but which in no 
way entered into the agglutination reaction. 
Although it is generally considered that virulence of microorganisms 
is associated with toxicity for man, there is disagreement as to the 
relationship of the degree of reactions elicited in man as well as the 
degree of immunity produced. Feemster (1932) found these two completely 
unrelated but did note that reactions following immunization were most 
severe in persons who previously recovered from typhoid fever. Lui ppold , 
Longfellow and Toporek (1947) observed that a reduction in dosage of 
typhoid vaccine in previously non-immunized individuals resulted in 
a decreased incidence of reactions but in an actual increase in mouse-
protective antibody titers. 
Unfortunately there has not been general agreement on a standard 
procedure for measuring the amount of active immunity produced in mice 
or other laboratory animals. However, in most cases, this had been 
approached (Siler, 1936; Siler et al., 1941; Griffitts, 1944), by 
vaccinating mice with a constant dose of vaocine and determining the 
level of their effective resistance by injecting increased multiples 
of lethal doses (MLD's or 1O;O's) to successive groups of the immunized 
mice. On the other hand, Batson (1948) compared the effectiveness of 
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graded immunizing doses as well as graded challenge doses in measuring 
the degree of protection afforded mice by active immunization. This 
investigator found that graded immunizing doses were much more effective. 
He also observed that at any one level of established immunity, survival 
or death was markedly independent of the size of challenge dose employed. 
Although several workers have employed various types of challenge sus-
pensions as well as different procedures for measuring the effective 
resistance of immunized animals, it is possible that the reported 
differenoes in the immunizing efficacy of vaccines prepared by different 
methods or from different strains may be due to true differences in 
immunogenicity (Batson, 1949). 
The development by Siler and his co-workers (1937) of the mouse-
protection test as a measure of the antibody level of sera has made it 
possible to extend laboratory investigations. However, the information 
obtained from mouse-protection tests, or any other laboratory test, 
is not expected to approach that obtained in the field under actual 
conditions of exposure to infection. On the other hand, in spite of 
the real possibility that immunity of humans to typhoid may be primarily 
a cellular immunity and the humoral antibodies only a manifestation 
of excess immUnity, the results obtained by mouse-protection tests 
appear to parallel the probable true resistance of the individual more 
closel.y than any other commonly employed laboratory assay procedure. 
Luippold, Longfellow, am Toporek (1947) reported that, on the 
basis of the level of mouse-protective antibodies produced, 3 injections 
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of 0.5 ml (subcutaneous) each stimulated as great an immune response 
as did the standard oourse (0.5, 1.0 and 1.0 ml, suboutaneously). 
Several workers, inoluding Stroebe (1929) and Taylor (1937) have noted 
under actual epidemic oonditions that at least 2 injections of vaccine 
are needed to provide adequate protection. These observations appear 
to be in agreement with those concerning the incidence of typhoid fever 
in partially immunized personnel in the U. S. Army (Siler, 1941). 
Apparently, from these reports, multiple inoculations are of importance 
in establishing an effective degree of immunity. 
There have been many reports on the value of oral immunization 
as compared with the usual parenteral (subcutaneous) injection. Those 
studies (Destouches, 1934), based on the actual occurrence or absence 
of infection, show that oral immunization affords little or no protection. 
However, Guerner (1927) reported a typhoid fever incidence of 0.01% 
in orally immunized persons in Brazil as compared with 0.17% in those 
vaccinated suboutaneously. In addition, Cluver (1929) reported that 
the oral immunization method was effective in controlling typhoid fever 
among laborers in the South African gold mines. 
The inadequacy of oral immunization based on serological or mouse-
protection tests has been reported by various workers (Tuft, Yagle and 
Rogers, 1932; Valentine et al., 1935; Downs and Bond, 1937; Elledge, 
Kennedy and Cumming, 1943). Moreover, Hoffstadt and Thompson (1929a, 1929b) 
and Hoffstadt, Martin and Thompson (1929) made a careful study of the 
antibody response to oral immunization and found that, although there 
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was a definite response produced by this method, titers were definitely 
lower than resulted from subcutaneous injection of vaccine. 
The degree of antibody response to intraoutaneous vaccination 
has also been studied by many investigators. Most workers (Tuft, 1931; 
Valentine, ~ al., 1935; Perry, 1937; Siler and Dunham, 1939; Naumer 
and Nerb, 1943) have reported that the antibody response is approximately 
equal to or greater than that obtained by the subcutaneous route even 
when the dosage is reduced markedly. Longfellow and Luippold (1940) 
and LUippold (1944) reported extensive studies of the response to intra-
cutaneous immunization based on mouse-protection tests. These authors 
suggested the method was adequate for restimulation of preViously 
vacoinated indiViduals but did not recommend the procedure for initial 
immunization. Presumably the major value of the intracutaneous injection 
procedure is that fewer systemic reactions occur than are obtained 
following subcutaneous injections of the larger amounts of vaccine. 
However, it is interesting to note that Luippold (1944), though admitting 
local and systemio reaotions are more frequent and pronounoed following 
administration of the standard subcutaneous doses of TAB vaocine than 
following the intraoutaneous injection of one-tenth or one-fifth of 
these doses, felt that the risk of any lowering of protection was not 
worth the questionable reward of milder reaotions. This author further 
reported that under the best conditions of immunological response to 
artifioial immunization it was not expeoted that the standard method of 
vacoination would be adequate at all times in the field to the challenge 
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of infecting organisms. Adoption of the intracutaneous injection of 
reduced doses of TAB vaccine~ according to this author, would seem to 
increase this inadequacy. 
Information concerning the duration of effective immunity following 
vaccination is probably best obtained from data on the incidence of 
typhoid fever in former military or similar personnel exposed to a 
common risk with non-immunized individuals. Employing this basis it 
appears that the duration of effective immunity is at least 2 or 3 
years (Pryor, 1928; Bowdoin and Petrie, 1940; Siler et al., 1941) 
and may be even 5 or more years (Halliday and Beck, 1928). For further 
discussion concerning the duration of effective immUnity, please see 
Part B of the Literature Review. 
Several workers (Davison, 1918; Maclean and Holt, 1940; Kolmer, 
Bond and Rule, 1942; Hitch, Ashcroft and Green, 1943) have reported on 
the use of polyvalent immunizing agents of which typhoid vaccine was 
a component part. In general, it appeared to these investigators that 
the inoculation of such mixtures does not subtract from the immunizing 
potency of anyone component; in fact, immunogenicity may even be 
enhanced. On the other hand~ the relative protection against typhoid 
effected by monovalent typhoid vaccine as well as polyvalent typhoid-
paratyphoid vaccine apparently has not been established with certainty. 
Some indication that response to the polyvalent vaccine was less than 
the monovalent vaccine was suggested by Longfellow and Luippo1d (1943). 
However, it is interesting to note that their reported difference was slight 
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and was not observed in a controlled comparison. Therefore, their 
findings should be considered inconclusive. 
With regard to the immunogenically important components of ~. 
typhosa, both the somatic 0 and the Vi antigens are considered responsible 
for the production of protective antibodies in animals and man. 
Much effort has been made to extract specific chemical fractions 
from the typhoid bacillus in hope of obtaining a fraction SUitable for 
use in active immunization. To be of practical value such a fraction 
should be stable, nontoxic, readily soluble, and of such nature as to 
permit its preparation in large quantities. At least partial attainment 
of the above objective has been reported by several investigators 
(See Part IV, Literature Review). The products obtained by these workers 
were more or less similar lipopolysaccharides of low nitrogen content 
even though the methods employed in extracting the antigenic fractions 
were different. In general, these products reacted with specific antisera 
and appeared to be strongly antigenic. In addition, some of these extracts 
have been shown to produce active immunity against typhoid fever in mice 
and to stimulate production of mouse-protective antibodies in man. 
Unfortunately, many of these antigenic fractions are highly toxic and efforts 
to detoxify these products will be presented in Part V of the ~terature 
Review. 
The discovery by Felix and Pitt (1934) of the Vi antigen resulted 
from their study that strains freshly isolated from typhoid patients 
often were inagglutlnable and that such strains were highly Virulent 
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for mioe; thus the name Vi. The meohanism of the virulenoe-enhanoing 
aotion of the Vi antigen has not been oompletely established but it has 
been suggested by some investigators (Bhatnagar, 1935; Felix and Bhatnagar, 
1935; Felix and Pitt, 1951a) to be the result of a proteotive aotion 
of the antigen against phagooytosis. The Vi antigen is different from 
and independent of the somatio 0 antigen (Felix and Pitt, 1935). 
Following injeotion of living Vi strains into rabbits, a specifio Vi 
antibody is produoed in a relatively low titer. The microorganisms rich 
in Vi antigen are agglutinated by sera oontaining Vi antibodies but not 
by sera containing only speoifio anti-O agglutinins~ Gladstone (1937) 
found that retention of the Vi antigen during propagation in culture 
media is dependent upon the utilization of gluoose or similarly oomplex 
carbohydrates while the 0 antigens apparently oan be synthesized fram 
Simpler oarbon oompounds. 
Although the Vi and 0 antigens are chemioally distinct, they are 
difficult to separate ohemioally (Topley ~ !l., 1937; Henderson, 1939a; 
Henderson, 1939b). In addition, the Vi antigen is more sensitive to 
heat than is the 0 antigen. That is, unlike the 0 antigen, the Vi 
antigen is rapidly destroyed when heated at 1000 0, and heating at 600 0 
for 30 minutes may also destroy it. Moreover, the immunizing quality 
of the Vi antigen is so altered by formalin that the resultant antibody 
produoed against it is defioient in protective potenoy while retaining 
its agglutinating properties (Felix and Bhatnagar, 1935; Felix and 
Petrie, 1938). Felix and Bhatnagar (1935) found that the immunogenioity 
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of the Vi antigen is essentially destroyed by 0.5% phenol. However, 
Bensted (1940) failed to confirm their findings and concluded further 
that both the 0 and Vi antigens are necessary for full protective immunity. 
Felix and Pitt (1936) observed that treatment with alcohol destroyed 
the specific Vi agglutinability of Vi strains but did not impair their 
ability to stimulate production of Vi antibodies in rabbits. It was 
on this basis that Felix and his coworkers (195lb, 1951c) developed 
the alcohol-killed and alcohol-preserved typhoid vaccine for immunization 
of humans. There is little doubt that this product can stimulate the 
production of specific Vi antibodies in a greater proportion of persons 
than does the heat-killed, phenol-preserved vaccine such as used today 
by the United States Armed Forces. Although the antibody response to 
the latter type of vaccine is predominantly of the anti-O type (Siler, 1941), 
there is no denying the fact that the most successful experiences to 
date in mass immunization ~ ~ (see below) have been accomplished 
with the heat-killed, phenol-preserved vaccine (Siler, 1941; Holt, 1948). 
However, as was suggested by Luippold (1946), it may well be that future 
research will indicate the possibility of modifying production 
procedures so as to retain the Vi antigen in an unaltered state or 
that it may be advisable to fortify the presently used vaccine with 
extracts containing Vi antigen. 
In recent years, Webster, Landy and Freeman (1952) and Landy 
and Webster (1952) have reported on the purification and immunological 
properties of a purified Vi antigen derived from Escherichia coli 
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5396/38. Their method for extracting this antigen from acetone dried 
organisms was an ethenol-salt fractionation procedure followed by acetic 
acid hydrolysis. The final product was a fraction free of contamination 
with ~. £2li somatic antigen and showed a high degree of serological 
activity and specificity especially when absorbed on either colloidion 
particles or on erythrocytes. Furthermore, this purified Vi antigen 
was markedly effective in the protection of mice against challenge With 
virulent strains of ~. typhosa. Later observations by Landy (1954) 
on the immunological response of human beings to this purified Vi 
antigen showed that, of a total of 432 subjects given a single sub-
cutaneous injection of 0.04 mg of antigen, 95~ developed Vi antibody 
which persisted for periods up to 2 years. This was in contrast to 
the rapid disappearance of Vi antibody following recovery from typhoid 
fever. 
In 1953 Landy (1953) described the preparation and standardization 
of a dehydrated typhoid vaccine from acetone-killed and dried ~. typhosa 
and paratyphoid components. From estimates of absolute and relative 
mouse protective potencies of dehydrated and of heat-killed, phenol-
preserved vaccines it was shown that the dehydrated vaccine was markedly 
superior in this respect. Moreover, the dehydrated vaccine stimulated 
the production of Vi antibody in rabbits. Passive mouse protection 
tests on the sera of rabbits immunized with the two products respectively 
revealed the immunogenic superiority of the dehydrated over the heat-
phenol vaccine. It was further reported that the stability of the 
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dehydrated vaccine was observed following storage in the dry state 
at 500 C for 1 year with no significant loss in Vi immunogenic 
activity. Evidence that the dehydrated vaccine stimulated the pro-
duction of Vi antibody in man was later reported by Landy et ale (1954). 
They found that of the vaccines tested in man all gave good 0 
agglutinin titers, whereas the Vi antibody levels were limited with 
the heat-phenol-vaccine but considerably higher for the acetone-
dehydrated producto 
More recently, a series of papers from the Walter Reed Army 
Institute of Research (Edsall et al v, 1954; Spring et al., 1956; Edsall 
~ !lo, 1960) have reported on the studies of infection and immunity 
in experimental typhoid fever employing the chimpanzee as the experi-
mental animal. Detailed clinical observations, stool and blood cultures, 
and serological studies confirmed the impression that the disease pro-
duced in these animals closely resembled the mild form of human typhoid 
fever frequently seen in childhoodv Furthermore, gross and histologic 
examination of intestines, mesenteric lymph nodes, liver, spleen, and 
other organs of orally infected chimpanzees demonstrated pathological 
findings that are essentially indistinguishable from those seen in 
mild typhoid fever in man o Moreover, the clinical symptoms observed 
in these animals ranged from moderately severe illness, through 
transitory illness, to afebrile infection with or without bacteriemia, 
occasionally leading to the development of persisting biliary infection 
and the carrier state. Thus the range of illness observed in 
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chimpanzees resembled that seen in man except that the severe and 
complicated forms of typhoid fever were not observed in the chimpanzee. 
This production of the spectrum of typhoid fever in the chimpanzee, 
according to these authors, had made it possible to study the basic 
problems in this disease which are not easily defined through the use 
of prevailing laboratory techniques. 
Further studies were made by Gaines and his coworkers (1956, 1961) 
on the efficacy of various antityphoid immunizing agents in immunizing 
chimpanzees against typhoid fever produced by feeding viable ~. typhosa. 
These workers found that both acetone-killed (Landy) and heat-killed, 
phenol-preserved typhoid vaccines were effective in protecting against 
infection produced by either homologous or heterologous strains of 
typhoid bacilli. On the other hand, purified 0 antigen (phosphorylated 
lipopolysaccharide) induced no discernible protection, whereas some 
immunity was afforded in the chimpanzee by the administration of 
purified Vi antigen (Webster)a 
No doubt the most thorough investigations to date of the immunizing 
efficacy of the various typhoid fever vaccine preparations in man 
have been the series of field trials conducted under the auspices of 
the World Health Organization. The first of these field studies was 
organized in 1954 in the town and district of Osijek, Yugoslavia 
(Yugoslav Typhoid Commission, 1962). One-half of a single large pool 
of bacterial harvest of ~. typhosa, strain Ty 2, was processed by the 
alcohol method of Felix (1941), and the other half was inactivated by 
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heating at 560 C for one hour and preserved with 0.5~ phenol. These 
vaccines were given, together with control vaccine made with Shigella 
flexneri, on a double-blind, strictly randomized basis. The three 
groups, each consisting of approximately 12,000 persons, were injected 
subcutaneously with two doses of vaccine at a three-week interval. 
The first dose was equivalent to 750 million and the second to 1500 
million organisms. A booster dose equal to the first dose was given 
after one year to 75~ of the volunteers. During the first two years, 
31 proven cases of typhoid occurred in the control group, 23 in the group 
given alcoholized vaccine, and only 9 in the phenolized vaccine group. 
The latter preparation evoked significant protection (approximately 
7~) particularly in children 5 to 14 years old. In addition, no 
increase in protection was observed in those who received the booster 
injection one year later, and comparable protection was still afforded 
in 1958. Moreover, preliminary serological results suggested a 
significant~ higher titer of Vi antibodies in those who had received 
the alcoholized vaccineo 
Reactions to inoculation in the primary course of immunization, 
in which local and systemic reactions were recorded in 640 persons 
chosen at random, were studied in 1954. Each person was visited 24, 
48 and 72 hours after each of the two injections. Although it was not 
possible to observe much difference in the reactions between the 
vaccines, it was generally observed that reactions were not severe. 
However, the reactions to the second injection were generally somewhat 
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greater and more frequent than those to the first one. Five persons 
developed sterile cysts, as no bacteria were found in their contents, 
at the inoculation site. 
In 1956, an additional study was carried out among military 
recruits in Zagreb, Yugoslavia where typhoid fever was not active. 
The immunization schedule, employing another lot of these same vaccines, 
consisted of three doses of 750 million, 1500 million, and 750 million 
organisms each at three-week intervals. Serial bleedings were obtained 
from 377 men representing the three vaccine groups. Specimens were 
obtained before vaccination, three weeks after the first dose of vaccine, 
three weeks after the second dose, immediately prior to revaccination 
which was done three months after completion of initial immunization, 
and three weeks after the revaccination. The results of these studies 
revealed that the H-agglutinin titers were consistently and significantly 
higher in the group given the phenolized vaccine. In addition, the 
O-agglutinin titer was higher soon after phenolized vacc1ne was given, 
whereas after five months the difference in 0 antibodies was not 
Significant in the Os~jek groupe In both the Osijek and the Zagreb 
studies, the mean Vi antibody level was slightly higher after primary 
immunization with phenolized vaccine, but after several months the Vi-
antibody titers were higher in those vaccinated with the alcoholized 
vaccine. It is of interest that Edsall et ale (1959) confirmed the 
superiority of this alcoholized vaccine used over the phenol-preserved 
product in employing the usual mouse protection tests (active and 
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passive) and in the production of Vi hemagglutinins in rabbits. However, 
as the studies show above, in man, the protection afforded by the 
alcoholized vaccine was inferior to that observed with the phenolized 
vaccine. 
Further evidence suggesting that high Vi antibody levels appear 
not to have any effeotiveness in protecting man against typhoid was 
seen in the 1960 field trials in British Guiana and in Yugoslavia. 
In British Guiana (Ashcroft, 1963, 1964; Ashcroft, Ritchie and 
Nicholson, 1964), a total of about 72,000 children, 5 to 14 years of 
age were immunized on a random basis with two doses of vaccine, given 
three to five weeks apart. Each dose consisted of 0.5 ml (500 million 
organisms) of either an acetone-inactivated and dried typhoid vacoine 
(Landy, 1953), a heat-killed, phenol-preserved vaccine, or tetanus 
toxoid controlo The effectiveness of these preparations in protecting 
against clinical disease revealed that five cases of typhoid fever 
occurred over the next three years in the acetone-inaotivated vaccine 
group, and 23 in the heat-phenol-inactivated vaccine group, as oompared 
with 83 in the control group, indicating an effectiveness of 93~ and 
75~ respectively. In groups of over 3300 each, the protection given 
by a single dose was of the same order as that given by two; that is, 
the disease incidence was 0.3 and 14 cases, respectively. 
The 1960 field study in Yugoslavia (Yugoslav Typhoid Commission, 
1964) was carried out simultaneously with the study in British Guiana 
and tested the same vacoines. Two doses of vaccine were given four 
weeks apart. Groups of approximately 6500 children each, ages 2 to 
14, received 0.5 ml doses of either the acetone-inactivated and dried 
vaccine or the heat-killed, phenol-preserved vaccine or the tetanus 
toxoid control. In addition, three groups of approximately 8700 each 
within the age range 15 to 60 years were given two 1 ml doses totaling 
2000 million organisms. Two years after immunization an outbreak of 
typhoid fever occurred in PriXtina and was the consequence of a three-
week contamination of the city water supply. Among the 5000 volunteers 
in each group in this community, 16 cases of blood-culture-positive 
typhoid fever occurred in the acetone-killed vaccine treated group, 
37 in the heat-phenol vaccine treated group, and 75 in the control 
group, indicating 7~ and 5l~ effectiveness, respectively, in the 
prevention of typhoid fever. 
The relative antigenic potency of the above vaccine preparations 
was estimated by the usual serological tests. These tests involved 
approximately 100 children who were bled two or more weeks before 
inoculation and again two weeks after the second dose of vaccine had 
been given. The typhoid vaccines had been administered at a normal 
dose level of 0.5 ml followed by a second dose three weeks later. 
Each dose contained approximately 500 million typhoid bacilli. The 
results of these serological tests revealed that the acetone treated 
vaccine elicited a significantly greater anti-H response, while the 
anti-O response was better after immunization with the heat-killed, 
phenolized vaccine. Moreover, no difference was found in Vi response 
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whether measured by direct bacterial agglutination or by hemagglutination 
of red blood cells sensitized with the Vi antigen. 
Reactions to inoculation were studied in 1,265 vaccinated persons 
in Bitola in which examinations were made on the first, second, third 
and fourth days at about 10, 24, 48, and 72 hours after inoculation. 
No real difference was seen between the reactions to the acetone-dried 
and the heat-phenol vaccines. Moreover, no differences in reactions 
were apparent between these vaccines and the alcoholized and heat-phenol 
vaccines used in the first Yugoslav field trial. In addition, the 
reactions to the acetone-dried and to the heat-phenol vaccines during 
the later trials were very similar. While there were more reactions 
to the first injection of heat-phenol vaccine than to the first acetone-
dried vaccine injection, it seemed that the second dose of acetone-
dried vaccine gave rise to more reactions than the second dose of 
heat-phenol vaccine. However, reactions to the second dose were 
significantly milder than to the first dose of either of the vaccines. 
Preliminary results of the field trials carried out during 1961 
in Poland in which over 800,000 individuals were vaccinated with several 
different preparations were reported by Benenson (1964). The typhoid 
vaccines employed for this study were prepared by the following 
techniques: acetone-inactivation and drying (vaccine p), formal-phenol 
(vaccine N), Westphal (vaccine S), and Grasset-Slopek (vaccine T). 
Tetanus toxoid was again used as the control preparation. Early results 
suggested that the acetone-inactivated and formal-phenol vaccines were 
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both highly effeotive in proteoting against typhoid. Furthermore, 
serologioal tests showed that the aoetone-inaotivation teohnique 
provoked the highest H-agglutinin response, despite the faot that only 
one-half as many baoteria were injeoted as oompared with the other 
preparations. The a-agglutinin response to the formal-phenol preparation, 
when oompared to the other preparations, was signifioantly higher, 
while the Vi antibody responses of all the vaooines were not signifioantly 
different. The antibody responses to the other two preparations were 
worthy of note also aooording to this author. The alum-absorbed extraot 
prepared by the Grasset-Slopek teohnique did not differ from the aoetone-
inaotivated vaooine in Vi and a responses, but the H antigenioity was 
suppressed. On the other hand, the Westphal vaooine, whioh is 
essentially a pure somatio substanoe, yielded an insignifioant rise 
in 0 antibodies with no ohange in H- and Vi-antibody titers. 
As previously mentioned, the aloohol method had been developed 
by Felix and his ooworkers (1941, 1951b, 19510) beoause it stabilized 
Vi antigen and was superior to other vaooines in proteoting mioe against 
intraperitoneal ohallenge with ~. typhosa. However, as the field trials 
in Yugoslavia show in whioh the hypothesis was tested that antibodies 
against the Vi antigen were the proteotive substanoe for man, the 
proteotion afforded by the alooholized vaooine was inferior to that 
provided by the phenol vaooine (Cvjetanovic, 1957). Although the 1960 
field trials in Yugoslavia showed no apparent differenoe between the 
two vaooines in the Vi-antibody levels, the proteotive differenoe in 
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the two preparations in man was significant. Thus, at least as far as 
these two field trials are concerned, the results (Benenson, 1964) 
argue against the concept that the titer of Vi antibodies measures the 
immunity of man against infection with the typhoid bacillus. 
The level of O-agglutinins, as a measure of protection in man 
against typhoid fever, has apparently been abandoned by the World Health 
Organization as a result of these field trials (Benenson, 1964). This 
decision follows from the elevated O-agglutinin response in only those 
individuals receiving the phenol vaccine during the 1954 field trial, 
whereas, in 1960, the O-agglutinin response was superior only in those 
who had received the alcoholized vaccine. 
Benenson (1964) further reported that, in the 1954 Yugoslav 
trials, the phenolized vaccine was superior to the alcoholized product 
only in its ability to evoke in man and rabbits a higher H-agglutinin 
level. In the 1960 field trials, both the acetone and the heat-phenol 
preparations were equally effective in protecting man against typhoid 
in British Guiana. In the Yugoslav studies, the phenol vaccine was 
effective in children, but only the acetone-inactivated vaccine was 
equally protective to individuals of all ages. According to this 
investigator, the outstanding characteristic of the aoetone-inactivated 
vaccine is its H antigenicity. That is, in two conclusive studies, 
the H antigenicity appeared to be the attribute of the vaccine which 
correlates best with protection of man against infeotion with ~. typhosa. 
Moreover, in the Polish studies, the acetone-inactivated vaocine was 
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again predominant in H antigenicity, and preliminary data indicated 
that this and the formal-phenol vaccines are the most protective. 
The concept that the H antibody is synonymous with resistance to 
infection by ~. typhosa is still difficult to evaluate at the present 
time. Tully and Gaines (1961) confirmed the work of many others in that 
they were unable to implicate H antigen or antibody in typhoid infection 
of the mouse. Furthermore, Tully, Gaines and Tigertt (1963) were unable 
to protect chimpanzees against a typhoid challenge by exposure to either 
a typhoid strain containing H but no Vi or 0 antigen (Mrs. S. Rough 
strain) or an acetone-inactivated and dried Mrs. S. Rough vaccine 
preparation, despite high anti-H titers. And, finally, the frequency 
of human relapses in the presence of high H-agglutinin titers suggests 
that a correlation between immunity to typhoid fever and H-antibody 
levels is highly unlikely. 
IV. A HISTORIAL REVIEW OF METHODS EMPLOYED 
IN THE EXTRACTION OF ENDOTOXIN 
The major connotation of the term "endotoxin" is a substance 
found in most all gram-negative bacteria which appears to be a structural 
component of the organism. Indeed, a body of information exists 
suggesting that the cell wall material of smooth strains of gram-negative 
bacteria are the major sources of endotoxin. Endotoxin is found in 
culture filtrates of gram-negative bacteria as a consequence of bacter-
ial lysis. Van Heyningen (1950) suggested that this endotoxin acts 
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on animals in the same way without regard to the bacterial source. 
In marked contrast to the exotoxins, the endotoxins are heat stable 
and not destroyed by alcohol at room temperatures. The chemical 
characteristics of endotoxin, according to the pioneer work of Boivin 
(1933), are largely those of a phospholipid-polysaccharide complex 
which has been identified serologically as the 0 or somatic antigen. 
These 0 antigens have been extracted from dysentery organisms (Boivin 
and Mesrobeanu, 1937; Morgan, 1937; Morgan and Partridge, 1941; Goebel 
et al., 1945; Smolens et al., 1946; Barnes et al., 1947) as well as the 
salmonella group (Boivin et al., 1933; Walker, 1940; Palmer and Gerlough, 
1940; Freeman, 1942; Roberts, 1949; Webster et al., 1955; Westphal, 
1957; Ribi et al., 1961; Haskins et al., 1961; Haskins et al., 1963). 
Also, antigens of this same general type have been found in brucella 
(Miles and Pirie, 1939), meningococcus and gonococcus organisms (Boor 
and Miller, 1944; Mergenhagen et al., 1963). In animals and man 0 
antigen or endotoxin has been found to produce a wide variety of effects 
including the production of fever, leukopenia, nonspecific enhancement 
of resistance and the Shwartzman reaction (Boivin et al., 1933; Boor 
and Miller, 1944; Hook and Wagner, 1959; Atkins, 1960). Repeated 
injections (Beeson, 1947a; Tennent and Ott, 1953) of endotoxin in 
rabbits induced tolerance to the fever effect, whereas in tumor bearing 
mice (Shear and Turner, 1943) endotoxin was shown to produoe hemorrhogic 
necrosis within the tumors. 
Several 0 antigen isolation procedures have been described since 
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that first reported by Boivin et al., (1933). Their trichloroacetic 
acid extraction procedure enabled them to isolate toxic and immunizing 
fractions from many gram-negative organisms. Their method of isolating 
endotoxin from enterobacteriaceal organisms was followed by many other 
extraction procedures. Using ethanol extraction after trypsin digestion, 
Raistrick and Topley (1934) were able to isolate antigenic material from 
a strain of Salmonella typhimurium. Their chemical findings suggested 
a substance very similar to that of Boivin and his colleagues using 
trichloroacetic acid on the same organism. Later, Morgan (1937) employed 
an extraction procedure which could be carried out at a neutral reaction 
and at low temperatures. This investigator was able to isolate a specific 
antigen which was assooiated with the "smooth" form of Shigella dysenteriae 
(Shiga). Depending upon the solubility of antigenic complexes in organic 
solvents, he was able to extract at 370 C an antigenic material with 
diethylene glycol followed by fractional precipitation of the active 
material from the aqueous solution by acetone or ethanol. This anti-
genic material was capable of inducing an anti-bacterial immunity 
response in mice which was qualitatively identical with that produced 
by the specific antigen of the intact microorganisms. 
Walker (1940), on the other hand, reported a method for the 
isolation of toxio and immunizing fractions from baoteria of the sal-
monella group employing aqueous solutions of urea. He found these 
substances to contain a large amount of carbohydrate with traces of 
protein. Also, these substances were highly toxic and, in addition, 
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could confer active immunity in mice. 
By employing an alcoholic precipitation procedure (sodium acetate 
and 95% ethanol), Morgan (1941) reported that an antigenic material had 
been prepared from cultures of ~. typhosa grown on a synthetic medium. 
This investigator further reported that, in sub-lethal amounts, this 
purified antigen was able to induce leukopenia and fever in rabbits as 
well as leukopenia in guinea pigs, rats and mice. Moreover, this antigen 
was able to induce the Shwartzman reaction in rabbits when employed 
either as the preparatory or eliciting agent. Later, Morgan (1945) 
found that this purified antigen as well as those prepared from cultures 
of Salmonella paratyphi and Salmonella schottmuelleri produced less 
(local and constitutional) reactions than those produced by the TAB 
bacterial vaccine when injected subcutaneously in man. These data and 
others suggested to this author, that these purified antigens possessed 
the advantages of potency, stability and compactness. 
A few of the early investigators developed methods for extracting 
antigenic polysaccharide substances from bacteria other than the entero-
bacteriaceal organisms. Fuller (1938) employed the formamide procedure 
for the extraction of polysaccharides from hemolytic streptococci. It 
was indicated by this author that this method had the advantage over the 
existing methods of obtaining antigenic substances from organisms by 
completely dissolving the bacteria thereby producing potent extracts 
as well as removing protein substances which might give cross-reactions. 
In addition, he suggested that this method might be applicable to all 
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species of bacteria. Using suspensions of "smooth" Brucella melitensis, 
Miles and Pirie (1939) were able to obtain with both chloroform-water 
and phenol a substance which appeared to contain the antigenic com-
ponents of the whole organism. They designated this substance as a 
phospholipid (PL), amino-polyhydroxy (AP), protein-like (S) complex 
or PLAPS. Extracting with organic solvents to remove the lipids and 
acetic acid to remove the protein-like material respectively, they obtained 
the resulting material called amino-polyhydroxy (AP). They considered 
AP analogous to the SSS that had been isolated from ~. typhimurium, 
~o typhosa, and ~. shigae as well as the somatic antigen isolated by 
Boivin et !l. from a number of gram-negative bacteria. In a later paper, 
Boor and Miller (1944) reported obtaining a carbohydrate-lipid fraction 
from both the gonococcus and meningococcus organisms. Extracting with 
trichloroacetic acid, they were able to show an extractable, toxic 
antigenic product which varied in amount with species, strain, and 
physical and chemical pre-treatment of cells. However, no difference 
was found by these authors in the toxicity of like quantities of 
glucolipid from various strains of gonococci and meningococci irrespective 
of virulence. Recently, Mergenhagen ~!l. (1963) described some of 
the properties of an endotoxin isolated by phenol-water extraction and 
further purified by differential ultracentrifugation from a Group C 
Neisseria meningitidis strain. Their lipopolysaccharide contained 20% 
lipid with polysaccharide constituents identified as glucose, galactose, 
glucosamine and sialic acid. In addition, their product contained 
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less than 1% protein, and less than 1% nucleic acid. Analytical ultra-
centrifugation and the separation of lipopolysaccharide and of capsular 
polysaccharide by gel filtration provided evidence that sialic acid 
formed an integral part of the biologically active lipopolysaccharide. 
Different ratios of phenol and water have been utilized by many 
investigators for the extraction of antigenic substances from entero-
bacteriaceal organisms. Palmer and Gerlough (1940) used repeated 
extractions of acetone dried typhoid bacilli (Panama carrier strain) 
with 95% phenol. They obtained a final product which gave strong 
precipitin reactions with antityphoid rabbit serum. In addition, 
they reported that a single intraperitoneal injection of 0.4 mg killed 
50% of 40 mice within 24 hours, whereas intravenous injections of 0.1 
mg in rabbits produced an average maximum elevation of temperature of 
2020 F (2 of the 10 rabbits died within 2 hours after injection). The 
first use of a 90% phenol and water solution for the removal of a water-
soluble antigenic complex isolated from a 'tsmooth" culture of §h. 
dysenteriae (Shiga) was reported by Morgan and Partridge (1941). In 
addition, by this procedure they obtained an approximately equal amount 
of a non-specific, water-insoluble simple protein. However, similar 
extraction of the corresponding tlrough" variant yielded no antigenic 
material but only a considerable quantity of the simple protein. When 
tested in rabbits, these investigators found the material extracted 
from the "smooth" strain to be a powerful "Shiga" antigen. Goebel and 
Barry (1958), in a paper reporting on a substance having colicine K 
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activity, found that 90% phenol could be used to dissociate the 
lipopolysaccharide-protein complex (0 antigen) of g. coli K235 to 
yield a protein-like constituent bearing the colicine K activity. 
The lipopolysaccharide portion of the complex comprised 80% of the 
original complex. In an earlier paper Goebel et al o (1945) used an 
aqueous pyridine solution (50%) for the extraction of the Type V specific 
antigens in the Flexnor group of dysentery bacilli. They found that 
their yield of antigen varied considerably depending upon the type of 
organism as well as the strain employed. 
Using the same group of organisms, Smolens et al. (1945) employed 
an HOI acid extraction procedure (560 C for 20 hours) which also proved 
successful in obtaining the somatic antigen. Their experiments with 
this apparent somatic antigen indicated an extremely potent antigen as 
well as being the principle carrier of the toxicity of the whole organism. 
However, they concluded from their immunization studies using both man 
and animals that their isolated somatic antigen did not appear to be 
superior to the killed whole bacterial cell as a vaccine against bacillary 
dysentery. In describing a simple and effective method, Roberts (1949), 
reported that water suspensions of~. ~when heated at 800 C for 60 
minutes could also yield a toxic and pyrogenic material apparently 
identical with the 0 antigen. 
The separation, characterization, and biological significance of 
a common antigen found in enterobacteriaceal organisms has been recently 
described by Kunin (1963). By employing DEAE cellulose chromatography, 
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this investigator has been able to isolate this antigen from closely 
associated endotoxin fractions. Unlike endotoxin, however, this purified 
common antigen failed to coat erythrocytes, was non-antigenic, and was 
composed primarily of polysaccharide and polypeptide. The author 
indicated that the most important property of this antigen thus far 
determined was its interference with the specificity of the hemagglutination 
test commonly employed to measure antibody to 0 antigen of Enterobacteriaceae. 
Moreover, this purified common antigen may have some significance in 
classification of this family of bacteria. 
Classically, the products obtained by these procedures are usually 
complexes consisting of varying amounts of proteins, lipids, and 
polysaccharides. They all apparently evoke the characteristic endotoxin 
reactions, but differ widely in their potency on a weight basis especially 
their capacity to produce lethal effects. Since the pioneer work of 
Boivin, little progress has been made in determining the composition 
and structure which elicits the characteristic reaction of endotoxins 
in mammals. In recent years, however, Landy and his associates (Webster 
~ ale, 1955; Landy ~ al., 1955; Landy and Johnson, 1955) described a 
method for the further purification of the 0 antigen from a strain of 
£. typhosa employing a series of fractionations using ethanol in high 
salt concentrations, ammonium sulfate, and ethanol respectively for the 
isolation of a phosphorylated lipopolysaccharide component essentially 
free of protein. They were able to show by immunological studies that 
when a somatic antigen is freed of protein, the resultant lipopolysaccharide 
has an increased antigenic activity in mice, rabbits and men. All 
evidence, including quantitative immunochemica1 procedures revealed that 
the immunologically active form of the somatic 0 antigen was the lipo-
polysaccharide component. These investigators further reported that 
microgram amounts of this protein-free lipopolysaccharide were capable 
of producing the various biological phenomena generally attributed to 
endotoxins. 
Employing heated phenol-water mixtures (approximately 1:1 by weight), 
Westphal and his colleagues (1957) were able to obtain a lipopolysaccharide 
fraction from a strain of ~. ~ which contained neither protein nor 
nucleic acid. Moreover, they reported that the yield of their material 
was in the range of 2 to 3% of the whole dry weight of the bacteria. 
In addition, their product was e1ectrophoretica11y homogeneous as well 
as being highly pyrogenic. 
Because of the association of lipid and polysaccharide in endotoxin, 
and the generally accepted idea that the protein moiety is not essential, 
there exists a current tacit assumption that these two components are 
responsible for the toxic and antigenic properties respectively. From 
such lipopolysaccharide complexes, Westphal and Luderitz (1954) showed 
that chloroform-soluble material obtained by hydrolysis of bacterial 
1ipopo1ysaccharides with dilute hydrochloric acid retained some of the 
endotoxic properties of the original material. Therefore, they postu-
lated that the lipid component (lipid A) was responsible for the endotoxic 
activities of lipopo1ysaccharides. Moreover, Westphal and his associates 
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(1954, 1957) further suggested that for lipid A to exert endotoxic 
effects, it must be suitably dispersed in an aqueous medium, and they 
further predicted that were it possible to disperse lipid A in water 
comparable to its original state when bound to the polysaccharide 
carrier, it would display activity similar to that of endotoxin. 
Experimentally, they found that lipid A exerted one-fifth the potency 
of the original endotoxin when it was dispersed by detergents or coupled 
to an inert protein. However, Landy and Ribi and their associates 
(Ribi ~ !l., 1961; Haskins et al., 1961) have accumulated evidence 
against the concept that lipid A is responsible for the biological 
effects of endotoxin. They obtained endotoxins prepared by the cold 
aqueous-ether procedure from Salmonella enteritidis which contained a 
much reduced content of lipid without any lowering of its pharmacologic 
or antigenic activity. In addition, parallel quantitative bioassays of 
both lipid A and the endotoxins from which they had been derived revealed 
that these lipids contained less than 1% of the potency of intact endotoxin. 
In support of the idea that lipids are not responsible for the 
biological effects of endotoxin, Tauber ~ ale (1961) presented data 
that the lipid moiety of endotoxin could be removed by hydroxylaminolysis. 
They noted marked differences between endotoxins prepared by the phenol-
water method from 3 different species of gram-negative bacteria. After 
hydroxylaminolysis, however, the differences between these 3 species 
were retained in spite of the loss of the lipid component from the 
endotoxins. In later studies, Creech, Breuninger and Adams (1964) 
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made determinations of the chemical composition and antitumor properties 
of several polysaccharide fractions obtained by high speed centrifugation 
of aqueous extraots of the cells of Serratia marcescens following phenol 
extraction and trypsin digestion. According to these investigators, 
the use of methods that insured complete removal of lipid gave polysaccharides 
containing firmly bound amino acid residues. These polysaccharides 
were highly effective in causing complete regression of tumors in mice. 
They further reported that the products derived primarily from the cell 
wall were more potent than the polysaccharides of extracellular and 
cytoplasmic origins. In addition, extensive differences were noted 
in the chemical composition of the polysaccharide complexes isolated 
from the two sources. 
On the other hand, Nowotny (1963b) described several methods for 
the extraction of lipids from their endotoxic 0 antigen from a strain 
of Serr. marcescens. Best results were obtained with dilute formic 
acid. He found that this crude lipid mixture, when analyzed by paper 
chromotography, consisted of at least 16 different components. These 
and other data comparing the chemical structure of the liberated lipid 
with that of the lipid intact in the cell wall suggested to this investi-
gator that there is still no method that will isolate all the lipid 
components intact and free from other constituents of the endotoxic 
o antigen. 
Recently, Haskins ~ al. (1963) reported on simplifying the 
procedure for purifying the ~. enteritidis endotoxin complex. By 
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treating the aqueous ether extract of ~. enteritidis with phenol-water, 
they were able to reduce the nitrogen content from as much as 6~ to 
approximately 0.5%, while most of the lipoidal material (initially as 
much as 6-8%) was removed by treatment with LiAlH4 (lithium aluminum 
hydride) a Their end product was a high molecular weight polysaccharide 
which contained only small amounts of fatty acids, nitrogenous material 
and phosphorous. 
That an aqueous ether extract of~. enteritidis endotoxin undergoes 
extensive changes when subjected to treatment with 0.1 N acetic acid 
was reported also by Haskins et!1. (1961). They were able to show a 
marked reduction in the biological potency which occurred within minutes 
after such treatment. This reduction in biological potency continued 
progressively and after 60-90 minutes almost all of the original endo-
toxic activity had been abolished. These investigators hypothesized 
that a complex of critically large size was essential and that the 
destructive effect of 0.1 N acetic acid represented a splitting of bonds 
by which particles of the size of haptene are held together. On the 
other hand, they hypothesized that the major endotoxin properties were 
due to some small moiety whose attachment to a macro-molecular carrier 
was essential for activity. To substantiate these hypotheses, Ribi 
et al. (1962) extensively investigated the immunochemical and physio-
chemical changes of the ~. enteritidis endotoxin complex when subjected 
to hydrolysis with 0.1 N acetic acid. Samples of the product of hydrolysis, 
removed at various intervals, were examined in gel diffusion tests, in 
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the optical ultracentrifuge, and were also assayed for biological 
activity. Their gel diffusion tests revealed evidence of a progressive 
increase in the concentration of haptene during the exposure of endotoxin 
to acid. In the ultracentrifuge, the starting endotoxin showed as a 
single entity. However, as hydrolysis progressed, Q. second much slower 
moving boundary appeared. In addition, they were able to show that as 
the area under the fast moving endotoxin boundary decreased, the area 
under the slow moving boundary increased correspondingly. Further, 
their bioassays (lethality for BeG treated mice, resistance to infection, 
tumor damage, and pyrogenicity) showed that the degree of hydrolysis 
of the parent endotoxin and the per cent destruction of biological 
activity were approximately paralleled. The results obtained by these 
investigators were consistent and revealed that the rate at which host 
reactive properties were abolished paralleled the rate of dissociation 
of the endotoxin complex into haptenic units, particles whose size 
was of the order of 1/100 that of the original endotoxin. 
The separation and purification of Vi and 0 antigens of ~. typhi 
employing a column precipitation technique has been reported recently 
by Griffiths, Diena and Greenberg (1963). These authors reported that 
both Vi and 0 antigen fractions have been obtained in purified as well 
as separated forms employing alcohol fractionation as well as salt 
fractionation of the crude extract on an inorganic column bed. Alcohol 
fractionations alone neither separated nor purified the antigens 
signifioantly. However, when cetyl pyridinium chloride was maintained 
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in constant concentration in the elution solvents, the Vi and 0 serologically 
active materials could not be eluted by the usual alcohol-water solvents, 
but could be removed in separated and purified forms by the addition 
of MgC12 to the above alcohol-water solvent. 
In other recent studies, Nowotny and coworkers (1963a), in trying 
to relate structure to function in somatic antigens involving the use 
of six different methods for the extraction of endotoxin from three 
different enterobacteria, reported that not one of the methods can be 
applied generally for all gram-negative 0 antigen isolations. The different 
tribes of Enterobacteriaceae, as investigated by these workers, each 
required a different isolation procedure. Studies of the chemical 
composition of their preparations revealed many differences with no 
correlation between the chemical components and lethal toxicity or 
their serological reactivity. They concluded that the structural 
components or properties responsible for biological activity cannot be 
detected by gross chemical analysis. 
The data and results reported above by the various invest~gators 
and especially the results reported by Nowotny and coworkers apparently 
suggest that some of the differences of opinion between various scientific 
groups may be due largely to the individual properties of the particular 
bacterial strain under study. That this observation might prove to be 
true is seen from the elegant studies of Osborn !i al. (1964). Acoording 
to these investigators, the use of mutants of ~. typhimurium in which 
biosynthesis of specific lipopolysaccharide precursors is blocked has 
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made possible both biosynthetic studies and structural analyses which 
provide the basis for the structure of the core polysaccharide. These 
workers found that the simplest mutant, which is unable to synthesize 
UDP-glucose, forms only the backbone structure, containing heptose, 
phosphate, and keto-deoxy-octonate. To this backbone are attached side 
chains containing glucose, galactose, and N-acetylglucosamine. The 
resulting core structure is found in the lipopolysaccharide of the 
rough strain, as well as in that of the GDP-mannose-deficient mutant. 
On the other hand, long O-antigenic chains composed of repeating units 
containing galactose, mannose, rhamnose, and abequose are linked to the 
core in the wild type organism. These authors further found that no 
mutants have thus far been detected which lack the backbone or lipid 
portions of the lipopolysaccharide. Furthermore, it was thought that 
these parts of the lipopolysaccharide might play an essential role in 
the physiology of the organism. 
The presence of substantial amounts of nucleic acid in certain 
endotoxic extracts was shown by Ribi (1964a, 1964b) and Milner (1963) 
and their associates as evidence that some cellular mechanism facilitates 
the transfer of protoplasmic constituents into the cell wall extracts. 
They noted that the integrity of the cell wall was maintained upon 
extraction with either TCA or with aqueous ether, whereas extraction 
with phenol-water resulted in rupture of this structure with the 
consequent mixture of protoplasm and cell wall components. They further 
noted that, although neither TCA nor aqueous ether appear to rupture 
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cell walls, nucleic acids, under some circumstances, can pass into 
the endotoxic extracts. With these experimental observations in mind, 
the possibility was recognized that proteins, peptides, lipids, and/or 
carbohydrates from the protoplasm might, during the process of 
extraction, form stable complexes with endotoxic material from the cell 
wall at the moment they become solubilized, thus giving misleading 
information regarding the chemical composition of bacterial endotoxins. 
To gain further insight into this problem, two strains of !. coli, one 
strain of ~. enteritidis, and a strain of Serr. marcescens were disrupted 
mechanically (Ribi Refrigerated Cell Fractionator - Servall) and 
separated into cell walls and protoplasm (Fukushi et al., 1964b). These 
fractions plus extracts from each were then compared as to gross chemical 
composition and biological properties. They reported that a sharp 
separation had been effected, with biological properties largely 
restricted to the cell wall fractione In addition, the protoplasm 
was rich in nitrogen as well as appreciable amounts of hexosamine, 
esterified and amidic linked fatty acids, and carbohydrates. Of special 
interest, however, was the very substantial amount of nondialyzable 
carbohydrate in protoplasm, which approximated that in the cell wall. 
By exploring this latter experimental observation further, these 
investigators (Milner et al., 1963; Anacker et al., 1964; Ribi et al., 
1964a, 1964b) noted that when protoplasmiC material from~. coli was 
extracted with TCA, as much as 6% of this protoplasm was extracted in 
this reagent. Following dialysis, the product which they obtained had 
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a gross chemical composition similar to that of endotoxin prepared 
from intact cells, but differed from endotoxin in that it failed to 
stimulate the production of antibodies and to elicit the various host 
reactions. Apparently, this protoplasmic extract possessed the same 
serologic specificity and mobility in gel as their preViously mentioned 
acid haptene produced by 0.1 N acetic acid hydrolysis for 90 minutes. 
Furthermore, qualitative sugar analysis of endotoxin and protoplasmic 
haptene by paper strip electrophoresis indicated similar composition. 
The haptene contained fatty acids (determined by the hydroxamic acid 
method and expressed as palmitic acid) in the same proportion as 
endotoxin from the same strain; however, it was not yet certain whether 
or not these are qualitatively the same. In addition, no significant 
differences were noted in the infrared spectra of the protoplasmic 
haptene, acid haptene and endotoxin. Chemically, this hapten differed 
from endotoxin and from acid hapten in that it lacked phosphorus, 
heptose, long-chain fatty acids, and 2-Keto-3-deoxyoctonate. Ultra-
centrifugation revealed that the acid haptene was polydisperse, whereas 
the protoplasmic product, which had a similar sedimentation constant, 
was much more uniform, and possibly even monodisperse. 
Although Ribi and his associates (1961, 1962) have previously 
shown that haptene is the product of acid hydrolysis of endotoxin or 
of degradation by host enzymes, they do not believe the haptene extracted 
from protoplasm is a cleavage product of cell wall antigen. However, 
they do feel it is an anabolic product and it remains to be elucidated 
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whether this haptene has the necessary attributes for organization 
into a larger structure solely by colloidal-physical means or whether 
an enzymatic process will be required to construct the endotoxin 
molecule which will possess the characteristic antigenic and endotoxic 
properties. 
New types of acid polysaccharides, apart from the typical 0-
antigen lipopolysaccharide, which are capable of evoking some of the 
endotoxic reactions in animals has been described by Orskov et ale 
(1963) and Westphal et ale (1964). Employing extensive studies with 
the genus of ~. coli; that is, more than a hundred serologically 
classified strains were extracted with phenol-water, and the water 
extracts were analyzed, Westphal and his associates found that many 
of the Escherichia strains produced an acid polysaccharide which can 
be separated from the lipopolysaccharide and nucleic acid fractions by 
ultracentrifugation followed by cetavlon fractionation of the supernatant. 
The acid polysaccharide derived from a representative !. coli 
strain was obtained in a yield of 5.5% of the dried bacteria. Analysis 
revealed no O-acyl other than O-acetyl linkages of carbohydrates and 
no amino acids were found. However, small amounts of N-acetyl and 
N-acyl carbohydrates amide bound to B-OH long-chain fatty acids were 
present. The ratio of glucosamine:rhamnose:glucuronic acid:mannose 
was close to 1:1:1:2. 
This acid polysaccharide formed rather viscous solutions in water, 
and the data obtained from the sedimentation and diffusion constants 
66 
permitted the calculation of the molecular weight as being close to 
100,000. Periodate oxidation of the original and of the alkali-treated 
substance gave exactly the same results suggesting a large proportion 
of the a-acetyl groups being linked to the C6 position of mannose units. 
On the other hand, these investigators reported that the 
lipopolysaccharide (endotoxin) from the same strain was obtained in 
a yield of 2.5 to 3.0% with the sugar constituents being glucosamine, 
heptose, galactose, glucose and mannose. It was noted also that heptose, 
and especially galactose and glucose occur only in the lipopolysaccharide 
and not in the acid polysaccharide. In addition, they further noted that 
this lipopolysaccharide contained 12% of long-chain fatty acid ester, 
whereas the acid polysaccharide material contained no detectable amount 
of long-chain fatty acid ester. On the basis of these chemical differences 
for this particular strain of coli, these workers felt that the 
acid polysaccharide contained less than 2% of lipopolysaccharide. 
From another strain of ~. ~, these authors reported the 
isolation of a similar acid polysaccharide which was obtained in a 
yield of 7 to 8%. The main constituents were galactose, fucose, and 
galacturonic acid (1:3:2) which accounted for 85% of the substance. 
The corresponding lipopolysaccharide was composed of the same constituents 
as the lipopolysaccharide from the previous ~. coli strain: glucosamine, 
heptose, galactose, glucose, and mannose, with additional N- and O-acetyl 
carbohydrates and long-chain fatty acids. 
The purest preparations of these acid polysaccharides plus the 
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homologous lipopolysaccharides were tested for pyrogenicity in rabbits 
and horses (iv) and for toxicity in mice (ip). The minimal pyrogenic 
dose (MPD) of the acid polysaccharide obtained from the first strain 
of !. coli was found to be 0.003 ug/kg, which was of the same order 
as for the homologous lipopolysaccharide - also 0.003 ug/kg. In 
addition, the same results were found for both preparations when tested 
in horses. However, lethality tests in mice indicated that the acid 
polysaccharide was about 10 times less toxic than the lipopolysaccharide. 
These workers also noted that short treatment with 0.1 N NaOH at 560 C 
or incubation of the acid polysaccharide in normal horse serum at 370 C 
for 6 to 24 hours led to complete inactivation of the pyrogenicity. 
The rather high pyrogenicity, but rather low tOxicity, of these prepar-
ations of acid polysaccharides, according to these investigators, is as 
yet unexplained. In addition, traces of lipopolysaccharide could not 
be excluded from all these preparations. However, they recalled that 
all acid polysaccharides analyzed so far have had three constituents 
in common with endotoxins, namely glucosamine, an amide-like bound 
Beta-hydroxy long-chain fatty acid, and O-acetyl groups. Since these 
constituents could not be fully excluded with certainty, the possibility 
remained that they may be an integral part of a structure, common to 
endotoxically active bacterial products. 
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v. ! REVIEW OF METHODS EMPLOYED IN THE DETOXIFICATION QE ENDOTOXIN. 
Many attempts have been made to alter either selected antigenic 
fractions or the whole organisms, but the apparent loss in toxicity 
has almost always been accompanied by a corresponding decrease in 
antigenicity. In 1936, Morgan (1936) briefly mentioned the preparation 
of a specific polysaccharide isolated from She dysenteriae (Shiga) 
by direct treatment of the micro-organisms with hot acetic acid obtaining 
a degraded polysaccharide with little or no serological activity. In 
a later paper, Morgan and Partridge (1940) found that repeated forma-
mide treatment of the soluble antigen, extracted from the same organism 
with diethylene glycol with subsequent ethanol fractionation, yielded 
a polysaccharide which was very similar to the earlier reported degraded 
polysaccharide. It is of interest, however, that neither of these 
preparations were active antigenically. On the other hand, there was 
an apparent loss in mouse toxicities reported with the latter preparation. 
Freeman (1942), in reporting on the chemical characterization 
of an acetylated derivative, employed acetic anhydride to a "crude" 
polysaccharide prepared by tryptic digestion followed by 0.1 N acetic 
acid hydrolysis from ~. typhosa Tyl. He obtained a colorless amorphous 
solid which was insoluble in cold ethanol, ether, and water, but was 
soluble in chloroform, pyridine and acetone. He showed that pyridine 
and chloroform solutions of this acetyl polysaccharide did not precipitate 
with ~. typhosa O-antiserum. He concluded from these serological studies 
that the polysaccharide haptene loses its property of specifically 
reacting with the homologous antibody on conversion into the triaoetyl 
compound. 
Freeman (1943) also reported that a degraded polysaccharide can 
be obtained by direot extraction of the antigenio complex of ~. typhosa 
with mild acetic acid hydrolysis. He found the liberated polysaooharide 
to be non-antigenic and relatively non-toxic with a minimum moleoular 
weight of 10,000. However, it was apparently responsible for the 
speoific properties of the intact antigenic complex. In addition, 
this author reported that similar procedures were applied to the anti-
genio complex of ~. typhimurium. The polysacoharide obtained from this 
organism yielded very similar results from those already obtained with 
~. typhosa, but quantitative differenoes in the nature of the specific 
polysaooharides were found whioh apparently aocounted for the immuno-
logioal dissimilarity of the two species. 
In attempts to detoxify the Type V antigen extracted by aqueous 
pyridine (50%) from Shigella paradysenteriae, Goebel ~ ale (1945) met 
with disappointment. Among other prooedures, aoetylation with ketene 
gas as well as deamination with nitrous acid had no effect. Their 
attempts to detoxify this antigen revealed the remarkable stability 
of the toxic component to ordinary ohemical manipulation. 
Neter et ale (1956), studying the effeots of heat and ohemioals 
on erythrocyte-modifying, antigenic, toxic and pyrogenio properties 
of enterobacteriaoeal lipopolysaooharides, reported that periodate-
treated lipopolysaccharides lose their antigenic specificity and toxicity 
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but retain their pyrogenicity. However, prolonged treatment (60 min) 
of enterobacteriaceal lipopolysaccharides with diluted NaOH caused a 
decrease in both pyrogenicity and toxicity. This apparent reduction 
of biological effects induced by chemical modification of the endotoxin 
molecule suggested to these investigators that there may be specific 
reactive sites responsible for various toxic properties. 
Although quite complete chemical characterizations have been 
made by these early investigators, little or no information on the 
biological properties of their fractions is available with the exception 
that acetylated antigens apparently did not react serologically with 
antisera to the whole bacteria. However, Treffers (1946), and Treffers, 
Rubin and Bell (1946a) reported on having prepared a series of acetylated 
derivatives which were antigenic and comparatively non-toxic from the 
somatic lipopolysaccharide complex of She dysenteriae (Shiga) and of 
~. typhosa (Army strain 58). They dissolved the soluble toxic antigens 
in a small amount of water, diluted with several volumes of pyridine, 
and then allowed it to react at room temperature with an excess of 
acetic anhydride. Generally, these workers followed the technique 
of Freeman (1942) with the exception that his samples were removed at 
shorter intervals, and the reactions stopped by pouring aliquots into 
water. In most cases, the water soluble fractions showed an appreciable 
decrease in tOxicity over that of the original material, but the water-
insoluble fractions after acetylation were the least toxic. Toxicity 
tests in mice with doses as high as 3.0 mg produced no lethality upon 
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ip injection with the aoetylated soluble fractions obtained from the 
2h. dysenteria organism, whereas the mice injected with the undetoxified 
Shiga soluble antigen all died at doses of 0.4 mg. These investigators 
further reported on the temperature response in rabbits and found that 
approximately a 60 fold increase in dose (0.3 mg) of the Shiga acetylated 
fraction produced responses which were approximately equal to those 
given by the original toxic material (0.005 mg). In addition, they 
were able to show that, by prolonged immunization of rabbits, the Shiga 
acetylated fractions gave rise to antibody levels which would form 
precipitates with the acetylated fractions but not agglutinate the 
intact organisms. More important, however, they were able to show 
some active protection against intracerebral challenge with live §h. 
dysenteriae organisms by subcutaneous or intraperitoneal injection 
(0.05 mg) of these same acetylated fractions. Preliminary experiments 
in animals employing the acetylated derivatives of ~. typhosa indicated 
to these investigators that a comparatively non-toxic substance was 
also produced which was apparently antigenic. 
In recent years the detoxification of endotoxin without the 
apparent loss of antigenicity by various chemical methods has been 
reported by several investigators. In a series of papers, Freedman 
et ale (1961), Freedman and Sultzer (1962), and Sultzer and Freedman 
(1962) described methods by which they were able to dissociate many 
of the biological properties from endotoxin by acetylation of a 
Boivin-type lipopolysaccharide extracted from ~. typhosa. They obtained 
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three fractions (L, E, and p) employing acetic anhydride in the presence 
of anhydrous sodium acetate. Whereas fraction E retained full endo-
toxin potency as compared to complete inactivity for fraction L, 
fraction P showed dissociation of some of the biological effects of the 
parent endotoxin. They reported that pyrogenicity and acute toxicity 
were markedly reduced, and the ability to confer tolerance to the 
lethality and pyrogenicityofhomologous or heterologous endotoxins was 
diminished. In contrast to these characteristics, they were able to 
show that this acetylated (p) fraction retained its ability to stimulate 
phagocytosis and to enhance nonspecific host resistance to infection 
to a variety of bacterial infections (~. ~, ~. typhimurium, 
Staphylococcus aureus, and Pseudomonas aeruginosa). Furthermore, 
they reported that their detoxification procedure was reversible. The 
original toxicity and pyrogenicity was recovered followed by mild 
saponification. It was suggested by their data that the observed 
dissociation of biological properties could not be explained either 
by deacetylation of the derivative in ~ or by the observable alteration 
of the gross physical state. 
Noll and Braude (1961) reported the detoxification of endotoxin 
by reductive cleavage of ester bonds employing LiAlH4 yielding a prepar-
ation (RE fraction) of high immunogenic potency from a Boivin antigen 
of &. coli. Their chemically modified product showed virtually no 
toxicity or pyrogenicity when tested in mice and rabbits respectively. 
This reduction of pyrogenicity and toxiCity was suggested by these 
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investigators from their infrared studies of the removal of fatty acid 
esters. Further, their product failed to cause leukopenia in rabbits 
as well as intradermal inflammation in man. Unlike Freedman and 
Sultzer's preparation, however, these investigators reported that 
their product conferred tolerance to both the pyrogenicity and lethality 
of the parent endotoxin. In addition, comparative studies showed that 
reduction with LiA1H4 and controlled alkaline hydrolysis with LiOH 
gave products of different chemical and biological properties. Mild 
alkaline hydrolysis caused only moderate reduction of the pyrogenicity 
for rabbits as well as lethal toxicity for mice. 
Haskins et al. (1963) noted that if endotoxin, when prepared 
from ~9 enteritidis by either the aqueous ether or the trichloroacetic 
acid method, was treated with LiA1H4 and the reaction mixture was 
decomposed by the use of 1.0 N Hel by employing the method of Noll 
and Braude (1961), approximately one-half of the endotoxin was pre-
cipitated with the aluminum hydroxide. That is, the material they 
recovered from the supernatant fluid retained pyrogenicity, toxicity and 
the ability to stimulate nonspecific resistance of mice to challenge 
with ~o typhosa. Further, the endotoxin they separated from the 
aluminum hydroxide precipitate by extraction with citric acid solution 
also retained these biological properties. However, when the reaction 
mixture was decomposed with water alone by the method of Noll and 
Braude (1961), the products obtained had a substantial loss of activity. 
This loss of activity was thought to be due to the high alkalinity 
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of the reaction mixture after addition of water. In a more recent 
paper, Fukushi et ale (1964a) reported on the results of studies with 
the same culture and procedures as employed above by Noll and Braude 
(1961). They sought to confirm their findings and to obtain additional 
chemical data on the nature of the changes in bacterial endotoxins 
produced by treatment with LiAIH4. These investigators found that 
treatment of Boivin-type endotoxin from ~. ~ with LiAIH4 according 
to the procedures of Noll and Braude (1961) yielded a small amount 
(about 10%) of an essentially pure nonphosphorylated polysaccharide 
which was nontoxic and nonpyrogenic. In contrast to Noll and Braude's 
RE fraction, this product did not stimulate the production of anti-
bodies in rabbits, precipitate antibody nor produce tolerance to 
endotoxin. Further, the bulk of the product resulting from treatment 
with LiAlH4 consisted of biologically unaltered endotoxin. This 
fraction was isolated as a rapidly soluble, lipid-containing aluminum 
citrate-endotoxin complex, the infrared spectrum of which was nearly 
i.dentical to that of Noll and Braude's RE fraction with lOO-fold reduced 
pyrogenicity. Moreover, no correlation was found between the fatty 
acid ester content, as estimated from infrared spectra, and the toxic 
and p,yrogenic properties of the endotoxin. 
The use of a variety of chemical procedures for the purpose of 
detoxifying endotoxin preparations has been recently reported by 
Nowotny and his coworkers (1962, 196) and by Johnson and Nowotny (1964). 
EmplOying endotoxin isolated by the trichloroacetic acid method of 
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Boivin from Serro marcescens, these investigators found that toxicity 
could be decreased or completely abolished by chemical methods such 
as treatment with borontrifluoride, potassium methylate, pyridinium 
formate, or anhydrous liquid ammonia gas. Moreover, the ability to 
induce the second fever peak of the biphasic fever response 
characteristic of endotoxin was abolished, and, in addition, the 
capacity to prepare for the local Shwartzman reaction was reduced after 
such treatments. On the other hand, the resulting preparations produced 
in all cases a specific antiserum. However, the borontrifluoride 
procedure apparently reduced the antigenic character of the endotoxin. 
Further, they found that these endotoxoids greatly enhanced the non-
specific resistance of mice and rabbits against experimental infections. 
Nowotny (1964) suggested that the structural changes brought about 
by the use of these detoxification procedures produced one common 
specificity: cleavage of O-acyl linkages of carbohydrates. He arrived 
at this conclusion by employing the above chemical detoxification 
procedures on several compounds which had identical or very similar 
linkages with those present in the endotoxic 0 antigen (among others, 
D-glucose pentacetate, Tween 20, N-acetyl D-glucosamine, methyl-D-
glucoside, D-glucosamine 6-phosphate, and bis-p-nitrophenyl-phosphate). 
Methods other than chemical have been suggested for the detoxi-
fication of somatic antigens. Goebel and coworkers (1945) reported 
that after 3 hours of ultraviolet irradiation, antigens prepared from 
the Flexnor group of dysentery bacilli either by aqueous pyridine or 
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diethylene glycol lost 90% of their toxicity. However, they concluded 
that this reduction in toxicity was closely paralleled by the loss 
of antigenicity, thus not favoring this procedure as a sound approach 
for the detoxification of somatic antigens. On the other hand, Barnes 
at !l. (1947) have been more optimistic about the use of ultraviolet 
irradiation. Using a somatic antigen extracted from She paradysenteriae 
(Flexnor) by acetone fractionation, they have been able to report the 
separation of the toxic property from the protective property if the 
irradiation procedure is carried out slowly and with a low degree of uv 
light intensity. They have shown that 90% or more net reduction in 
tOxicity can be achieved when the antigen is irradiated for 12 hours 
with little loss of antigenicity. 
Mergenhage~Martin and Schiffmann (1963a) have recently isolated 
and characterized the endotoxin from a strain of a group C !. meningitidis. 
They reported that the lipoid isolated from this endotoxin appeared 
to be nontoxic and nonpyrogenic when tested for endotoxin activity. 
However, this same lipoid material in microgram quantities stimulated 
resistance in mice against a lethal !. ~ infection. In additional 
studies, Mergenhagen ~!1. (1963b) reported that, contrary to observations 
with similar doses of lipopolysaccharide, lipid-treated animals developed 
no phase of negative resistance to a lethal dose of !.~. They 
noted that the livers and spleens from the lipid-treated mice took up 
large numbers of !. coli after intravenous injection in comparison to 
those from untreated animals. In contrast to the protection afforded 
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mice against !. coli endotoxin pretreatment with meningococcal 
lipopolysaccharide, meningococcal lipid-treated mice appeared to be 
more susceptible to graded doses of endotoxin. Further, these investi-
gators reported that a particulate fraction from mouse liver released 
chloroform-soluble lipid from meningococcal lipopolysaccharide. as 
shown by the release of C14-labeled lipid from C14-labeled meningococcal 
lipopolysaccharide. This lipid was also able to increase host resistance 
in mice. From these data, the investigators proposed that lipid, 
released from lipopolysaccharide in ~ by tissue enzymes, may be 
one of the mediators of increased host resistance induced by lipopoly-
saccharides. 
In recent years, the method of detoxifying endotoxin by soluble 
tissue extracts has been described. Although the main body of this line 
of research is primarily interested in the degree in which most animals 
are able to destroy or detoxify endotoxins by natural resistance 
mechanisms, it is worthwhile noting the possible significance that 
might be achieved in vivo without the use of an outside stimulus such 
as specific immunization. That is, if the natural body defense mechanisms 
responsible for the inactivation of endotoxin could be stimulated at 
the time of an enterobacteriaceal infection, the clinician could have 
at his disposal another weapon for combating diseases caused by the 
gram-negative bacteria. 
Trapani and his associates (1962) have described the in vitro 
inactivation of endotoxin extracted from both ~. marcescens and 
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~. enteritidis by animal tissues. Their experiments indicated that 
cell free extracts of perfused rabbit liver inactivated these endotoxins, 
whereas rabbit liver slices yielded negative results. Of the other 
organs of the perfused rabbit which they examined, brain, heart and 
spleen produced negative results while the adrenal, kidney, and lymph 
nodes yielded produots of significant activity. They suggested that 
detoxification by the agent from rabbit liver was consistent with the 
requirements of an enzyme-oatalyzed reaction. Keene (1962), in describing 
the detoxification of baoterial endotoxin by soluble tissue extracts, 
also suggested that detoxification of endotoxin by tissue extracts is 
enzymatio in nature. He found that in vitro incubation of water-soluble 
extracts of rabbit liver, kidney, spleen and heart with endotoxin 
derived from ~. maroesoens resulted in inaotivation of the pyrogenic 
and tumor-neorotizing properties of endotoxin and was found to be 
dependent upon time and temperature of incubation. However, Smith ~!l. 
(1963) have described an endotoxin-detoxifying factor in tissue whioh 
differed from those reported by Trapani et aL and by Keene. They 
demonstrated their endotoxin-detoxification factor in dog spleen, and 
in low concentration in the liver, but not in other tissues of this 
animal. Further, they reported this factor to be a non-particulate 
fraction of dog spleen as well as being a protein with an esterase type 
of enzymatio behavior. Corwin and Farrar (1964), in reporting on the 
nature of the endotoxin-inactivating principle in guinea pig liver, 
found that these liver preparations inactivated ~. marcescens 
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endotoxin as assayed by the sensitive chick embryo test. The activity 
was optimal at pH 6.5 to 7.0 and 8.5 to 9.0. In additiont it was 
found that the mitochrondia and the supernatant fraction containing 
microsomes possessed activity with the mitochrondia being active only 
at the acid pH optimum. These workers further reported that the 
activity of acetone powder extracts of mitochrondia was increased 
by adenosine triphosphate and nicotinamide adenine dinucleotide, whereas 
the mitochrondia themselves were also activated by malate. It was con-
cluded from these studies that the enzymes which inactivate endotoxin 
involve fatty acid activation and oxidation thus suggesting to these 
authors that the lipid moiety of endotoxin is required for toxicity. 
In addition to these methods of detoxifying endotoxin by soluble 
tissue extracts t the incubation of bacterial endotoxins in either 
human serum or defibrinated plasma has been shown to result in repression 
of many of the biological properties of endotoxin (Atkins, 1960). 
Recently, Rudbach and Johnson (1962) and Yoshioka and Johnson (1962) 
reported on the characteristics of endotoxin altering fractions obtained 
from normal human serum. Employing the alcoholic fractionation of 
normal human defibrinated plasma by Cohn's method 10, these workers 
obtained two fractions capable of altering bacterial endotoXins. The 
incubation of endotoxin in Fraction IVlt resulted in a marked reduction 
in the ability of the specific antiserum to precipitate endotoxin. 
In addition the ability of this endotoxin to elicit a pyrogenic 
response in rabbits was also abolished. They further reported that 
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Fraction 1110 was generally incapable of producing such effects unless 
it was activated by several procedures. All other fractions resulted 
in no effect on these properties of endotoxins. It is of interest 
that the alteration of the lethal activity of endotoxin was not evident 
after incubation in Fraction lVI' but was rect~lced after exposure to 
activated Fraction 1110. They suggested that their data were consistent 
with the hypothesis that a possible enzyme system in normal human serum 
was responsible for destruction of the pyrogenic and serologic properties 
of endotoxin. Their results indicate this enzyme activity to be con-
fined to Fractions 1110 and IVI. 
The in vitro inactivation of gram-negative bacterial endotoxins 
by papain has been recently reported by Kim and Watson (1964). They 
found that reduced crystalline papain inactivated the pyrogenic and 
lethal activities of purified gram-negative bacterial endotoxins. 
The possible presence of peptide, ester and amide linkages within the 
macromolecular toxin and the known ability of the enzyme to split 
linkages of all 3 types indicated that it was not possible to implicate 
a specific linkage or group in endotoxin activity. However, they suggested 
that this purified enzyme may prove useful for further studies on the 
chemical nature of the active groups within the endotoxin molecule. 
Mergenhagen and Martin (1964) have recently described a phenol-
water preparation of C14_labeled ~. coli endotoxin of low solubility 
by treatment with lysozyme at pH 5.0 or 8.0 which effected a dissociation 
of this preparation. The products of dissociation were equally 
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distributed in the chloroform and water phases after extraction. It 
was further noted by these authors that concomitant with dissociation, 
recoverable endotoxin after lysozyme treatment had a reduced content 
of bound lipid, and dissolved easily in aqueous media to yield a clear 
solution~ Moreover, ultracentrifugation of the lysozyme-treated 
endotoxin revealed that it sedimented as a single major boundary with 
a sedimentation coefficient of 13.3. In addition, lysozyme-treated 
endotoxin was more potent than was the conventional endotoxin as shown 
by lethal activity in rabbits and pertussis-sensitized mice. Gel 
diffusion analysis also indicated to these investigators that the 
higher molecular weight component associated with conventional 
endotoxin was separated by lysozyme treatment, whereas lysozyme-
treated endotoxin, as shown by immunoelectrophoresis, was observed 
as a single sharp band of precipitation which migrated toward the 
cathode. 
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MATERIALS AND METHODS 
I • EXPERD1ENTAL ANIMALS 
A. Rabbits 
Testing for pyrogenicity was done in rabbits (Oryctoloagus 
cuniculus) that had been properly "screened tt by methods previously 
reported (Martin and Marcus, 1964b). To summarize, previously sham 
and pyrogen-free (PF) saline tested male and female rabbits obtained 
from a local source were used for testing. All rabbits weighed between 
3 and 5 kg, and were caged individually or in pairs in a constant 
temperature room. Pyrogen tests were carried out according to tech-
niques described in the United States Pharmacopeia (USp), XVI, (1960) 
with the following exceptions: all glassware was boiled in detergent 
solution, then rinsed with nonpyrogenic distilled water and heated 
in an oven at 2500 C for 2 hours; solutions to be tested were at room 
temperature rather than 370 C; temperature recordings were taken prior 
to injection and at 15 minutes, 1, 2, and 3 hours after injection. 
The results were interpreted as per the USP. 
In each experiment one group of rabbits injected with PF saline 
was included. This group served as a control for technique and other 
external factors such as temperature, humidity and noise. Rectal 
temperatures were measured with an electric-type thermometer operating 
on the thermocouple principle (model TE3; Ellab Instruments, Copenhagen, 
Denmark). Rabbits which yielded positive fever results, and were used 
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in more than one experiment involving pyrogenioity, were "rested" for 
two or more weeks as outlined by the United States Pharmacopeia (1960). 
B. Mice 
Tests for immunogenioity and lethality were performed in white 
Swiss mice (~musoulus) weighing approximately 20-25 grams; deaths 
were reoorded for a period of one week. 
II • CULTURES 
A. Baoterial Strains 
One strain eaoh of Salmonella tennessee and ~. typhimurium was 
employed. These organisms were originally obtained from the Utah State 
Department of Health. The organisms are maintained by transfer culture 
at monthly intervals on tryptose-phosphate agar slants, incubated at 
370 C for 24 hours and thereafter kept at room temperature. 
In order to determine the oomparative virulence of these two 
strains, the following mouse ohallenge experiment was performed. 
Eighteen hour cultures of both ~. tennessee and ~~ typhimurium grown on 
tryptose-phosphate agar slants were harvested with P.F water. The 
turbidity of eaoh suspension was adjusted approximately to a MoFarland 3 
employing the turbidity referenoe standard of the Division of Biologioal 
Standards (DBS), National Institutes of Health (NIH). Both live and 
muoin oell suspensions were prepared for ohallenge inooulum by employing 
serial 10-fold dilutions using PF water. The muoin suspension was 
prepared by suspending 5 grams of dehydrated hog gastrio muoin (Wilson, 
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type l70l-W) in 100 ml of distilled water. The pH was adjusted to 
7.2-7.4 with sodium hydroxide and the mucin suspension stirred with 
a magnetic stirrer at about 800 C for 15 minutes. The suspension was 
then strained through gauze and autoclaved for 30 minutes. Five-tenths 
ml of each of the 10-1 and 10-7 dilutions was added to 4.5 ml of the 5~ 
mucin preparation thereby obtaining 10-2 and 10-8 dilutions of the 
organisms in the mucin suspension. In addition 10-2 and 10-8 dilutions 
containing live cell suspensions (without mucin) were employed. Each 
set of six mice was inoculated intraperitoneally (ip) with 0.5 ml of the 
appropriate challenge inoculum. Moreover, one set of mice served as 
a control, being injected with PF water. All mice were observed over 
a three-day period which is the minimal observation time suggested by 
the Division of Biological Standards (DBS) of the National Institutes 
of Health (1953). 
The results of the virulence tests employing both organisms 
in mice are recorded in Table 1. It is apparent that the approximate 
MLD of the ip administered challenge was the dilution containing 10-2 
org./0.5 ml for both organisms regardless of whether mucin was present 
or not. However, the strain of ~. typhimurium appeared to be slightly 
more virulent under these conditions. This strain was employed 
exclusively in all of the experimental procedures to follow. 
III. PREPARATIONS 
A. Roschka-Edwards (RE) Procedure: Crude pyrogen substance was prepared 
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TABLE 1 
VIRULENCE TESTS IN MICE EMPLOYING THE FOLLOWING SUSPENSIONS 
OF SAIMONELLA TENNESSEE AND SALMONELLA TYPHIMURIUM 
Dilution Deaths 72 hours after Challenge * Organism 0.5 ml ip Live Mucin 
~. t~nne§~~~ 10-2 3/6 6/6 
10-8 2/6 2/6 
§.. tll2himurium 10-2 6/6 6/6 
10-8 2/6 0/6 
Control (PF water) 0/6 
* mortality ratio (deaths/total) 
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according to the following procedure (Edwards, 1951): 
Roux bottles containing approximately 100 ml of tryptose-phosphate 
broth (Difco) plus 2% agar were incubated with ~. typhimurium for 18 
hours at 370 C and the growth gently washed off with saline. The pooled 
washings were then heated in a boiling water bath for 2 hours. Sterility 
tests performed at this time and after 4 days were found to be negative. 
The sterile cell suspension was centrifuged at 40 C for 1/2 hour and the 
sediment was resuspended in 50 ml of absolute ethanol, incubated for 
24 hours at 370 C, and recentrifuged at 40 C. The sediment was re-
suspended in 50 ml of absolute ethanol and incubated for another 24 
hours at 370 C. The cells were again centrifuged at 40 C, the alcohol 
was replaced with acetone, and then taken through two further changes 
of acetone. The sediment was dried at 370 C and then ground to a fine 
powder. This powder, consisting primarily of the "hulls" of these 
Salmonella organisms, was further disintegrated by the use of an 
ultrasonic disintegrating device. Fifteen ml of PF water was added to 
1500 mg of this crude endotoxin and disintegrated (Sonifier, Branson 
Instruments, Stanford, Connecticut) for 15 minutes under sterile conditions. 
The suspension was then filtered (Millipore filter) and the precipitate 
dried overnight at 370 C. Employing this procedure of sonification 
produced no visible changes in yield or in alteration of this crude 
endotoxin. Hereafter, this product will be referred to as the parent 
RE preparation. 
B. Acetylation Procedure (Freedman and Sultzer, 1962): 
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To 500 mg of sonified parent RE preparation were added 115 ml 
of acetic anhydride and 75 mg of anhydrous powdered sodium acetate 
as a basic catalyst. The reaction mixture was heated in a capped 
centrifuged bottle in a boiling water bath for 4 hours with occasional 
mixing 0 After cooling, the acetic anhydride was removed as a clear 
solution by decantationo The remaining insoluble material was freed 
of anhydride by drying at room temperature under a stream of nitrogen. 
Once dried, it was ground to a powder by mortar and pestle. This 
was washed 3 times with 100 ml portions of saline and once with water. 
The washes were removed by centrifugation at low speed yielding a 
clear supernatant solution which was discarded due to its apparent 
inactivity in the test animal. However, Freedman and Sultzer (1962) 
obtained an opalescent solution at this point. By dialyzing their 
combined washes, they were able to obtain a preparation (fraction E) 
which amounted to 20-25% of their starting material which retained 
full endotoxic potencyo However, unlike our starting material, they 
started with a Boivin preparation. The washed precipitate was dried 
under nitrogen and ground to a powder. This powder, amounting to 
approximately 65% of the starting material, was granular in appearance, 
light tan in color and strongly lyophobic. The yield was 324 mg 
(64.8%) with some loss due to personal technique. Chemical analysis 
of the acetyl content (Australian Microanalytical Service, University 
of Melbourne) as COCH) (methanolic NaOH used as the sapOnification 
agent) was 6.8%. A stock solution of 50 mg/IO ml was readily 
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prepared by adding a small amount (0.5-1 ml) of saline and tritur-
ating thoroughly with a mortar and pestle in order to wet and 
disperse the solids. Saline was added in small aliquots as the 
lyophobio powder was worked into suspension. It should be noted 
that, as with the parent RE preparation, this stook solution should 
be mixed thoroughly before testing since the suspension is rather 
dense and separates readily. Hereafter, this product will be referred 
to as the aoetylated Roschka-Edwards (Acet-RE) preparation. 
Attempts to reoover an anhydride-soluble, water-insoluble material 
by pouring the anhydride solution into excess cold water and filtering 
it yielded a small amount of solids which accounted for less than 
10% of our starting material. Since the yield was small, no attempt 
was made to test its biological effects in animals. Freedman and 
Sultzer (1962), however, obtained a rather large amount (30-35~) of 
this anhydride-soluble, water-insoluble material from their Boivin 
preparation of endotoxin (fraction L) which they reported as having 
complete inactivity for pyrogenicity and lethality in their test animals. 
Co Periodate Procedure (Neter et al., 1956): 
The periodate-treated RE crude endotoxin was prepared as follows: 
200 mg of the parent RE preparation was suspended in 160 ml of PF 
distilled water; 20 ml of 1.0 N sodium acetate buffer (pH 5.0) as 
well as 20 ml of 0.1 N potassium periodate solution were added. 
This material was kept in the dark for 24 hours at room temperature 
and then dialyzed in cellophane (Visking)casing against distilled 
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water for 24 hours. Finally, it was concentrated by pervaporation 
at room temperature and lyophilized. The resulting product was a 
light, white, fluffy powder with a yield of 112 mg (56%). Although 
Neter and his associates employed 0.1 N sodium periodate solution 
in their procedure, it is of interest to note that the potassium 
periodate-treated RE material in identical concentrations reacted 
in a similar manner; i.e., our lyophilized oxidation product was also 
insoluble in distilled water, but was soluble upon the addition of 
small amounts of 1.0 M NaOH and subsequent neutralization with dilute 
acetic acid. The soluble stock suspension of 50 mg/IO ml was readily 
prepared and had a characteristic milky color. 
D. Potassium Methylate Procedure (Nowotny, 1963): 
The parent RE preparation was "purified" by extraction with 
anhydrous methanol, a procedure which removes inert impurities but 
does not alter the biological properties of endotoxins (Nowotny et !l., 
1963). To 1 gram of dry RE preparation, 250 ml of methanol were added, 
and the resulting suspension refluxed on a hot-plate with continuous 
magnet-stirring for 60 minutes, cooled and finally centrifuged in 
the cold at 2,500 rpm for 10 minutes. The clear supernatant was 
drawn off and the precipitate dried in a vacuum desicator for 48 
hours. This "purified" RE preparation was subjected to the following 
chemical procedures. To 200 mg of the foregoing RE preparation, 40 
ml of 0.02 M potassium methylate in anhydrous methanol were added 
and the mixture refluxed for 60 minutes. The insoluble residue was 
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oentrifuged in the oold at 2,500 rpm for 10 minutes, washed with 
methanol and dried in a vaouum desioator. This preparation, unlike 
the Aoet-RE preparation was a very fine, light powder whioh was ivory 
in oolor, and sparingly soluble in saline in small amounts. The 
yield was 169.1 mg (84.6%). 
E. Boron Trifluoride (BF3) Prooedure (Nowotny, 1963): 
In this prooedure 500 mg of previously I'purified It (methanol 
refluxed) RE preparation was refluxed for 1 hour with 50 ml of 2% 
boron trifluoride in anhydrous methanol (~. 800 C). The reaotion 
mixture was diluted with 4 volumes of water and dialysed against 
distilled water for 96 hours. The dialysed material~as then 
oentrifuged in the oold at 2,500 rpm for 10 minutes and the resulting 
residue dried in a vacuum desicator. This preparation resembled the 
Aoet-RE preparation in that it was tan in oolor, granular in 
appearance with a oonsistenoy of fine sand and mildly lyophobio. 
The yield was 233.3 mg (46.7%). 
Stock solutions of the potassium methylate and BF3 preparations 
were prepared in the following manner. A stock solution of 50 mg/IO ml 
was readily prepared by adding 0.1 ml of saline and triturating with 
mortar and pestle in order to thoroughly wet and disperse the solids. 
Saline was added in small aliquots as the powder was worked into 
suspension. It should be noted that, as with the Acet-RE and HE 
preparations, these stock solutions should be thoroughly mixed before 
testing since both suspensions are dense and separate readily. 
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In all procedures, precautions to avoid contamination by 
extraneous pyrogens were rigorously observed. All glassware and 
other apparatus were heated at 2500 C for 2 hours before use and 
saline and distilled water were proved to be pyrogen-free (PF). 
F. Boivin Preparation: 
Lipopolysaccharide extracted by trichloroacetic acid (TCA) 
from §.. typhimurium was used as the source of "pure" endotoxin 
(Difco Laboratories, Detroit). 
G. ~-Killed, Phenol-Preserved (HP) Vaccine: 
A freshly prepared heat-killed, phenol-preserved (HP) vaccine 
of §.. typhimurium was prepared in the following manner. Eighteen-
hour cultures of §.. typhimurium, grown on tryptose-phosphate (Difco) 
agar, were harvested in saline. After filtering the suspension 
through sterile glass wool, the organisms were heated in a 560 C 
waterbath for 2 hours. Following heating, the suspension was cooled 
to room temperature and standardized turbidimetrically by the McFarland 
Method (Kolmer and Boerner, 1945). Dilutions were prepared in PF 
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saline to give a final concentration of 1.8 x 10 organisms per ml 
(McFarland #6) of saline containing 0.5~ phenol. The vaccine was 
then put up in sterile Vials, fitted with the appropriate sterile 
rubber stoppers, and stored in the refrigerator until ready for use. 
All sterility tests made on each lot of vaocine were negative for 
growth. 
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IV • METHOD OF CHALLENGE 
AQ Active-Immunized Mouse Protection Test: 
The potency of the vaccines was, for the most part, determined 
by active-immunized mouse protection tests as outlined by the Public 
Health Service, Division of Biologic Standards (1953). In each test, 
groups of 20 mice were immunized with 2 weekly subcutaneous (sc) 
injections in a volume of 005 mI. The number of bacteria in 0.5 ml 
of the HP vaccine was approximately 900 x 106 organisms. A group 
of 20 mice given 0.5 ml of saline served as a control for each 
challenge. All mice were challenged with the same ~. typhimurium 
strain 7 days after immunization with approximately 10 1050 (1084) 
doses by the ip route. This challenge dose was sufficient to kill 
about 80-90% of the mice in the saline control group within 24-48 
hours and was prepared from the harvest of an 18 hour tryptose-phosphate 
agar slant suspended in PF watero This harvest was standardized 
turbidimetrically by employing the turbidity reference standard 
(DBS, NIH), and confirming the challenge numbers by subsequent viability 
oounts. The mouse virulence of each challenge oulture was ascertained 
by ip inoculation of 0.5 ml of the culture suspended in PF water. 
1050 values of approximately 2.66 x 106 bacilli, as calculated by 
both the methods of Reed and Muench (1938) and Miller and Tainter 
(1944) were obtained. For further discussion conoerning ~. typhimurium 
as a challenge inoculum reference please see Experimental Results, 
Part III. 
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V .. SEROLOGICAL TESTS 
.A.. Preparation of ~-Q. Serum (Edwards and Ewing, 1962): 
Since the procedure for preparing the parent RE crude endotoxin 
inactivates the H antigen while retaining the 0 antigen, this preparation 
was used to immunize rabbits for the production of anti-O serum. 
Each rabbit received four intravenous (iv) injections administered 
at 4 day intervals, the first of which consisted of 0.5 ml of a 
suspension comparable in density to a 24-hour broth culture. The 
doses were increased in volume (twofold increments) at each injection 
and the suspensions rapidly increased in density 50 that very large 
numbers of the organisms are administered at the third and fourth 
injections. Employing standard agglutination procedures, high titered 
sera ( 1:2560) were obtained by this method. The immune sera were 
obtained from these animals by cardiac puncture six days after the 
last injection. The serum was separated from the clot, heated at 
560 C for 30 minutes, and stored in a refrigerator at _200 C. 
B. Double Diffusion Test Procedure: 
Agar gel precipitin tests were carried out by the method of 
Ouchterlony (1948)0 Different concentrations of endotoxoids as well as 
immune and normal rabbit sera were placed in the wells appropriately 
arranged in agar plates. In other experiments different endotoxoid 
preparations but at the same concentrations were similarly placed in 
the wells and tested against either immune or normal rabbit sera. The 
diameter of the antigen and antibody wells was 7 mm and 9 rom respectively, 
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and the distance between centers of the wells was 18 Mm. In order 
to inhibit nonspecific band formation in these tests, two per cent 
agar (Difco) in pH 7.2 glycine buffer (14%) was employed. The bands 




I. EXPERIMENTS DESIGNED TO STUDY THE PYROGENIC PROPERTIES OF 
SALMONELLA TYPHIMURIUM ENDOTOXOID PREPARATIONS 
A. Effect of injecting rabbits with ~ parent RE preparation. 
Results reported previously (Martin and Marcus, 1964a) indicated 
that the minimum pyrogenic dose (MPD) of dry material from either an 
RE or a Boivin preparation from the 055:B5 strain of ~. coli was 
approximately 1.0 ug. Table 2 shows similar results in rabbits when 
an RE preparation from ~. typhimurium was employed. Both the 1 and 10 
ug amounts of this preparation produced comparable fevers in rabbits 
as interpreted by USP procedure. 
B. Effect of injecting rabbits with !. Boivin preparation. 
In this experiment, rabbits were injected with a comparatively 
"pure" endotoxin. A TCA extract of the working strain of 2,. typhimurium 
yielded the data shown in Table 3. As was noted previously concerning 
the ~. coli preparations, these results in Table 3 as well as those 
in Table 2 show excellent agreement with the results obtained with 
the same 2 preparations from a strain of 2,. typhimurium. That is, 
a 1 ug amount of either an RE or a Boivin preparation from a strain 
of 2,. typhimurium also represents the MPD. Moreover, these results 
indicate that the RE preparation is pyrogenic in rabbits in concen-
trations similar to the relatively "pure" endotoxin (Tables 2 and J). 
C. Effect of injecting rabbits ~ ~ potassium periodate RE preparation. 
Tables 4 and 5 show the pyrogen test results obtained with the 
potassium periodate RE preparation as interpreted by USP definition. 
It can be seen from Table 4 (Maximum Temperature Change column) that 
all of the rabbits tested with this preparation gave negative results 
to the 1, 10, and 50 ug test amounts. On the other hand, Table 5 
shows a MPD response in rabbits with 200 ug of the potassium periodate 
RE preparation as compared to the negative pyrogen test results reoorded 
for the control animals shown in both Tables 4 and 5. 
D. Effect of injecting rabbits with !!! Acet-RE preparation. 
The pyrogen test results obtained with the Acet-RE preparation 
are shown in Tables 6 and 7. It can be seen from the Maximum Temperature 
Change column in Table 6 that all of the doses tested for pyrogenioity 
in rabbits gave negative results. However, definite febrile responses 
in rabbits are shown in Table 7 tested with 200, 500, and 1,000 ug 
amounts, respectively. Negative results recorded for the control 
animals are shown in both Table 6 and 7. 
E. Effect of injeoting rabbits with ~ potassium methylate RE preparation. 
Tables 8 and 9 show the pyrogen test results obtained with the 
potassium methylate, and BF3 preparations as interpreted by USP definition. 
It can be seen from the Maximum Temperature Change column in Table 8 
that only the 1 ug amount of the potassium methylate preparation tested 
for pyrogenicity in rabbits gave a negative result, whereas the 10 
and 100 ug amounts both yielded positive febrile responses in rabbits 
respectively. 
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Fo Effect of injecting rabbits with ~ boron trifluoride RE preparation. 
Table 9 shows the fever responses in rabbits when injected with 
1, 10 and 100 ug amounts of the BF) preparation. With the exception 
of the saline injected control animals, all) of these preparations 
were pyrogenic in rabbits. 
Go ! summary of the wogen ~ responses in rabbits employing the 
endotoxoid preparations. 
The pronounced reduction in pyrogenicity exhibited by the Acet-RE 
and the potassium periodate RE preparations are shown in summary form 
in Table 10. The data indicate a )100 <: 200 fold reduction in rabbit 
pyrogenicity for both preparations when compared with comparable doses 
of parent RE and Boivin preparations. Although these experiments 
approximate the upper and lower limits of decrease in pyrogenicity 
for the preparations concerned in this dissertation only, it is 
interesting to note that the pyrogen test results with the Acet-RE 
preparation compare favorably with those reported by Freedman and Sultzer 
(1962). On the other hand, the results obtained with the potassium 
periodate HE preparation indicate an approximate 25,000 fold reduction 
in pyrogenicity when compared to the periodate-treated !. ~ lipopoly-
saccharide (MPD 0.001) ug/kg) as reported by Neter et ale (1956). 
Furthermore, under similar conditions, the potassium methylate and BF) 
procedures yielded a 10 fold loss and no loss of pyrogenicity respectively 
when compared to the parent RE preparation. As elaborated upon in the 
Discussion these results are comparable with those recently reported 

















EFFECT OF INJECTING RABBITS INTRAVENOUSLY WITH A 






0.1 ug/33 ml PBS 
.. 
II 
1 ug/33 m1 PSS 
.. 
.t 


















1 hr. 2 hr. 3 hr. 
39.7 39.7 39.7 
40.0 39.8 39.9 
39.7 39.5 39.7 
39.6 39.7 39.8 
39.7 39.8 39.8 
39.4 39.5 39.4 
39.4 39.6 39.9 
40.6 41.4 41.5 
40.6 40.7 41.0 
41.1 41.0 41.4 
40.3 40.6 40.2 
40.1 40.2 40.3 
+ interpreted as per USP XVI procedure 




























EFFECT OF INJECTING RABBITS INTRAVENOUSLY WITH A 
BOIVIN PREPARATION EXTRACTED FROM SALMONELLA TYPHIMURIUM + 
Amounts Control Temperature, 0C 
Tested Temp. 15' 1 hr. 2 hr. 3 hr. 
PFPSS * 39.9 40.3 40.0 39.7 40.0 
" 
40.6 40.7 40.3 39.9 40.2 
n 40.2 40.4 40.1 39.9 40.3 
0.1 ug/33 m1 PSS 40.4 40.6 40.3 40.2 40.5 
" 
40.5 40.4 40.2 39.7 40.0 
" 
40.4 40.2 40.2 40.2 40.5 
1.0 ug/33 m1 PSS 39.9 39.7 39.9 40.4 40.6 
" 
39.6 39.4 39.8 39.8 40.3 
" 
40.0 39.7 39.7 40.3 40.5 
+ interpreted as per USP XVI procedure 














EFFECT OF INJECTING RABBITS INTRAVENOUSLY WITH A 
POTASSIUM PERIODATE RE SALMONELLA TYPHIMURIUM PREPARATION + 
Rabbit Amounts Control Temperature, °C 
Number Tested Temp. 15' 1 hr. 2 hr. 3 hr. 
25 PFPSS * 40.3 38.7 38.7 39.1 40.0 
24 
" 
40.4 38.8 38.9 39.4 40.8 
23 
" 39.9 38.7 38.6 38.9 39.1 
22 1 ug/33 ml PSS 40.2 38.4 38.5 38.8 39.1 
20 
" 
40.2 38.4 38.5 39.0 39.5 
18 
" 
40.2 38.7 38.8 39.1 39.5 
17 10 ug/33 ml PSS 40.4 38.6 38.7 39.2 39.8 
15 " 40.2 38.7 38.9 39.2 39.7 
4 .. 40.3 38.8 39.0 39.3 39.7 
3 50 ug/33 m1 PSS 40.3 40.7 40.6 39.9 40.6 
5 " 40.2 40.5 40.4 40.2 40.5 
6 II 40.1 40.3 40.4 39.8 40.6 
+ interpreted as per USP XVI prooedure 































EFFECT OF INJECTING RABBITS INTRAVENOUSLY WITH A 
POTASSIUM PERIODATE HE SALMONELLA TYPHIMURIUM PREPARATION + 
Amounts Control Temperature, °c 
Tested Temp. 15' 1 hr. 2 hr. 3 hr. 
PFPSS * 40.4 40.6 40.6 40.6 40.1 
n 40.2 40.5 40.4 40.4 40.2 
It 39.6 39.9 39.9 40.0 39.6 
100 ug/33 m1 PSS 39.9 38.2 38.6 39.3 39.8 
.. 40.5 38.9 39.4 40.6 41.0 
It 40.5 39.1 39.9 40.4 40.7 
200 ug/33 m1 PSS 40.3 40.3 40.6 40.3 41.3 
" 39.8 40.1 39.4 39.8 40.9 
It 40.1 40.3 40.6 40.4 41.5 
500 ug/33 m1 PSS 39.8 40.2 40.8 40.0 40.7 
" 
40.1 40.6 41.2 41.1 41.1 
" 
40.2 40.6 41.4 40.3 42.1 
+ interpreted as per USP XVI procedure 































EFFECT OF INJECTING RABBITS INTRAVENOUSLY WITH AN 
ACET-RE SALMONELLA TYPHIMURIUM PREPARATION + 
Amounts Control Temperature, °c 
Tested Temp 15' 1 hr. 2 hr. 3 hr. 
PFPSS * 40.1 40.4 40.1 40.0 39.8 
II 40.1 40.1 40.2 39.8 39.7 
" 40.5 40.5 40.5 40.0 40.1 
1 ug/33 m1 PSS 40.6 40.6 40.6 40.3 40.4 
It 40.3 39.9 40.1 39.9 39.9 
*' 40.4 39.9 40.1 40.0 40.3 
10 ug/33 m1 PSS 40.9 40.7 40.3 40.4 41.0 
.. 40.6 40.4 39.9 40.5 41.0 
" 
40.1 39.6 39.3 39.3 39.6 
100 ug/33 m1 PSS 40.8 40.4 40.6 40.7 41.0 
II 40.9 40.3 40.4 40.6 40.9 
tt 40.7 40.3 40.4 40.6 41.2 
+ interpreted as per USP XVI procedure 































EFFECT OF INJECTING RABBITS INTRAVENOUSLY WITH AN 
ACET-RE SALMONELLA TYPHIMURIUM PREPARATION + 
Amounts Control Temperature, °c 
Tested Temp. 15' 1 hr. 2 hr. 3 hr. 
PFPSS * 40.3 40.2 40.0 39.4 39.5 
.t 39.7 39.8 39.7 39.5 39.7 
II 40.0 40.1 39.9 39.8 39.7 
200 ug/33 ml PSS 40.4 40.3 40.8 41.1 41.0 
.. 40.5 40.5 40.7 41.2 41.3 
" 
40.3 40.4 40.6 40.8 40.7 
500 ug/33 ml PSS 39.5 39.7 39.9 39.9 40.3 
.. 40.3 40.3 40.8 40.8 41.3 
II 40.4 40.2 40.7 40.7 40.9 
1000 ug/33 ml PSS 40.1 40.1 40.4 40.4 41.1 
" 
40.6 40.2 40.4 40.5 41.3 
" 
40.5 40.4 40.9 40.7 41.2 
+ interpreted as per USP XVI procedure 































EFFECT OF INJECTING RABBITS INTRAVENOUSLY WITH A 
POTASSIUM ¥JETHYLATE RE SALMONELLA TYPHIMURIUM PREPARATION + 
Amounts Control Temperature, °C 
Tested Temp. 15 ' 1 hr. 2 hr. :3 hr. 
PFPSS * 39.5 39.1 39.5 39.5 39.7 
" 
40.0 39.7 40.2 40.2 40.4 
" 39.9 39.6 39.8 39.6 39.8 
1 ug/33 m1 PSS 39.3 38.9 39.2 39.2 39.6 
It 40.3 40.1 40.1 40.2 40.5 
" 39.4 39.0 39.2 39.2 39.4 
10 ug/33 m1 PSS 39.8 39.7 40.3 40.2 40.5 
" 39.9 39.8 41.0 40.9 41.2 
II 39.9 39.7 40.2 40.8 40.9 
100 ug/33 m1 PSS 40.0 40.3 41.0 40.9 41.6 
" 39.3 38.8 39.2 39.6 40.1 
n 39.2 39.5 39.9 40.2 40.5 
+ interpreted as per USP XVI prooedure 































EFFECT OF INJECTING RABBITS INTRAVENOUSLY WITH A 
BORON TRIFLUORIDE RE SAIMONELLA TYPHIMURIUM PREPARATION + 
Amounts Control Temperature, °c 
Tested Temp. 15 ' 1 hr. 2 hr. 3 hr. 
PFPSS * 39.7 39.6 39.6 39.6 39.7 
!' 39.5 39.5 39.5 39.6 39.8 
.. 39.3 39.4 39.4 39.5 39.7 
1 ug/33 m1 PSS 39.6 39.8 40.0 40.2 40.5 
" 39.9 40.0 40.4 40.6 40.9 
.. 39.4 39.5 39.6 39.7 39.8 
10 ug/33 m1 PSS 39.0 39.0 39.2 39.5 39.7 
" 
40.0 39.8 40.0 40.3 40.4 
tI 39.4 39.4 39.7 40.4 40.5 
100 ug/33 m1 PSS 39.6 39.7 40.5 40.5 40.5 
tt 40.2 40.3 40.5 40.9 41.2 
tt 39.3 39.5 40.1 40.5 40.5 
+ interpreted as per USF XVI procedure 
















A SUMMARY OF THE PYROGEN TEST RESPONSES IN RABBITS EMPLOYING 
THE ENDOTOXOID PREPARATIONS OF SALMONELLA TYPHIMURIUM 
-' 
~mounts Fever Responses with 
rrested * RE Boivin Acet-RE BF) Potassium Periodate 
0.1 
- -
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II. EXPERIMENTS DESIGNED TO STUDY THE LETHAL EFFECTS OF 
SALMONELLA TYPHIMURIUM ENDOTOXOID PREPARATIONS 
A. Lethality of potassium periodate RE, RE, and Boivin preparations 
injected intraperitoneally ~ ~. 
Table 11 presents the data from experiments comparing the lethality 
in mice of ip injections of 5 individual potassium periodate RE concen-
trations with that of the parent RE and Boivin preparations, respectively. 
Both the periodate-treated RE and the parent RE preparations, employing 
similar conditions, indicate no lethality in mice at the concentrations 
shown ()2,500 ug). These data suggest that the oxidation of the parent 
RE preparations with potassium periodate had little effect on mouse 
lethality. Moreover, these results correlate well with the findings 
of Neter et ale (1956) in that the periodate procedure yields a com-
pound of low toxicity. The results shown for the Boivin (TCA) 
preparation indicate that a "pure" endotoxin is much more lethal at 
higher concentrations than either the potassium periodate RE or parent 
RE preparations, respectively. That is, the Boivin preparation shows 
an LD.50 response in mice with approximately 2 mg, whereas under 
similar conditions, neither the periodate-treated nor the parent RE 
preparations approach an LD.50 response in mice 7 days after ip injection 
of 2 • .5 mg. 
B. Lethality of Acet-RE, RE, and Boivin preparations injeoted intra-
peritoneally ~ ~. 
The data from experiments comparing mouse lethality by ip injeotion 
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of 5 individual acetylated concentrations with that of the parent RE 
and Boivin preparations respectively are shown in Table 12. Comparing 
the parent RE preparation, which again is apparently non-lethal for mice 
at the doses shown, with similar amounts of Acet-RE preparations 
suggests that acetylation may induce lethality in mice at high concen-
trations (> 500 ug)o However, as was shown in the previous table (Table 11), 
the Boivin preparation shows an LD50 response between 500 ug and 2000 ug, 
whereas neither the Acet-RE nor the RE preparations approach an 1050 
response throughout the observation period with any of the doses shown. 
As elaborated upon in the Discussion, these data are in line with those 
of Freedman and Sultzer (1962). 
c. Lethality of potassium methylate RE, boron trifluoride RE, ~ RE 
preparations injected intraperi toneally into mice. 
Table I) shows the data from experiments comparing the lethality 
in mice by ip injection of 5 individual potassium methylate and BF3 
preparations with that of the parent RE preparation. A comparison of 
the parent RE preparation with similar amounts of potassium methylate 
and BF) preparations suggests that neither of these procedures altered 
the lethality of the parent endotoxin molecule. That is, all of the 
preparations are apparently non-toxic in mice in amounts of at least 
2.5 mg. Furthermore, the mouse lethality data shown for the potassium 
methylate and BF3 preparations in Table 13 agree with those of Johnson 




LETHALITY OF POTASSIUM PERIODATE RE, RE, AND BOIVIN PREPARATIONS 
OF SALMONEl/LA TYPHIMURIUM INJECTED INTRAPERITONEALLY INTO MICE 
Dose * No. of Cumulative Deaths, in Days 
Preparation (ug) Mice 1 2 3 
Potassium 2.5 8 0 0 0 
Periodate 
RE 25 8 0 0 0 
250 8 0 0 0 
500 8 0 0 0 
2500 8 0 0 0 
RE 2.5 8 0 0 0 
25 8 0 0 0 
250 8 0 0 0 
500 8 0 0 0 
2500 8 0 0 1 
Boivin 2.5 8 0 0 0 
25 8 0 0 0 
250 8 0 0 0 
500 8 2 2 3 
2500 8 5 7 7 
Saline Controls 8 0 0 0 




















LETHAUTY OF ACET-RE, RE, AND BOIVIN PREPARATIONS OF 
SALMONELLA TYPHIMURIUM INJECTED INTRAPERITONEALLY INTO MICE 
Dose * No. of Cumulative Deaths, in Days 
Preparation (ug) Mice 1 2 3 7 
Acet-RE 2.5 8 0 0 0 0 
25 8 0 0 0 0 
250 8 0 0 0 0 
500 8 1 1 1 1 
2500 8 2 2 2 2 
RE 2.5 8 0 0 0 0 
25 8 0 0 0 0 
250 8 0 1 1 1 
500 8 0 0 0 0 
2500 8 0 0 0 0 
Boivin 2.5 8 0 0 0 0 
25 8 0 0 0 0 
250 8 1 1 1 1 
500 8 1 2 4 4 
2500 8 6 7 7 7 
Saline Controls 8 0 0 0 0 
* 
all preparations given in 0.5 m1 saline 
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TABLE 13 
LETHAUTY OF POTASSIUM METHYLATE RE, BORON TRIFLUORIDE RE, AND RE 
PREPARATIONS OF SALMONELLA TYPHIMURIUM INJECTED INTRAPERITONEALLY INTO MICE 
Dose * No. of Cumulative Deaths, in Days 
Preparation (ug) Mice 1 2 3 7 
Potassium 2.5 8 0 0 0 0 
lVlethylate 
RE 25 8 0 0 0 0 
250 8 0 0 0 0 
500 8 0 0 0 0 
2500 8 0 0 0 0 
Boron 2.5 8 0 0 0 0 
Trifluoride 
RE 25 8 0 0 0 0 
250 8 0 0 0 0 
500 8 1 1 1 1 
2500 8 0 0 0 0 
RE 2.5 8 0 0 0 0 
25 8 0 0 0 0 
250 8 1 1 1 1 
500 8 1 1 1 1 
2500 8 0 0 0 0 
Saline Controls 8 0 0 0 0 
* all preparations given in 0.5 ml saline 
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III. EXPERIMENTS DESIGNED TO STUDY THE IMMUNOGENIC PROPERTIES 
Q[~ SALMONELLA TYPHIMURIUM ENDOTOXOID PREPARATIONS 
A. Preparation of ~ challenge inoculum reference standard from ~ 
strain of ~. typhimurium. 
The expected efficacy of the various vaccine preparations in 
humans depends upon an experimental design consisting of a prescribed 
method of immunization of mice followed by parenteral challenge. In 
order to standardize as nearly as possible the challenge inoculum of 
~. typhimurium to be used against the various vaccine preparations, 
the following experiment was performed. The challenge dose was prepared 
by harvesting an 18 hour tryptose-phosphate agar slant in PF water, 
standardizing the suspension turbidimetrically by employing the 
turbidity reference standard (DBS, NIH) and confirming the challenge 
numbers by subsequent viability counts employing one ml portions diluted 
10-6 through 10-9. The data shown in Table 14 suggest that the proper 
dilution permitting a plate count is in the range of 10-7• Thus, 
each ml contained approximately 133 x 107 organisms. The mouse virulence 
of the 10-1 through 10-4 dilutions of ~. typhimurium, as shown in 
Table 15, was ascertained by ip injection of 0.5 ml employing PF 
water suspensions of the organisms. Employing the protocol of the 
U. S. Department of Health, Education, and Welfare for typhoid fever 
vaccine indicated that the 10-1 dilution will kill all of the mice 
injected within a 3 day period. Moreover, it can be seen from Table 15 
that an approximate MLD was obtained only for the 10-1 and 10-2 dilutions 
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TABLE 14 
AVERAGE VIABLE PLATE COUNTS AFTER 24 HOURS 
INCUBATION AT 370 C 





* calculated from 3 plates per dilution 
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TABLE 15 
VIRULENCE TESTS IN MICE EMPLOYING THE FOLLOWING 
DILUTIONS OF SALMONELLA TYPHIMURIUM 
No. of bacteria No. of Cumulative Deaths, in Days 
Dilution per mouse ip* Mice 1 2 3 4 5 6 7 
10-1 6.65 x 107/0.5 IIl1 10 9 10 10 10 10 10 10 
10-2 6.65 x 106/0.5 ml 10 2 5 6 8 9 9 9 
10-3 6.65 x 105/0.5 ml 10 1 1 2 5 6 7 7 
10-4 6.65 x 104/0.5 IIl1 10 1 1 1 1 4 6 6 
Control PF water/O.5 ml 10 0 0 0 0 0 0 0 
* from Table 14 where undiluted suspension contained approximately 
133 x 107 org./ml 
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in a 7 day period. The LDSO determination employing the 72 hour end-
point for mortality was calculated by the method of Reed and Muench 
(1938) as shown in Table 16. It can readily be seen that the LDSO 
dilution for this particular experiment was equal to the 10-2•4 
dilution. That is, the ip injection of 2.66 x 106 ~. typhimurium 
organisms per 0.5 ml into 10 mice should kill so% of them within 72 
hours. 
In order to further evaluate the above 1OSO calculation, the 
same data (Table IS) were subjected to the probit (LOSO) method of 
Miller and Tainter (1944). Table 17 shows the probit values corresponding 
to the respective mouse deaths for each dilution. These data are 
depicted graphically in Figure 1 showing both the LDSO (probit S) and 
the 10LDSO (probit 6) doses. Thus, it can be seen from this graph 
that there is good agreement with both methods in determining the 
LDSO as well as the 10LDSO dose response. 
B. The immunogenic effect of HP vaccine preparation in ~ against 
~ LDSO !n[ ~ 10LD50 challenge 2f ~o typhimurium. 
The following experiment was carried out in order to evaluate the 
protective capacity of the HP vaccine, as well as the challenge assay 
procedure, against both an LDSO and a 10LDSO challenge of ~. typhimurium. 
Two groups of mice were immunized with the HP vaccine by sc injection 
with two O.S ml doses (900 x 106 org./O.S ml) at 7 day intervals. 
In addition, one group of mice served as controls receiving only sc 








DETERMINATION OF THE LD50 WITHIN A 3 DAY PERIOD 
BY THE METHOD OF REED A ND MUENCH 
No. of bacteria Died Survived Cumulative Values 
per mouse ip* Died Survived Ratio 
6.65 x 107/0.5 m1 10 0 19 0 19/19 
6.65 x 106/0.5 m1 6 4 9 4 9/13 
6.65 x 105/0.5 m1 2 8 3 12 3/15 
6.65 x 104/0.5 m1 1 9 1 21 1/22 
* from Table 14 where undiluted suspensions contained approximately 
133 x 107 org/m1 
Calculations: 
a) 
b) Negative log of 1050 titer ~ negative log of dilution plus 
proportionate distance above 50% mortality. Therefore, the 
negative log of the 1OSO titer = 2.0 + 0.4 = 2.4 ~ the 1050 
titer = 10-2•4 • 
c) LDSO titer of 10-2•4 is also equal to the following number of 








DETERMINATION OF THE LD50 AND 10LD50 CHALLENGE WITHIN A 
3 DAY PERIOD BY THE METHOD OF MILLER AND TAINTER 
Dilution Mortality Ratio * 
10-1 10/10 100 
10-2 6/10 60 
10-3 2/10 20 




Calculation of the S.E.LD50: 
Probit 5 (LD50) ~ 10-2•4 = 2.66 x 106/0.5 m1 
Probit 6 ~ 10-1•25 = 3.73 x 107/0.5 ml 
Probit 4 ~ 10-3•38 = 2.77 x 105/0.5 m1 
2S = p6-P4 = 367.2 x 105 

































immunized mice as well as the group of saline control mice were 
challenged ip with approximately 10LDSO doses, whereas the second 
group of immunized mice received an LDSO challenge dose. From Table 
18, it can be seen that by employing the DBS criteria for recording 
mortalities (3 days), both groups of immunized mice were protected 
against their respective challenges. However, the saline control 
mice show mortalities of greater than 90% in the same 3 day period 
thus indicating good agreement with the estimate of a 10LDSO response. 
It is of interest to note that after 3 days, the cumulative deaths of 
the immunized mice challenged with the 10LDSO dose showed a marked 
increase in mortality on the fourth day, whereas the immunized mice 
challenged with an LDSO dose were protected through the sixth day. 
c. ~ immunogenic effect of potassium periodate RE, RE, and HP 
vaccine perparations in mice against ~ 101050 challenge of ~. typhimurium. 
Since it was shown in the previous experiment that a 10LDSO 
challenge dose gave a reproducible endpoint within the 3 day observation 
period, it was decided to employ this dose for all challenge experiments 
involving the various vaccine preparations. Table 19 shows results 
obtained with four groups of mice immunized with potassium periodate RE, 
RE, saline, and HP vaccine preparations, respectively. Each animal 
received 2 sc injections, 7 days apart, containing an arbitrarily 
arrived at dose of 100 ug/O.S ml since <200 ug of the potassium 
periodate RE preparation was found to be the approximate MPD in rabbits 
(see Part I of the Experimental Results). All groups of mice, including 
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TABLE 18 
EFFECT OF IMMUNIZATION OF HP VACCINE PREPARATION IN MICE AGAINST AN 
LD50 AND A 10LD50 CHALLENGE OF SALMONELLA TYPHIMURIUM 
Treatment. No. of bacteria No. of Cumulative Deaths, in Days 
0,,5 ml, sc + per mouse ip* Mice 1 2 3 4 .5 6 7 
Immunized 3.73 x 107/0.5 ml 20 0 0 1 14 16 18 19 
(HP vaccine) (lOLD,O) 
Immunized 2.66 x 106/0., ml 17 0 0 0 0 0 8 13 
(HP vaccine) (LD,O) 
Non-immunized 3.73 x 107/0.5 ml 25 19 22 23 24 25 25 2.5 
Saline Controls (lOLD,O) 
+ 2 injections 7 days apart 
* challenged 7 days from last injection 
TABLE 19 
EFFECT OF IMMUNIZATION OF POTASSIUM PERIODATE RE, RE, AND HP VACCINE 
PREPARATIONS IN MICE AGAINST A lOLD50 CHALLENGE OF SAIMONELLA TYPHIMURIUM • 
Treatment Immun<;> No. of Cumulative Deaths, in Days 
005 ml, sc+ Dose Mice 1 2 3 4 5 6 7 
Potassium 100 ug 20 12 14 17 19 20 20 20 
Periodate (5:).05)1 (S:).05) 
RE (HP:(.Ol) (HP:<.Ol) 




19 0 0 0 5 6 9 11 (S:(.Ol) (S:<.Ol) 
Saline 
--
20 16 19 19 20 20 20 20 
• challenged ip 7 days from last injection with approximately 3.32 x 107 org./0.5 ml 
+ 2 injections 7 days apart 





the saline control group, were challenged one week after the last immunizing 
injection with an approximate 10LD50 of .§.. typhimurium. By employing 
the DBS criteria of recording lethalities over a 3 day period, it can 
be seen in Table 19 that the HP vaccine immunized mice show the best 
protection followed by the parent RE and potassium periodate RE preparations, 
respectively. These data show that for all practical purposes the 
potassium periodate (oxidation) procedure destroys vaccine immunogenicity. 
It can be seen that at the 100 ug immunizing dose level there is an 85~ 
mouse mortality within the 72 hour observation period which correlates 
well with the saline control mice mortality of greater than 90%. That 
is, both groups are responding to the 10LD50 challenge within the 3 day 
observation period. Further evidence that the periodate procedure 
destroys mouse immunogenicity is seen also with the parent RE preparation 
in Table 19. When compared to this vaccine preparation under similar 
conditions, it is obvious that the procedure of periodation has a 
deleterious effect on the immunogenicity of the parent RE preparation. 
Statistical treatment of the above data, as well as all subsequent 
challenge data, by chi-square analysis (Mainland, Herrera, and Sutcliffe, 
1956) suggest with confidence that the potassium periodate procedure 
destroys immunogenicity. The difference in protective capacity between 
the periodate vaccine preparation and the saline (S:) control mice at 
both the third and seventh day of the observation period, as shown in 
Table 19, indicates no level of protection. However, when the periodate 
preparation was compared with the HP vaccine (HP:) preparation on the 
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same days of observation the results were significant at the one per 
cent level. That is, the mouse protection afforded by the HP vaccine 
compared to the potassium periodate RE vaccine preparation was 
significantly different. 
D. .Ih! immunogenic effect of ~-RE, RE, Boivin, ~ HP vaccine 
preparations in mice against ~ 10LDSO challenge of ~. typhimurium. 
The data in the next two tables (Tables 20 and 21) show results 
of groups of mice immunized with the Acet-RE, RE, Boivin, saline, and HP 
vaccine preparations, respectively. Each animal received 2 sc injections, 
7 days apart, with the amounts shown under the column headed Immunizing 
Dose. The immunizing doses of 100 and 200 ug/O.5 ml for the various 
preparations shown in both tables were arbitrarily arrived at since, 
as mentioned earlier in Part I of the Experimental Results, < 200 ug of 
the Acet-RE preparation was found to be nonpyrogenic in rabbits. All 
groups of mice, including the saline control group, were challenged 
one week after the last immunizing injection with an approximate 10LD50 
dose. 
By employing again the DBS criteria of recording deaths over a 
3 day period, it can be seen in both of these tables that the HP vaccine 
provided the best protection when compared to the respective saline 
control mice as well as the mice immunized with 100 ug dose amounts. 
Of the latter, as shown in Table 20, the Boivin preparation immunized 
mice show the greatest protection followed by the RE and Acet-RE vaccine 
preparations, respectively. However, as shown in Table 21, the deaths 
TABLE 20 
EFFECT OF IMMUNIZATION OF ACET-RE, RE, BOIVIN, AND HP VACCINE PREPARATIONS IN MICE 
AGAINST A lOLD50 CHALLENGE OF SALMONELLA TYPHIMURIUM * 
Treatment Irmnun .. No" of Cumulative Deaths, in Days 
0 .. 5 m1, sc+ Dose Mice 1 2 3 4 5 6 7 
Acet-RE 100 ug 20 10 13 13 15 18 18 18 
(5:<.01)# (S:).05) 
(HP:( .01) 
RE 100 ug 20 2 11 11 15 17 18 18 
(S:(.Ol) (S:).05) 
Boivin 100 ug 19 3 5 7 11 15 16 17 
(S:(.Ol) (S:).05) 
HP -- 20 0 0 1 6 9 13 16 
(S:(.Ol) (S:).05) 
Saline -- 20 17 20 20 20 20 20 20 
-- L....--. 
-
* challenged ip 7 days from last injection with approximately 3.47 x 107 org./0.5 m1 
+ 2 injections 7 days apart 




EFFECT OF IMMUNIZATION OF ACET-RE, RE, AND HP VACCINE PREPARATIONS IN MICE AGAINST 
A 10LD50 CHALLENGE OF SALMONELLA TYPHIMURIUM * 
Treatment Immuno No& of Cumulative Deaths, in Days 
0.5 ml, sc+ Dose :tvlice 1 2 3 4 5 6 7 
Acet-RE 200 ug 20 1 2 7 10 17 20 20 (S:(.Ol)# (S:).05) 
(HP:).05) 
RE 200 ug 19 1 1 4 9 12 15 17 (S: <.01) (S:).05) 
HP -- 20 1 1 2 5 8 
1
3J( 15 sa1i~e __ J (S:(.Ol) (S:>.01-(.05) -- 20 ~6 18 20 20 20 20 20 
~ 
* challenged ip 7 days from last injection with approximately 2.95 x 107 org./0.5 ml 
+ 2 injections 7 days apart 




recorded over a 3 day period in mice immunized with two 200 ug (two times 
the MPD) doses using the same Acet-RE vaccine preparation indicate a 
good protective effect when compared to the saline immunized mice 
following challenge. Moreover, these results seem to correlate well with 
the results obtained with the HP vaccine immunized mice challenged with 
the same 10LDSO dose. Further evidence of this correlation between the 
Acet-RE and HP vaccine preparations was shown by chi-square analysis. 
Although both of these preparations show Significant protection at the 
one per cent level when compared to the saline control group after 3 days, 
the mouse protection between the Acet-RE and HP vaccine preparations 
was not significant (HP:).OS). Thus, under the conditions of these 
experiments, the 200 ug immunizing dose of the Acet-RE vaccine prepar~ 
ation, but not the 100 ug dose, yielded results not significantly different 
from those obtained with HP vaccine. 
It is interesting to note that no significant difference in mouse 
protection occurs with either the RE or the Acet-RE vaccine preparations 
(Tables 20 and 21) throughout the observation period, whereas similari-
ties in mouse protection with the Boivin and HP vaccine immunized mice 
are apparent only during the first 4 days. Moreover, the results with 
the saline controls suggest a reliable 10LDSO challenge dose response in 
both experiments during the first 24 hours. Therefore, it is apparent 
that all of the vaccine preparations are showing some protection when 
compared to the controls during the first few days of the observation 
period. This impression is supported by chi-square analysis of the data 
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at both the third and seventh day after ip challenge. 
E. The immunogenic effect employing various concentrations of ~~-
S! vaccine preparation in mice against ~ 10LD50 challenge 2£~. typhimurium. 
The data in previous experiments indicate that the MPD of the 
Acet-RE preparation is approximately 100 ug and the minimal immunogenic 
dose (MID) is 200 ug. The question was asked whether prolonged immunization 
of mice employing the MPD or lessor amounts of the same Acet-RE prepar-
ation might yield significant protection against challenge. In this 
experiment, seven groups of mice were immunized in the manner shown 
in Table 22. The effect of 3 weekly immunizations in mice employing 
50 and 100 ug doses of the Acet-RE vaccine preparation followed by 
approximate 101050 challenge 7 days after the last immunizing dose is 
shown in Table 23. Although the single and three weekly 50 and 100 ug 
immunizing doses yielded little or no protective effect at the end of 
72 hours, there is some protection when compared to the control mice 
receiving saline. However, when compared to either of the HP vaccine 
immunized mice, the 100 ug amount of the Acet-RE vaccine preparation 
is still less effective in its protective capacity in mice at the critical 
3 day observation period. Treatment of these data by chi-square analysis 
and comparison of the various Acet-RE preparations with either the saline 
control mice or the HF vaccine immunized mice lend further support to 
these observations. That is, the level of significance of the difference 
in the vaccine preparations at 72 hours with three weekly so injections 
of either 50 or 100 ug dose amounts of the Aoet-RE preparation when 
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TABLE 22 
MOUSE IMMUNIZATION SCHEDULE 
Mouse Immunizing Weeks before challenge 
Group Dose * 3 2 1 
1 50 ug Acet-RE 
2 50 ug Acet-RE Acet-RE Acet-RE 
3 100 ug Acet-RE 
4 100 ug Acet-RE Acet-RE Acet-RE 
5 9 x 108 org. HP 
6 9 x 108 org. HP HP 
7 Saline 
* each immunizing dose injected subcutaneously in a volume of 0.5 ml 
TABLE 23 
EFFECT OF IMMUNIZATION EMPLOYING VARIOUS CONCENTRATIONS OF AN ACET-RE VACCINE 
PREPARATION IN MICE AGAINST A lOLD50 CHALLENGE OF SAIMONELLA TYPHIMURIUM * 
Treatment Immun. No. of Cumulative Deaths, in Days 
0.5 m1, sc Dose Mice 1 2 3 
Acet-RE1 50 20 16 17 20 
(5 :>.05)# 
(HP2:(.01) 
licet-RE3 50 20 9 11 12 (S: .01) 
(HP2:(.01) 
Acet-RE1 100 18 6 11 16 
(S:).05) 
(HP2:(.01) 













20 14 18 20 
-
lone injection 7 days before challenge 
2 two injections 7 and 14 days before challenge 
3 three injections 7, 14 and 21 days before challenge 





























compared to the saline immunized mice is at the one per cent level. 
In addition, these same preparations when compared to the HP vaccine 
are also significant at the one per cent level indicating that this 
latter vaccine is, under the conditions of this experiment, still more 
protective in mice. It is interesting to note from Table 23 that after 
? days of challenge none of the vaccine preparations have capacity to 
protect mice. 
F. The immunogenic effect emploYing two 100 !y! immunizing doses per 
~ (total 400 !y!) of the Acet-RE vaccine preparation in ~ against' 
~ 101050 challenge of ~. typhimurium. 
In the experiment to be described, four groups of mice were 
immunized in the manner shown in Table 24. The 100 ug dose of the 
Acet-RE vaccine preparation was again arbitrarily selected for this 
mouse protection experiment since <200 ug of this same preparation was 
found previously to be nonpyrogenic in rabbits (Part I, Experimental 
Results). All groups of mice, including the saline treated control 
grouB were challenged with an approximate 101050 one week after the 
last immunizing injection. By employing the DBS criteria of recording 
lethalities over a three day period, it can be seen in Table 25 that 
there is no significant difference in protection between the mice 
immunized with one weekly 100 ug dose and mice immunized with two per 
week 100 ug doses of the Acet-RE vaccine preparation. That is, there is 
no significant protection in mice receiving a total of 200 ug as compared 
to 400 ug immunizing doses over a two week period followed by the same 
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TABLE 24 
MOUSE IMMUNIZATION SCHEDULE 
Mouse Immunizing Days before challenge 
Group Dose * 18 14 11 7 
1 100 ug Acet-RE Acet-RE Acet-RE Acet-RE 
2 100 ug Acet-RE Acet-RE 
3 9 x 108 org. HP HP 
4 Saline 
* each immunizing dose injected subcutaneously in a volume of 0.5 ml 
TABLE 25 
EFFECT OF IMMUNIZATION EMPLOYING TWO 100 ug IMMUNIZING DOSES PER WEEK (TOTAL 400 ug) 
OF AN ACET-RE VACCINE PREPARATION IN MICE AGAINST A 10LD50 CHALlENGE OF SAlMONELLA TYPHIMURIUM* 
~ 
Treatmant Immun. No. of Cumulative Deaths, in Days _. 
0.5 ml, se Dose Mice 1 2 3 4 5 6 7 
Acet-REI 100 ug 19 3 6 12 13 16 17 18 (S: .01)* (S:).05) 
(HP:(.Ol) 
Acet-RE2 100 ug 20 5 12 14 17 18 20 20 
(S:.05) (5:>.05) 
(HP:(.Ol) 
HP2 I 18 0 0 0 2 6 11 r 12 i --
I (5:(.01) (8:) .01-(.05) 
5aline2 t -- 20 15 19 20 20 20 20 20 i 
-
* challenged ip 7 days from last injection with approximately 2.13 x 107 org.10.5 ml 
1 two weekly injections over a two week period - 4 injection total 
2 one weekly injection over a two week period - 2 injection total 




10LD50 challenge. Although there is good evidence of mouse protection 
with these two Acet-RE preparations when compared with the saline 
control mice (S:Ol and 5:05, respectively), these same vaccines when 
compared to the HP vaccine show little protective effect (HP: <.01 
and HP:(.Ol, respectively). Moreover, the mouse protective data seven 
days after challenge show that both the immunizing doses of the Acet-RE 
preparation (S:).05) have diminished protective capacity in mice when 
again compared to the HP vaccine (S:).Ol -(.05). Thus, the cumulative 
deaths recorded on post-challenge days 5, 6, and 7 suggest that all of 
the vaccine preparations, including the HP vaccine, were less effective 
in mice four or more days after challenge. This latter observation 
has been consistently observed with all our vaccine preparations. 
G. ~ immunogenic effect employing two weekly 500 ~ immunizing doses 
(total 1,000 ~) of ~ ~-RE vaccine preparation ~ ~ against ~ 
10LDSO challenge of ~. typhimurium. 
Since all previous results indicated that the HP vaccine is more 
protective in mice against a 10LD50 challenge than any of the Acet-RE 
immunizing doses employed (50, 100, 200 ug), the hypothesis that the 
Acet-RE vaccine preparation is not as immunogenic as the HP vaccine 
was examined. That is, rather than relying on the approximate MPD of 
the Acet-RE preparation as the MID to employ in mouse immunization 
experiments, the following considerations suggested other possibilities. 
Approximately 1 mg of wet bacteria contains 109 bacterial cells (Oginsky 
and Umbriet, 1959). The HP vaccine employed in our active mouse 
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immunization experiment contains approximately 900 x 106 bacteria per 
0.5 mI. This value suggests that our mice are receiving anywhere from 
500 to 1000 ug per immunizing dose, whereas our Acet-RE preparations 
have been used only in 50, 100 and 200 ug/0.5 ml immunizing doses 
since the MPD of this preparation is approximately 100 ug. Thus, the 
difference in vaccine strength between these two vaccines may be 5 to 10 
times and, on a weight basis, we may be administering 5 to 10 times 
more of the HP vaccine than of the Acet-RE preparation. On the basis 
of this reasoning the following experiment was carried out. To test 
both the HP and Acet-RE vaccines at approximately equivalent concentrations 
and compare their respective immunogenic capacities under similar 
conditions, two weekly 500 ug mouse immunizing doses of the Acet-RE 
as well as the HP vaccine were given followed 7 days later by a 10LD50 
challenge of £. typhimurium. 
The results shown in Table 26 support the above hypothesis that 
there is a factor of approximately 5 to 10 in vaccine strength between 
the two vaccines. That is, there appears to be no significant difference 
in mouse mortality either at the 3 day or 7 day observation period. 
These data suggest that the difference between the MPD (100 ug) and 
the effective immunogenic dose (EID) (500 ug) is approximately 5 to 10 
in rabbits and mice, respectively. In other words, it takes approximately 
5 to 10 times the MPD of the Acet-RE preparation to give an immunogenic 
dose (EID) equal to that of the HP vaccine. 
TABLE 26 
EFFECT OF IMMUNIZATION EMPlOYING TWO WEEKLY 500 ug IMMUNIZING DOSES (TOTAL 1,000 ug) 
OF AN ACET-RE VACCINE PREPARATION IN MICE AGAINST A lOLDSO CHALLENGE OF 
SAlMONELLA TYPHIMURIUM * 
--'-- . ::=--:.: : ....... 
Treatment Immun. No. of Cumulative Deaths, in Days 
O.S ml, sc+ Dose Mice 1 2 3 4 5 6 7 
Acet-RE SOO ug 20 0 0 3 8 9 11 13 (S:<.Ol)# (S: .01) 
(HP:).OS) 
! I I I 
HF 
--
18 0 0 0 S 8 10 i 13 ! (S:(.Ol) (S:) .01-<.OS) 
Saline 
--
20 16 18 19 20 20 20 20 
* challenged ip 7 days from last injection with app~oximately 3.23 x 107 org./O.S ml 
+ 2 injections 7 days apart 




H. ~ immunogenic effect of potassium methylate RE, boron trifluoride 
RE, RE, ~ HP vaccine preparations in m!£! against ~ lOLDSO challenge 
of ~. typhimurium. 
In this experiment, five groups of mice were immunized with 
potassium methylate RE, boron trifluoride RE, saline, HP vaccine, and 
RE preparations, respectively. Each animal received 2 sc injections, 
7 days apart, containing an arbitrary dose of 100 ugjO., mI. All groups 
of mice, including the saline control groups, were challenged ip one 
week after the last immunizing injection with an approximate 10LD,O 
dose. By employing the DBS criteria (recording deaths over a three day 
period), it can be seen in Table 27 that, with the exception of the 
HP vaccine protected mice, the potassium methylate RE immunized mice 
showed the most protection followed by the RE and BF3 preparations, 
respectively. It is interesting to note that the 100 ug immunizing 
dose of the potassium methylate RE preparation gave approximately twice 
the protection in mice obtained with similar amounts of the BF3' the RE 
and, as elaborated in the Discussion, the Acet-RE immunizing preparations. 
Thus, the cumulative deaths for both the potassium methylate RE and the 
HP vaccine preparations were very similar in their protective capacity 
in mice throughout the observation period, whereas the boron trifluoride 
RE and the RE preparations showed a definite breakdown in mouse immunity 
after 48 hours. The significance of these observations is seen from the 
respective chi-square analysis shown in Table 27 for both the third and 
seventh day after ip challenge. That is, there is no significant 
TABLE 27 
EFFECT OF IMMUNIZATION OF POTASSIUM METHYLATE RE, BORON TRIFLUORIDE RE, RE, AND HP 
VACCINE PREPARATIONS IN MICE AGAINST A lOLD50 CHALLENGE OF SAIMONELLA TYPHIMURIUM * 
.-
Treatment Innnun. No. of Cumulative Deaths, in Days 
0.5 mIt so+ Dose Mioe 1 2 3 4 5 6 7 
Potassium 100 ug 20 2 3 5 8 11 12 13 
Methylate (S:<.Ol)# (S: .01) 
HE (HP:).05) (HP:).05) 
Boron 100 ug 20 7 12 16 19 20 20 20 
Trifluoride (8:).05) (S:>.05) 
RE (HP:<.Ol) 





20 1 1 2 t 5 8 13 15 (S:<.Ol) ! , (S:.05) 
! 
I Saline -- 20 16 18 I 20 1 20 20 20 20 
* challenged ip 7 days from last injeotion with approximately 2.95 x 107 org.10.5 ml 
+ 2 injections 7 days apart 





difference (HP: >.05) in mouse protection between the potassium methylate 
HE and the HP vaccine preparation during the entire observation period. 
On the other hand, the boron trifluoride RE preparation, under similar 
conditions, shows very little mouse protection. Comparing the third 
day data between the saline control and the BF:3 treated mice respectively, 
there is no significant difference. However, compared to the saline 
control mice it is apparent that all 4 vaccine preparations are showing 
some protection (HP > potassium methylate> RE > BF3) during the first 
48 hours of the observation period. 
I. ~ immunogenic effect employing various concentrations of the 
potassium methylate RE vaccine preparation in ~ against ~ 10LDSO 
challenge of §.. typhimurium. 
Since it has been previously shown (Part I, Experimental Results) 
that the MPD of the potassium methylate RE vaccine preparation is 
approximately 10 ug (>1 < 10), an attempt was made to determine whether 
the immunogenic effect in mice is retained by decreasing the immunizing 
dose of this preparation to 2 sc injections containing 10 and 50 ug/0.5 
ml, respectively. Table 28 shows the results of this experiment. Com-
pared to the saline immunized mice following challenge, the 10 ug 
immunizing dose of the potassium methylate RE vaccine preparation 
shows some protection for a 48 hour period following challenge. However, 
the 50 ug immunizing dose of this preparation indicates a definite 
protective effect in mice during the first :3 days of the observation 
period. In addition, these latter results seem to compare favorably 
TABLE 28 
EFFECT OF IMMUNIZATION EMPLOYING VARIOUS CONCENTRATIONS OF A POTASSIUM METHYLATE RE 
VACCINE PREPARATION IN MICE AGAINST A lOLD50 CHALLENGE OF SAIMONELLA TYPHIMURIUM • 
Treatment Immun. No. of Cumulative Deaths, in Days 
0.5 ml, sc+ Dose Mice 1 2 3 4 5 6 7 
Potassium 10 ug 20 8 11 18 19 19 19 19 
Methylate RE (5 :).05)# (5:).05) 
(HP:(.Ol) 
Potassium 50 ug 20 3 5 9 14 18 19 19 




20 0 0 2 7 10 12 13 (5:(.01) (5:.01) 
Saline 
--
20 16 18 19 19 19 20 20 
• challenged ip 7 days from last injection with approximately 2.78 x 107 org./0.5 ml 
+ 2 injections 7 days apart 





with the results obtained with HP vaccine immunized mice challenged 
With the same 10LD50 dose. Chi-square analysis of these data reveal 
that 72 hours after challenge the difference in mouse protection 
between the potassium methylate RE and HP vaccine preparations is highly 
significant (HP: (.01) employing the 10 ug immunizing dose whereas the 
50 ug dose is significant just at the 5% level (HP: .05). These data 
(Tables 27 and 28) suggest that the EID of the potassium methylate RE 
vaccine preparation is approximately 100 ug. However, as previously 
shown and elaborated in the Discussion, these results suggest a ten fold 
discrepancy between the MPD and the possible EID. 
IV. EXPERIMENTS DESIGNED TO STUDY THE IN VITRO 
ANTIGENIC SPECIFICITY OF ~ SAlMONELLA TYPHIMURIUM 
ENDOTOXOID PREPARATIONS 
A. The serological specificity of the various vaccine preparations as 
determined !2z ~ agar gel diffusion ~ (Ouchterlony). 
The follOwing experiments employing the gel double diffusion test 
vIere carried out in order to determine whether an antigen-antibody 
reaction can occur between the altered antigens (endotoxoids) and sera 
obtained from rabbits which had been previously immunized with the parent 
RE preparation (see Part V, Materials and Methods). These studies were 
designed to determine whether certain antigen-antibody identities of the 
various endotoxoids were similar in character. Such findings would 
indicate that the immunogenioity of the parent RE preparation was not 
altered and/or destrqyed by chemical manipulation. Diagrams of the 
results of duplicate experiments can be seen in Figure 2 in which 10 
fold dilutions of the respective endotoxoids were placed in adjacent 
wells around the immune rabbit antiserum (IRS). Under these experimental 
conditions characteristic lines of precipitation occurred with all but 
the boron trifluoride RE and the potassium periodate RE vaccine prep-
arations. These data correlate well with the previous observations that 
both the BF3 and the potassium periodate preparations yielded endotoxoids 
with poor immunogenicity in the active-immunized mouse protection tests. 
Duplicate plates set up with normal rabbit serum (NRS) showed no lines 
of precipitation with any of the endotoxoids tested further supporting 
the validity of these observations. 
In order to characterize the antigen-antibody identities of the 
various endotoxoids further, immunodiffusion tests were set up as 
shown in Figure 3. All antigen preparations, including the Boivin 
antigen, were employed in concentrations of 1 mg/ml and set up in 
duplicate plates placed in adjacent wells around either IRS or NRS. 
Although the potassium periodate or the BF3 preparations show no lines 
of precipitation with either the IRS or the NRS, it is obvious that 
the Boivin, Acet-RE, potassium methylate RE, and RE preparations show 
characteristic identities which appear, in some cases, to be merging 
with one another. Moreover, these results suggest that certain antigenic 
sites were completely abolished as with the boron trifluoride RE and the 
potassium periodate RE preparations, whereas the remaining endotoxoid 
Fig.2 
SEROLOGICAL SPECIFICITY OF THE VARIOUS VACCINE PREPARATIONS AS 
DETERMINED BY THE AGAR GEL DIFFUSION TEST. 
Parent R E Prep. Acet- RE Potassiu m Methy lote R E 
Imglml ImgAnI 
o 
pss 0 ~ 100).l9 
oeo 
pss 0 ~OOJlg eO 
Img/ml 
pss 0 ~IOO}J.g eO 
O.l).1g ° OIO)1g 
IJlg 
Boron Trifluoride R E 
Negative at a II Concentrations 




Potassium Periodate R E 
Negative at all Concentrations 
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Fig.3 
SEROLOGICAL SPECIFICITY OF THE VARIOUS VACCINE PREPARATIONS AS 
DETERMINED BY THE AGAR GEL DIFFUSION TEST. 
B ' . + ,..---~---- OIVIn -----,.c;---. 
Qj O--+-- Potassium Periodate RE +----.f---O 
R E + --t-- 0 ~ 0 Boron Trifluoride R E + €Y 
~~---""CJa'AtJ·, Acet RE +---lot---
'------ Potassium Methylate RE+-----




preparations, with their lines of precipitation, show evidence of either 
alteration and/or incomplete destruction of their respective antigenic 
sites. These observations correlate well with those obtained with the 
v~rious endotoxoids employed in mouse immunization experiments. 
V. EXPERIMENTS DESIGNED TO STUDY THE REPRODUCIBILITY OF THE 
ACETYLATION PROCEDURE IN REGARD TO PYROGENICITY, 
LETHALITY AND ACTIVE MOUSE IMMUNIZATION STUDIES 
A. ! summary of the pyrogen test responses in rabbits employing k2. 
~ ~-~ preparations. 
Two new acetylated-RE preparations (Acet-RE-I and Acet-RE-II, 
respectively) were prepared from the original parent RE £. typhimurium 
preparation. The only departure from the original acetylation procedure 
(see Part III, Materials and Methods) was that the Acet-RE-II preparation 
was acetylated in a boiling water bath for 6 hours instead of the usual 
4 hours and, in addition, instead of grinding the acetylated material by 
mortar and pestle by hand, both of the new acetylated preparations were 
ground to a powder (apprOximately 20 minutes) by employing a motor driven 
mortar and pestle (Fisher Mortar Grinder). This motor driven mortar 
grinder, however, was not employed when triturating with saline to make 
up the stock suspensions (50 ug/IO ml) prior to testing in animals. That 
is, both the Acet-RE-I and the Acet-RE-II stock suspensions were tritur-
a ting in saline suspension employing a hand mortar and pestle. From an 
initial weight of 500 mg, the yields of both the Acet-RE-I and Acet-RE-II 
preparations were 421.8 mg (84.4%) and 406.6 mg (81.3%) respectively. 
Both final products were strongly lyophobic and were granular 
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in appearance. Unlike the original Acet-RE and Acet-RE-I preparations, 
however, the color of the final produot of the Acet-RE-II preparation 
was rust-like instead of light tan in color. Chemical analysis of the 
respective acetyl contents (Australian Microanalytical SerVioe, 
University of Melbourne) as COCH3 (methanolic NaOH used as the saponi-
fication agent) was ll.~ for Acet-RE-I and 10.5% for Acet-RE-II. 
Although the method of preparation, yields and acetyl content 
of these two preparations were generally the same, it was necessary to 
test these preparations, under similar conditions, for pyrogen1city, 
lethality and active mouse-protection. These experiments were 
designed to yield information concerning the reproducibility of the 
acetylation procedure by comparing these data with the data obtained 
from the original Acet-RE preparation. That is, does the acetylation 
of a crude endotoxin prepared by the RE method from a strain of 
§.. typhimurium produce a product t-Ii th consistent biological effects 
with relation to pyrogenicity, lethality and active mouse immunization 
studies? The following animal data (T2bles 29, 30, and 31) indicate 
that the results of acetylation are reproducible. 
The reduction in pyrogenicity exhibited by the three Acet-RE 
preparations is shown in summary form in Table 29. It is interesting 
to note that the two new Acet-RE preparations (Aoet-RE-I and Acet-RE-II) 
both show MPD of 50 ug, whereas the original Acet-RE preparation shows 
a MPD of 100 ug. Moreover, 6 hours of acetylation (Aoet-RE-II) when 
compared to 4 hours of acetylation (Acet-RE and Aoet-RE-I) apparently 
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TABLE 29 
A SUMMARY OF THE PYROGEN TEST RESPONSES IN RABBITS EMPLOYING 
Tl"JO NEw ACET-RE PREPARATIONS 
Aoetyl Content Amounts Pyrogen Test 
% + Tested * Result 
Aoet .. RE 6.8 1.0 
Preparation 10 




Aoet-RE-I 11.7 1.0 
Preparation 10 
(4 hours) 50 
100 + 
500 + 
Aoet-RE-II 10.5 1.0 
Preparation 10 
(6 hours) 50 
100 + 
500 + 
RE 1.0 + 
Preparation 10 + 
* ug/;; ml PFPSS 
+ oaloulated as COCH; 
147 
TABLE 30 
A SUMMARY OF MOUSE LETHALITY RESPONSES EMPLOYING 
TWO NEW ACET-RE PREPARATIONS 
Dose * No. of Cumulative Deaths, 
Preparation (ug). Mice 1 2 3 
Acet-RE 2.5 8 0 0 0 
Preparation 25 8 0 0 0 
(4 hours) 250 8 0 0 0 
500 8 1 1 1 
2500 8 2 2 2 
Acet-RE-I 2.5 8 0 0 0 
Preparation 25 8 0 0 0 
(4 hours) 250 8 0 0 0 
500 8 0 0 0 
2500 8 2 3 3 
Acet-RE-II 2.5 8 0 0 0 
Preparation 25 8 0 0 0 (6 hours) 250 8 0 0 0 
500 8 0 0 0 
2500 8 0 0 0 
RE 2.5 8 0 0 0 
Preparation 25 8 0 0 0 
250 8 0 0 0 
500 8 1 1 1 
2500 8 1 1 1 
Saline Controls 8 0 0 0 
* 

























EFFECT OF IMMUNIZATION EMPlDYING TWO NEW ACET-RE VACCINE PREPARATIONS (ACET-RE-I AND 
ACET-RE-II) IN MICE AGAINST A lOLD50 CHALLENGE OF SALMONELLA TYPHIMURIUM * 
Treatment Immun. No. of Cumulative Deaths,in Days 
0.5 ml, sc+ Dose Mice 1 2 3 4 5 6 7 
Acet-RE 50 ug 20 5 12 14 17 18 19 19 (S: .05)# (S:).05) 
(HP:(.Ol) 
Acet-RE-I 50 ug 20 6 10 16 18 19 19 20 
(S:).05) (S:>.05) 
(HP:<.Ol) 
Acet-RE-II 50 ug 20 10 13 15 19 20 20 20 













19 15 18 I 19 19 19 19 19 
* challenged ip 7 days from last injection with approximately 2.96 x 107 org./0.5 ml 
+ 2 injections 7 days apart 
I P value 
g 
has little or no effect on rabbit pyrogenicity. Thus, it appears there 
is only a two fold decrease in rabbit pyrogenicity with both the 4 
and 6 hour acetylated preparations (Acet-RE-I and Acet-RE-II, respectively) 
when compared to the original Acet-RE preparation. 
These data suggest that the MPD of these acetylated endotoxin 
preparations, when compared to the MPD (1 ug) of the parent RE preparation, 
is )50 <100 ug as interpreted by the USP rabbit pyrogen test. 
B. Ii summary of mouse lethality responses employing .E!2. ~ Acet-~ 
prep!rations. 
Table 30 shows the data from experiments comparing the lethality 
in mice by ip injection of the various acetylated preparations with 
that of the parent RE endotoxin preparation. As noted earlier in 
Part II of the Experimental Results by comparing the parent RE preparation, 
which is apparently non-lethal for mice at the doses shown, with similar 
amounts of Acet-RE preparations suggests that acetylation may induce 
lethality in mice at high concentrations (>500 ug). However, the results 
shown for the Acet-RE-II preparation reveal no mouse lethalities even 
at high concentrations suggesting that 6 hours of acetylation (as 
compared to 4 hours) may aid in altering and/or decreasing the toxic 
portion induced apparently by the 4 hour acetylation prooedure. 
c. .Ih2. immunogenic effect employing ~ ~ .li2.!i ... ~ vacoine preparations 
(.li2.!i-~-1 and .li2.!i-f§.-U) .lll ~ against !. 10LD,O ohallenge .2!. §.. 
tYphimurium. 
Since it had been shown previously that the MPD of the two new 
l5D 
Acet-RE preparations (Table 29) was approximately 50 ug, the following 
experiment shows data employing all of the respective Acet-RE vaccine 
preparations in two weekly sc 50 ug (total 100 ug) mouse immunizing 
doses. In addition, these data, under similar conditions, are compared 
with the HP vaccine as well as with 50 ug immunizing doses of the parent 
HE preparation. All groups of immunized mice, including the saline 
group, were challenged one week after the last immunizing injection 
with an approximate 10LD50 dose. As can be seen in Table 31 and by 
employing the DES criteria of recording deaths over a three day period, 
there is little or no significant difference (3:.05 or >.05) in mouse 
protection with any of the acetylated preparations as well as with the 
parent RE preparation when compared to the saline control mice. Although 
there was very little significant difference in mouse protection with 
any of the Acet-RE vaccine preparations, whether at the 3 or 7 day 
observation period, it can be noted that the overall protection is 
small when compared to the HP vaccine (HP: (.01). That is, there is 
no significant difference in protection throughout the observation period 
with either the saline or any of the Acet-RE immunized mice. 
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DISCUSSION 
The data reported in this dissertation show that treatment of a 
crude endotoxin prepared by the HE procedure from a strain of ~. 
typhimurium with the various chemical procedures described yielded 
certain significant changes in biological activity. Others have 
reported similar data employing a more purified endotoxin as the 
starting material. That is, with the exception of the potassium 
periodate RE preparation, the results obtained with our endotoxoids 
compared favorably with those prepared by others with regard to yield, 
pyrogenicity, lethality, and mouse immunogenicity. Where differences 
do occur, it may be due to the various gram-negative organisms employed 
as well as the "purity" of the respective endotoxins used as starting 
materials. On the other hand, it is interesting to note that under 
similar conditions we have tested an HE and a Boivin preparation from 
an ~. typhimurium strain in rabbits and that both of these preparations 
yielded identical lower limit fever responses of 1.0 ug per rabbit 
(Tables 2, 3 and 10). Since the RE method must represent primarily 
denaturation of bacterial protein, these results suggest that the 
molecular site or sites responsible for fever in rabbits are not altered 
to any great extent when the bacterial cell walls are extraoted with 
TCA as is done in the Boivin procedure. However, molecular sites 
responsible for biological properties other than fever may be subjected 
to alteration upon TCA extraction. Moreover, the effects of physioal 
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and chemical agents on the biological properties of purified entero-
bacterial lipopolysaccharides indicate that the various biological 
activities of bacterial endotoxins are affected differentially by 
different physical and chemical agents (Neter ~ al., 1956). The 
latter concept is also evident in our studies. The results using the 
RE preparation as the parent endotoxin suggest that the molecular site 
or sites were not altered and/or exposed to the same extent as compared 
to the bacterial cell walls which were extracted with the many procedures 
capable of yielding a much "cleaner" preparation of endotoxin. There-
fore, the differences reported that do exist between the endotoxoids 
studied in this thesis and those prepared by others as noted (pps. 69, 
71, and 74 in Literature Review) are not of great magnitude. 
As was pointed out in the Introduction, a main purpose of this 
study was the possible development of a less toxic enteric fever vaccine. 
Each endotoxoid preparation vTas tested for pyrogenici ty in rabbits as 
well as mouse lethality and immunogenicity, and these data were compared 
with similarly obtained parent RE preparation data. With this in mind 
and also for convenience and clarity, each of the endotoxoid preparations 
studied will be discussed in the general order of rabbit pyrogenicity, 
followed by mouse lethality, and then mouse immunogenicity. 
The pyrogen test responses of the respective Acet-RE and the 
potassium periodate RE preparations indicated a > 100 < 200 fold reduction 
in pyrogenicity for both preparations when compared to similar doses 
of parent RE and Boivin preparations. Although these experimental data 
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approximate the upper and lower limits of decrease in pyrogenicity 
under our conditions only, it is of interest to note that the pyrogen 
test results with the Acet-RE preparation compare favorably with those 
reported by Freedman and Sultzer (1962). These investigators noted 
a marked reduotion in pyrogenicity with their acetylated endotoxin 
(fraction p) of 1000 fold and 100 fold, respectively. On the other hand, 
the results obtained with the potassium periodate RE preparation indicated 
a )10,000 ,(50,000 fold reduction in rabbit pyrogenicity when compared 
to the periodate-treated !. coli lipopolysaccharide of Neter and his 
associates (1956). These workers reported that oxidation of their 
~. coli lipopolysaccharide vdth sodium periodate, prepared by the phenol/ 
water method, yielded a compound of low toxicity and marked pyrogenioity 
(MPD .0013 ug/kg). Although the possibility of using potassium periodate 
instead of sodium periodate as the oxidizing agent cannot be discounted 
entirely, the apparent wide discrepancy between the two endotoxin 
preparations, at least with regard to MPD, suggests that the parent RE 
preparation responds more readily to the periodation procedure. The 
difference in "purity" of endotoxin starting material in this particular 
case apparently determines whether the molecular site or sites responsible 
for fever in rabbits will be altered as a result of chemical oxidation. 
Under similar conditions the potassium methylate RE preparation 
showed a reduced fever effect in rabbits, whereas the boron trifluoride 
RE preparation showed no reduction in pyrogenicity when compared to the 
parent RE preparatio~ respectively. Johnson and Nowotny (1964) noted 
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in their pyrogen studies that 1 ug amounts of their preparations 
would eliminate only the second peak in the biphasic fever responses 
with their boron trifluoride preparation causing the most drastic 
reduction in this parameter. In contrast, employing the USP rabbit 
pyrogen test (1961), our data indicate that the potassium methylate 
RE preparation reduced pyrogenicity from 1 ug (parent RE compound) 
to 10 ug per rabbit. However, the BF) preparation showed no reduction 
in pyrogenicity «1 ug) as per USP interpretation. Although our results 
correlate well with those of Johnson and Nowotny (1964), the differences 
that do exist in rabbit pyrogenicity with the various endotoxoids may 
be due once again to the "purity" of the respective parent endotoxins. 
Whereas the latter authors employed a TeA extract from a strain of 
Serr. marcescens as their starting material, we employed an RE prepar-
ation obtained from a strain of ~. typhimurium. 
No enhancement or diminution in mouse lethality of the potassium 
periodate, potassium methylate, and BF) preparations was noted when 
compared to the parent RE preparation. That is, none of these prepar-
ations approached a mouse LD50 with the amounts tested (2,500 ug). 
These results show general agreement ,~th those reported by Neter at al. 
(1956) and those of Johnson and Nowotny (1964) respectively. Neter 
and his coworkers reported that a mouse LD50 value for their sodium 
periodate preparation was approximately )0 mg/kg (or 600 ug per 20 gm 
mouse), whereas Johnson and Nowotny (1964) reported respective LD50 
values for their potassium methylate and BF) preparations of >4,000 ug 
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and> 2,000 ug per mouse. However, the respective parent endotoxin 
mouse LD50 values were 3.0 mg/kg, or 60 ug per 20 gm mouse (Neter !1 !l.), 
and 180 ug per mouse (Johnson and Nowotny) as compared to a mouse LD50 
of)2,500 ug for the RE preparation. The results indicated to Neter 
et!l. (1956), as well as Johnson and Nowotny (1964), that their 
respective procedures were capable of reducing the mouse lethality of 
their parent purified endotoxins. 
Of interest, however, is the finding that the mouse 1050 of both 
the Acet-RE and the HE preparations was also >2,500 ug, whereas Freedman 
and Sultzer (1962), by acetylating a purified endotoxin, showed data 
similar to those reported by the above authors. These investigators 
reported an 1050 response in mice of 250 ug with a Boivin-type endotoxin 
derived from ~. typhosa, whereas acetylation of this same endotoxin 
yielded a mouse LD50 of approximately 2,000 ug. The mouse LD50 of our 
TCA extract of ~. typhimurium was approximately 500 ug which agrees 
favorably with data reported by Freedman and Sultzer. These additional 
observations by Freedman and Sultzer lend support to the idea that the 
molecular site or sites of the RE preparation responsible for mouse 
lethality are apparently "masked". On the other hand, the purified 
endotoxins apparently have their site or sites exposed to such an extent 
that microgram amounts are capable of inducing equivalent LD50 results 
in mice. Anywhere from 10 to 50 times more of the parent RE prepar-
ation ()2,500 ug) is needed to produce the same LD50 response as those 
reported above for the respective purified endotoxins. 
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It is apparent that the above methods of detoxification of crude 
endotoxin prepared by the RE procedure from a strain of ~. typhimurium 
yielded end products which, with the exception of the BF) preparation, 
had reduced fever effects in rabbits as well as reduced toxicity in 
mice. A critical evaluation of the immunogenicity of the respective 
endotoxoids was obtained by employing the active-immunized mouse 
protection test. That is, a readily reproducible method of challenge 
with a 10LDSO dose instead of the usual LDSO dose simplified the problem 
of evaluating immunogenicity of the respective vaccines. The repro-
ducibility of the 10LDSO challenge dose in each of the active mouse-
protection tests shown in Part III of the Experimental Results has 
been remarkably consistent employing these conditions of challenge. 
The saline control mice included in each experiment consistently showed 
a reproduoible 10LDSO response within 72 hours after ip challenge with 
the test strain of ~. typhimurium. Therefore, it was generally assumed 
that protection was dependent on the immunogen and the immunization 
schedule. Furthermore, this was observed in mioe with all of the 
endotoxoid preparations when comparison was made with both the HP vaccine 
and the saline treated mice. 
A comparison of the immunogenic effect in mice of the HP vaccine 
to two subcutaneous 100 ug immunizing doses of the potassium periodate 
(Table 19) as well as the potassium methylate, BF) and RE preparations 
respectively (Table 27) showed that the potassium methylate RE vaccine 
preparation gives the best protection. In contrast, both the BF) 
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and the periodate preparations were the least protective. In addition, 
the potassium methylate preparation showed some protection in mice 
immunized with two weekly subcutaneous doses as low as 10 ug when com-
pared with the saline immunized mice (Table 28). These data strongly 
indicate that the potassium methylate procedure when applied to an RE 
endotoxin preparation greatly increases its antigenicity in mice, 
whereas the respective BF3 and periodate treatments of the same parent 
endotoxin show almost identical decreased mouse antigenicity (Tables 
19 and 27). However, Johnson and Nowotny (1964) reported that, when 
compared to their parent endotoxin, both of their chemical methods 
(BF3 and potassium methylation) resulted in decreased antigenicity 
in rabbits when each of these preparations was given intravenously in 
a single dose of 1 ug. They further reported that the BF3 procedure 
appeared to be more drastic in disrupting antigenicity than the 
potassium methylate procedure. These results were similar to those 
previously published by Nowotny (1963), where it was shown that several 
injections of the BF3-treated preparation into rabbits resulted in 
antibody levels lower than those of the potassium methylate preparation, 
as well as the control endotoxin. In addition, this investigator 
suggested that this BF3 procedure destroyed the 0 antigen determinant 
group (carbohydrates), whereas the potassium methylate procedure 
appeared not to affect this component. Our data, employing these 
preparations as vaccines in mice, show general agreement with these 
observations. In contrast to Johnson and Nowotny's preparations, 
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our potassium methylated RE preparation showed increased antigenicity 
in mice when compared to the parent endotoxin (RE), whereas the BF) 
preparation indicated a decreased antigenicity. Again, these 
differences are probably due to the respective parent endotoxins. 
The effect of decreased antigenicity of the potassium periodate 
RE vacoine preparation suggests that oxidation of the parent HE 
preparation is also destroying or, at least, modifying the specific 
antigenic sites involved in mouse protection. Neter et!l. (1956) 
concluded from their 1n vitro studies that periodate-treated purified 
~. coli lipopolysaocharide had antigenic characteristics whioh were 
markedly altered. They suggested that the amount of periodate used 
up corresponds to 1 c-c-cleavage of every fourth sugar unit, with eaoh 
cleavage resulting in 2 titerable aldehyde groups. With this type of 
severe oxidation, it is not surprising that our potassium periodate-
treated RE preparation is poorly antigenic in mice. 
The protection afforded mioe by the HP vaccine as compared with 
two sc 100 ug immunizing doses of the Aoet-RE, RE, and Boivin vaocine 
preparations (Table 20) suggests once again that the HP vacoine is more 
proteotive against a 101050 ohallenge of ~. typhimurium. On the other 
hand, experiments in mioe employing the Aoet-RE preparation in two sc 
200 ug immunizing doses (Table 21) followed one week later with the 
same 101050 ohallenge, strongly indicates a definite proteotive effeot 
when compared to the HP vaccine. At the end of 72 hours, per DES 
oriteria, the HP vaccine proteoted 95~ of the mice as oompared to 75~ 
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protection in the Acet-RE (200 ug) immunized mice. However, it should 
be noted that all of our endotoxoid vaccine preparations, as well as 
the BoiVin, RE, and HP vaccines, had a diminished protective effect 
in mice 72-96 hours after a 101050 challenge dose. These observations 
were observed consistently and suggest that with our strain of ~. 
typhimurium, the 101050 challenge dose overwhelms the mouse immunity 
by the fourth day since none of the vaccine preparations were pro-
tective to any great extent after 96 hours. 
Of interest also is the apparent similarity between the RE and 
Acet-RE preparations in their protective ability in mice (see Tables 
20 and 21). That is, the acetylation procedure had not destroyed 
the antigenic site or sites to any great extent on the original RE 
preparation. The exact nature of the antigenic site or sites disrupted 
by acetylation as well as the potassium periodate, potassium methylate, 
and BF) procedures, which leads to apparent detoxification, is as yet 
unknown. However, whatever the nature of the antigenic site or sites 
disrupted by these chemical procedures, the method of acetylation held 
the most promise for our purpose of trying to develop a less toxic 
enteric fever vaccine. Although our data indicated that the difference 
between the MPD (100 ug vs 10 ug) and the MID (200 ug vs 50 ug) is 
approximately the same for both the acety1ated and the potassium 
methylate preparations, it was felt that the procedure of acetylation, 
which apparently has the greatest effect on reducing pyrogenioity, should 
be oonsidered further (see below). Furthermore, the results with the 
l6Q 
immunodiffusion tests (Figures 2 and 3) support these observations. 
The acetylated as well as the potassium methylate RE vaccine prepar-
ations, in contrast to the BF3 and periodate preparations, reacted 
specifically with the IRS thus indicating that antigenicity was intact. 
Although the above considerations led us to select the Acet-RE vaccine 
preparation for further study in mouse protection, the observation that 
the potassium methylate RE vaccine preparation demonstrates twice the 
protective response in mice against the same 10LD50 challenge on a 
dose-response relationship must not be overlooked. 
By comparing the protective effect in mice of the HP vaccine 
to one, two and even three weekly sc 100 ug immunizing doses of the 
Acet-RE preparation, it was apparent that the HP vaccine is more 
protective against a similar 101050 challenge of £. typhimurium 
(Table 23). Further evidenoe to support these data is seen in Table 
25, which shows the effect of two per week (total 400 ug) injeotions 
as compared to one weekly injection (total 200 ug) of the Aoet-RE 
preparation both given over a two-week period (Table 24). The apparent 
dose-response effeot with the Acet-RE preparations as determined by 
comparing the respective total mouse immunizing doses of 200 ug with 
400 ug suggests a twofold increase in mouse protection for the first 
few days of the observation period. However, as compared to one week~ 
100 ug immunizing dose given over a three-week period (total 300 ug) 
Tables 22 and 23), the mouse protection afforded with the same dose 
but given in two per week immunizing injections (instead of one) showed 
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less overall protection when challenged with the same approximate 
10LD50 dose. Moreover, the protective effect when compared to the 
HP is also less. On the other hand, there is a protective effect when 
compared to the saline control mice. These data and all previous 
data have indicated that the HP vaccine is more protective than any of 
the Acet-RE immunizing doses employed so far. However, this observation 
may mean that the Acet-RE preparation is weakly immunogenic at the MPD 
of 100 ug. By comparison, the immunizing dose of the HP vaccine 
employed (900 x 106 org./O.5 ml) is a much stronger dose than the 
previously used Acet-RE immunizing doses~ An indication that this may 
be true was noted earlier (Table 21) when an immunizing dose of 200 ug 
was injected sc into mice over a two week period. At the end of the 
three day observation period as per DBS criteria, the HP vaccine pro-
tected approximately 90 to 95% of the mice as compared to 70 to 75% 
protection in the immunized mice receiving two 200 ug (total 400 ug) 
doses of the Acet-RE preparation. Applying this method of comparison 
for testing each of the vaccine preparations but at approximate eqUivalent 
concentrations and comparing their respective immunogenic capaoities 
under similar conditions it was observed that the above assumptions 
(see Part G, Experimental Results) were correct. That is, on a weight 
basis, there appears to be a differential faotor from 5 to 10 in vaooine 
strength between the Aoet-RE preparation and the HP vaccine. That this 
was borne out is seen from the above experiment (Table 26) when two 500 
ug immunizing doses of the Aoet-RE preparation were employed. Mouse 
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protection results were almost identical throughout the entire observation 
period for both the HP vaccine and the Acet-RE preparation against 
the same 10LD50 challenge. Thus, these data suggest that it takes 5 to 
10 times the MPD of the Acet-RE preparation to approach an approximate 
effective immunogenic dose (EID) equal to that of the HP vaccine. 
However, the difference of approximately a 50 to 100 fold reduction 
in rabbit pyrogenicity over that of the parent RE preparation should 
not be overlooked. This observation suggests a less toxic and particu-
larly a less pyrogenic vaccine if it is to be used under the same 
conditions as that of the HP vaccine. 
The reproducibility of the acetylation procedure determined by 
comparing the original Acet-RE preparation data (Tables 29, 30 and 31) 
with the data obtained with the two new Acet-RE preparations (Acet-RE-I 
and Acet-RE-II) has indicated the feasibility of using this method for 
detoxifying the parent RE endotoxin. That is, with regard to rabbit 
pyrogenicity, mouse lethality, and active mouse immunization, the 
acetylation of a crude endotoxin prepared by the RE method from a 
strain of ~. typhimurium produced, in general, consistant biological 
results. However, some discrepancies with regard to both the rabbit 
pyrogen and mouse lethality data are worthy of note. The rabbit 
pyrogen data (Table 29) suggested a MPD of 50 ug for both the Acet-RE-I 
and Acet-RE-II preparations respectively, whereas the original 
Acet-RE preparation, under similar conditions, yielded a MPD of 100 ug. 
These results are of interest when one considers the acetyl contents 
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of the respective acetylated preparations. The acetyl content of the 
two new Acet-RE preparations was approximately double that (I ~ 11.7% 
and II :!!! 10.5%) of the original Acet-RE preparation (6.8%); thus 
suggesting a decrease in pyrogenicity as the acetyl content is in-
creased in the parent RE preparation. As pointed out earlier within 
Part V, Experimental Results section, the changes incorporated with 
the two new Acet-RE preparations were the use of a power-driven mortar 
and pestle for grinding both preparations to a fine powder. In addition, 
the Acet-RE-II preparation was acetylated in a boiling water bath for 
6 instead of 4 hours. It is obvious this latter change in experimental 
procedure has had some effect on the acetyl content between the Acet-RE~I 
and Acet-RE-II preparations respectively but not enough to affect the 
MPD (50 ug) in rabbits. Thus, the apparent two fold difference in MPD 
between the original and the two new Acet-RE preparations is thought 
to be due to the use of the power driven mortar and pestle. Although 
Freedman and Sultzer (1962) reported a reduction in pyrogenicity with 
one of their acetylated Boivin endotoxin preparations as 1000 fold, 
it is interesting to note that a second identical preparation of theirs 
showed a reduction in rabbit pyrogenicity of only 100 fold. These 
authors indicated that their results represented the upper and lower 
limits of decrease in pyrogenicity for all of their preparations. On 
the other hand, our results with acetylated crude RE endotoxin indicate 
(Table 29) a reduction in pyrogenici ty of > 50 < 100 ug. 
Although the effect of 6 hours acetylation (Acet-RE-II), when 
oompared to Acet-RE-I, appears to have little or no effect on either 
the acetyl content or on the MPD in rabbits, it does apparently in-
fluenoe mouse lethality. As noted in the above experiments on mouse 
lethality (Table 30), the effect of 4 hours of acetylation, when 
oompared to the parent RE preparation, may induce an increase in mouse 
tOxicity. This observation was partioularly true with the Acet-RE-I 
preparation which revealed that an ip injection of 2.S mg per mouse 
tended to approximate an LDSO dose, whereas the same injection of 
the parent RE preparation resulted in only one death under similar 
oonditions. This latter observation with the parent RE preparation 
has been consistently observed in several mouse lethality experiments. 
On the other hand, the effect of 6 hours aoetylation (Acet-RE-II) 
apparently reduoed lethality of the material for the mouse. That is, 
no deaths were observed with any of the amounts injected throughout 
the entire observation period. Although these differenoes between the 
two new Aoet-RE preparations appear to be real, it remains to be deter-
mined whether the effect of 6 hours acetylation may aid in altering 
and/or deoreasing the toxicity observed for the 4 hours aoetylation 
prooedure since the parent RE preparation is apparently non-toxio also. 
The immunogenioity in mioe afforded by the two new Aoet-RE 
preparations (Aoet-RE-I and Acet-RE-II, respectively) against a 101050 
challenge of e. typhimurium indicated no significant proteotion with 
either of these preparations when the MPD (50 ug) is employed as the MID. 
Moreover, the mouse protective effects of all the acety1ated as well as 
the parent RE preparations (Table 31) were almost identical. It should 
be noted that this latter observation gives evidence that the above 
alterations in the two methods of acetylation do not appear to alter 
the antigenicity of the parent RE preparation. On the other hand, the 
mouse protection afforded by employing two 50 ug MPD of these acetylated 
preparations as immunizing doses is low when compared to HP vaccine. 
However, as earlier data showed (Table 26) when compared with the HP 
vaccine, the EID with the original Acet-RE preparation is approximately 
5 to 10 times greater than the MPD. Since all of these acetylated 
preparations appear to be identical in their mouse immunogenicity, 
at least at the 50 ug level, it seems not unreasonable at this point 
to assume a similar relation between the HP vaccine and the two new 
Aoet-RE preparations. That is, a current working assumption is that 
the ratio between the EID (500 ug) and the MPD (50 ug) when compared 




Chemical modification of a crude endotoxin prepared by the HE 
procedure from a strain of ~. typhimurium yielded certain significant 
changes in biological activity. The chemical procedures employed 
were oxidation by boron trifluoride and potassium periodate, acety-
lation, and methylation. The results obtained with these endotoxoids, 
with the exception of the potassium periodate RE preparation, compared 
favorably with those reported by other investigators with regard to 
yield, pyrogenicity, lethality, and mouse immunogenicity. Where 
differences occurred these may have been due to the different strains 
of gram-negative organisms employed as well as the "puri ty't of the 
respective endotoxins used as starting materials. 
A main purpose for the use of chemically altered crude endotoxins 
was the possible development of a less toxic enteric fever vaccine. 
Each endotoxoid preparation was tested for pyrogen1city in rabbits as 
well as mouse lethality and immunogenicity, and these data were compared 
with similarly obtained parent RE preparation data as well as standard 
vaccine. 
The pyrogen test results with Acet-RE and the potassium periodate 
RE preparations indicated that these, on a weight basis, were 
approximately 100 times less pyrogenic than the preparations of Boivin 
and parent RE. Under similar conditions the potassium methylate RE 
preparation showed an approximate 10 fold reduction in fever effects 
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in rabbits, and the boron trifluoride RE preparation showed no reduction 
in pyrogenicity. 
No enhancement or diminution in mouse lethality of the potassium 
periodate, potassium methylate, Acet-RE, and boron trifluoride prepar-
ations was noted when compared to comparable doses of the parent RE 
preparation. That is, none of these preparations approached a mouse 
1050 with the amounts tested (2,500 ug). 
Studies were also undertaken to determine immunogenicity in mice 
by comparing Boivin, RE, and the previously mentioned endotoxoid 
preparations with a heat-killed, phenol-preserved (HP) vaccine 
prepared from the same strain of ~. typhimurium. With the exception 
of using 101050 instead of an 1050 challenge, the immunogenicity of 
the respective vaccines was determined for the most part by active-
immunized mouse protection tests as outlined by the Division of Biological 
Standards, Public Health Service. Although two 100 ug immunizing doses 
of the Boivin, RE, and the respective endotoxoid preparations varied 
in mouse protection (potassium methylate RE ) Boivin > RE > Acet-RE > boron 
trifluoride RE) potassium periodate RE), it was obvious, with the 
exception of the potassium methylate preparation, that the HP vaccine 
yielded greatest protection against the 101050 challenge with e. 
typhimurium. Further mouse protection studies indicated the minimal 
immunogenic dose (MID) of the potassium methylate RE vaccine preparation 
to be approximately 50 ug. These data suggested an approximate five 
fold differenoe between the minimal pyrogenic dose (MPD) of 10 ug and 
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the MID (50 ug). 
The procedure of acetylation, which apparently has the greatest 
effect on reducing rabbit pyrogenicity, received major experimental 
attention in the effort to develop a less toxic enteric fever vaccine. 
Active-immunized mouse protection experiments in mice employing the 
Acet-RE vaccine preparation in two 200 ug and 500 ug immunizing 
(pyrogenic) doses indicated a definite protective effect against a 
10LD50 challenge when compared to the HP vaccine. Furthermore, the 
apparent similarity between the parent RE and Acet-RE vaccine prepar-
ations in their protective ability in mice suggested that acetylation 
had not altered immunogenically the antigenic sites to any great extent 
on the original RE preparation. These results indicated at most a 
five fold difference between the MPD in the rabbit and the approximate 
effective immunogenic dose (EID) in the mouse. Results with both 
the Acet-RE and potassium methylate RE vaccine preparations should 
be considered further in the search for a less toxic enteric fever vaccine. 
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RESEARCH PROPOSALS 
1. It has been reported by investigators that endotoxins can 
increase non-specific resistance in the host animal against challenge 
to several types of pathogenic microorganisms. Moreover, the 
acetylation of a Boivin preparation has been reported to have retained 
the property of stimulating non-specific resistance in mice. The use 
of the endotoxoids described should be studied for their effect in 
animals on induction on non-specific resistance. 
2. Hemorrhagic necrosis of tumors in mice may be brought about 
by injection of endotoxins in the animal. The effect of the parent RE 
and the respective endotoxoids should be investigated also for mouse 
tumor necrosis. 
3. Dermal hypersensitivity to endotoxins in both rabbits and guinea 
pigs has been reported by many workers. By employing this biological 
parameter, it would be of interest to determine whether an RE prepar-
ation as well as endotoxoid RE preparations can induce dermal hyper-
sensitivity in the host animal. 
4. Procedures such as double diffusion analysis, immunoelectrophoresis, 
and chromatography should be employed to analyze the sugar and protein 
contents of both the parent RE and the endotoxoid preparations by 
comparing these results with known standards. 
5. The chiok embryo bioassay procedure has been reoently reported 
as an extremely sensitive method for the detection of lethality against 
2 
endotoxin. The lethal effect, if any, of the RE preparation as well as 
the detoxified RE preparations should be investigated employing this 
bioassay procedure. 
6. Comparative determinations of the antibody response in mice 
to immunization by RE preparations andfue associated endotoxoids should 
be carried out. Antibody should be determined by a standard procedure 
as well as methods which will detect nonagglutinating components. 
7. The stability or keeping qualities of any vaccine is significant 
particularly if large volumes are shipped and stored under field con-
ditions. All vaccine preparations mentioned in this thesis should be 
subjected to identical environmental situations for varying periods of 
time and then retested for pyrogenicity, lethality, and immunogenicity. 
8. At present Landy's acetone-inactivated vaccine has shown superiority 
over all other vaccines in protection against typhoid fever as reported 
by the Norld Health Organizatione Since the parent RE preparation 
(alcohol-acetone inactivated) suggests similarity to the acetone-
inactivated vaccine, the possibility of detoxifying the latter vaccine 
should be investigated. 
90 The preparation and immunological properties of detoxified 
bacterial endotoxins prepared by the RE method from a strain of 
Salmonella typhosa should be carried out. 
10. The final test of a vaooine is its ability to protect man 
against typhoid fever with a minimum of systemic reactions. Carefully 
controlled studies employing human volunteers should be attempted 
3 
in order to compare the immunogenicity as well as the side reactions 
with the RE and the most promising of the endotoxoid preparations o 
